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2Abstract
Sound  overstimulation  and  exposure to  ototoxic  drugs  damage  cochlear hair cells 
(HCs)  and cause their death.  The  surrounding  support cells maintain  an  epithelial 
barrier  and  the  appropriate  physiological  environment  for  surviving  HCs  during 
pathological  conditions.  Coordination of this  homeostatic process requires  cellular 
signalling.  However,  the  signalling events that are  activated during damage  in the 
mammalian cochlea, are poorly understood.
Neonatal rat cochlear explants were subjected to mechanical damage or exposed to 
neomycin -  an ototoxin. Mechanical damage triggered the immediate propagation of 
an intercellular wave of increased intracellular Ca2+ from the lesion site into distinct 
cochlear regions.  The properties of the Ca2+ wave and the source of Ca2+ required 
were  specific to the cochlear region.  IP3-mediated release from intracellular stores 
and influx of extracellular Ca2+  contribute  differentially to  the rise  in  intracellular 
Ca2+. The release of extracellular ATP is crucial for the propagation of the damage- 
induced Ca2+ wave.  Gap junctions or connexin hemichannels also contribute to its 
formation.
A  subsequent damage-induced signalling  event is the  transient phosphorylation  of 
ERK1/2  that  arises  within  minutes  of  the  insult  occurring  in  support  cells 
specifically. Similarly to the formation of the Ca2+ wave, release of extracellular ATP 
and  gap  junctions  are  critical  for  ERK1/2  activation.  UTP-induced  activation  of 
ERK1/2 reveals the involvement of P2Y receptors. In addition, a requirement for the 
influx of extracellular Ca2+ also suggests a role for ion channels -  potentially P2X 
receptors. P2 X2,3 ,4 and P2 Y2,4 ,11 receptors were expressed in cochlear explants with 
P2 X2  and  P2 Y2  being  exclusive  to  support  cells.  Damage-induced  currents  were 
recorded  from  Deiters’  cells  in  a  syncytium  during  mechanical  damage  of  the 
cochlea.
Finally,  when  HCs  were  specifically  targeted using  neomycin,  ERK1/2  activation 
occurred  in  support  cells  surrounding  pyknotic  HC  nuclei.  Inhibition  of ERK1/2 
delayed HC death.
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14Chapter 1  -  Introduction
1. Introduction
1.1 Hearing loss and deafness
In the UK, 9 million people are affected by deafness or hearing deficits and 55 % of 
people over the age of 60 are hearing impaired1. Beside inherited forms of deafness, 
sound overexposure, treatment with drugs with ototoxic side effects and ageing are 
the most common causes of hearing impairment.  Modem-life risk factors especially 
for the younger generation are frequent overexposure to loud music in night clubs, at 
concerts and due to the overuse of headphones with personal music devices. Thus it is 
likely  that  people  will  experience  hearing  deficits  at  an  even  earlier  age  and  the 
percentage  of hearing  impaired  people  will  almost  certainly  rise  throughout  the 
coming decades. Hearing loss results most commonly from damage or death of the 
sensory  hair  cells  (HC)  -   the  sound  converting  receptors  in  the  cochlea.  This 
introduction will describe the structure and function of the ear and its hearing organ, 
the cochlea. Subsequently, the cellular and molecular signalling processes that occur 
during drug and noise-induced hearing loss will be described.
1.1.1 Structure and function of the ear
The ear is the entity that enables us to hear and balance and is subdivided into the 
outer,  middle  and inner  ear.  The  outer ear comprises  the pinna and  ear canal  that 
funnel sound waves onto the tympanic membrane, the interface between the outer and 
middle  ear.  The  tympanic  membrane  is  connected  to  the  malleus  -   one  of three 
ossicles in the middle ear cavity.  The malleus links via the incus to the stapes that 
attaches  to  the  oval window  of the  cochlea.  The  cochlea is the  hearing organ and 
together  with  the  organs  of balance  forms  the  inner  ear.  The  balance  organs  are 
comprised of three ampullae of the semicircular canals and two otolith organs,  the 
utriculus and sacculus. The function of all of these organs is based on the presence of 
the mechano-transducing cells -  the HCs. Here the focus will be directed towards the 
structure and function of the cochlea only, as this is the subject of this thesis.
1  information obtained from www.deafnessresearch.org.uk
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A   .__ ,  >----------------------------   Stria vascularis
Scala vestibuli
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Fig 1.1 Cross section of the cochlea
A) Schematic of the cochlear compartments. Fig modified from (Pickles,  1988). Red square 
demarks the organ of Corti.
B)  Structure of the organ  of Corti.  The schematic shows the different cell types of the organ 
of  Corti  and  was  modified  after  Retzius,  1884.  Images  throughout  this  PhD  thesis  are 
presented  in a similar orientation  along the x-axis as x-y (view on top of the epithelium) and 
x-z views.
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The cochlea
The  cochlea  is  compartmentalised  into  distinct  fluid  chambers  that  are  the  scala 
media,  scala tympani  and scala vestibuli  (Fig 1.1 A).  The  scala media differs  in  its 
fluid composition to that of the scala tympani and vestibuli. The fluid within the scala 
media  is  called  endolymph,  and  is  rich  in  K+  and  low  Na+  and  micromolar  Ca2+  
concentrations  and  is  thus  somewhat  similar to  cytoplasmic  ion  concentrations.  In 
contrast, the scala tympani and vestibuli contain perilymph which is alike in its low 
K+,  high  Na+  and  millimolar  Ca2+  concentrations  to  cerebro-spinal  and  other 
extracellular fluids  (Wangemann and  Schacht,  1996).  The  scala media is  separated 
from the scala vestibuli by the Reissner’s membrane whereas the sensory epithelium 
of the cochlea, the organ of Corti resting on the basilar membrane forms an apical 
border of the scala tympani.  The electrogenic  activity of the stria vascularis on the 
lateral  side  of  the  scala  media  generates  an  electro-chemical  gradient  -   the 
endocochlear potential -  across the endo- and perilymphatic fluid compartments. This 
endocochlear potential acts as an electromotive force that drives sound transduction. 
The concerted action of the epithelial barriers of the organ of Corti,  spiral ligament 
and constant activity of stria vascularis maintain this electro-chemical gradient across 
the compartments.
The organ of Corti and hair cells
The  organ  of Corti  consists  of the mechano-transducing HCs  and various types  of 
support  cells  which  contact  the  basilar  membrane  (Fig 1.1B).  In  the  mammalian 
cochlea two types of HCs are present -  the inner (IHC) and outer hair cells (OHCs). 
One row of IHCs and three rows of OHCs are arranged in parallel along the length of 
the cochlea (spiral). Hair cells are characterised by actin-rich membrane protrusions 
at their apical surfaces -  the stereocilia (reviewed in Raphael and Altschuler, 2003). 
These are organised in a staircase-like manner forming a stereocilial  ‘hair bundle’. 
Stereocilia (in the staircase) are joined towards their apical ends by small filaments 
known  as  ‘tip  links’  (Pickles  et al.,  1984).  The hair bundles  of the  entire hair cell 
population  are  orientated  in  a  specific  direction,  with  their tallest  stereocilia being 
most lateral.
At the basal poles of HCs, contacts are established with neurons. 90-95 % of afferent 
type I  spiral  ganglion  neurons  synapse  onto  IHCs  and  send  information  of  the
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transduced  sound  to  the  cochlear  nucleus.  Efferent  fibres  do  not  innervate  IHCs 
directly but instead synapse onto their afferent neuronal dendrites. In contrast, OHCs 
have minimal afferent innervation and are characterised by the active motor-processes 
they exhibit which are thought to amplify and sharpen the sound-induced movements 
of the basilar membrane to enhance the input to IHCs. The OHCs are innervated by 
type II  spiral  ganglion  neurons  but  also  have  efferent  innervation  where  fibres 
synapse directly onto the OHC body.
The organ of Corti and support cells
Different subtypes of support cells are found in the organ of Corti. The support cells 
that surround the IHCs are the phalangeal and border cells whereas those of the OHCs 
are  the  Deiters’  cells.  The  cell  bodies  including  the  nuclei  of the  aforementioned 
support cells are situated beneath HCs and they extend phalangeal processes to the 
surface  of the  epithelium,  the  reticular  lamina  where  they  interdigitate  with  HCs. 
Tight junctions join the apical aspects of support cells and HCs to form the epithelial 
barrier that is essential  for maintenance of the fluid compositions of the  endo-  and 
perilymph. Consequently the apical aspects of HCs and support cells are exposed to 
endolymph whereas their basolateral sites are bathed in perilymph.  Inner and outer 
pillar cells, another type of support cell,  form the tunnel of Corti that separates the 
IHC from the OHC region. In addition to forming epithelial barriers, support cells, as 
their name suggests, give structural  support to the organ and are also thought to be 
involved in maintaining the  ion homeostasis through K+ recycling  (Boettger et al.,
2002).  Gap  junctions  that  are  formed  between  neighbouring  support  cells  are 
suggested  to  partake  in  K+  recycling.  Connexins  are  the  units  that  assemble  to 
connexon hemichannels which form gap junctions when two opposing hemichannels 
meet. Two connexin subtypes are specific to cochlear function and these are connexin 
26 and 30. Cochlear support cells have also been shown to remove neurotransmitters 
such  as  glutamate  (Glowatzki  et  al.,  2006).  In  the  latter  case,  removal  of excess 
glutamate  will  help  to  terminate  signalling  between  HCs  and  neurons  and  to 
re-establish the appropriate environment of HCs for subsequent sound stimuli.
Sound transduction
Sound waves enter the ear via the pinna and ear canal and are channelled onto the 
tympanic membrane which consequently vibrates. A force is thereby transmitted onto
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the middle ear ossicles resulting in their displacement and consequently that of the 
oval  window  of the  cochlea.  This  then  drives  movement of the basilar membrane 
which results in the displacement of IHC hair stereocilia,  stretching of the tip-links 
and  opening  of  the  mechano-transduction  channel  to  drive  a  receptor  potential. 
Movements  of  the  basilar  membrane  will  also  result  in  transduction  in  OHCs. 
Depolarisation and hyperpolarisation of OHCs triggers contraction and lengthening of 
these  cells,  respectively  and this  is  thought to  contribute  to  cochlear amplification 
(reviewed in Pickles,  1988; Holley,  1996).  Some aspects of the processes occurring 
during transduction are discussed in section 1.2 with focus on the role of Ca2+.
1.1.2  Hair cell epithelia and damage
The cochlear is tonotopically arranged to encode high frequency sounds in the base 
and low frequencies towards the apex.  Following exposure to sound of a particular 
frequency only hair cells in a specific region are activated and transduce the sound at 
any given  frequency.  Consequently,  in the majority of cases  sound overstimulation 
results  in  hearing  deficits  according  to  the  environmental  sound  frequencies. 
Depending  on  the  magnitude  and  duration  of the  insult  temporary  or  permanent 
threshold shifts (PTS) can occur.  PTS  is most commonly a result of hair cell death 
(Wang et al., 2002b; Nicotera et al., 2003; Wang et al., 2003a). More severe damage 
can result in the rupture of the epithelium (Wang et al., 2002b).
Aminoglycoside antibiotics such as neomycin and gentamicin to only name a few, or 
neoplastic  drugs  including  cisplatin  also  cause  HC  death.  Until  recently  it  was 
thought that the mode  of entry  of aminoglycosides  was  through  receptor-mediated 
endocytosis (Hashino and Shero,  1995; Hashino et al., 1997). More recently evidence 
for  the  entry  of  aminoglycosides  into  HCs  through  the  mechano-transduction 
channels has been provided (Gale et al., 2001; Marcotti et al., 2005). Once inside the 
cell  they mediate  the  generation  of free radicals  including reactive  oxygen  species 
(ROS, Hirose et al., 1997; Hirose et al., 1999) that are then thought to trigger hair cell 
death  through  apoptosis  and/or necrosis  (Forge  and  Li,  2000;  Pirvola  et al.,  2000; 
Jiang  et  al.,  2006).  ROS  are  also  implicated  in  cell  death  following  noise- 
overexposure.  In  support  of this,  treatment  with  free  radical  scavengers  has  been 
shown to reduce the degree of damage following exposure both to aminoglycosides
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and noise (Garetz et al., 1994; Ohinata et al., 2003). Stress-induced cellular signalling 
triggered by aminoglycosides  or noise results  in the  activation of c-Jun-N-terminal 
kinases  (JNK,  see 1.4.4)  and  caspases  in  HCs.  In  the  mammalian  cochlea  the 
activation  of  several  caspases  has  been  demonstrated  following  noise  damage 
(Nicotera et al., 2003; Jiang et al., 2006). However, evidence is lacking for a role for 
caspases during aminoglycoside induced HC death in the mammalian cochlea (Jiang 
et  al.,  2006)  whereas  their  activation  has  been  demonstrated  in  the  avian  hearing 
organ (Cheng et al., 2003; Mangiardi  et al.,  2004).  Functional  studies  investigating 
the  potency  of  caspase-inhibitors  as  protective  tools  are  only  reported  for 
cisplatin-induced toxicity in the mammalian cochlea.  The degree of cell death  was 
reduced, when caspase activation was inhibited during cisplatin-exposure (Wang et 
al., 2004). Similar results are also demonstrated for the action of aminoglycosides in 
chick and mouse utricles (Cunningham et al., 2002; Matsui et al., 2002; Cunningham 
et al.,  2004;  Matsui  et al.,  2004).  Other signals  such as release of cytochrome c or 
apoptosis inducing factor have been investigated as markers for HC death (Nicotera et 
al., 2003; Mangiardi et al., 2004; Matsui et al., 2004; Han et al., 2006).
1.1.3 Repair of damaged hair cell epithelia
When HCs are damaged or die the surrounding support cells must close the resulting 
wound  to  preserve  the  physiological  environment  for  surviving  hair  cells  (Forge, 
1985;  Raphael  and  Altschuler,  1991;  Leonova  and  Raphael,  1997;  Forge  and  Li,
2000). Moreover, support cells have also been suggested to actively participate in the 
removal of dying/dead hair cells (Li et al.,  1995; Gale et al., 2002; Abrashkin et al., 
2006). Recently, it has been shown that support cells engage in an actin purse string 
mechanism that requires Rho kinase function to mediate the closure of large puncture 
wounds  in  neonatal  mammalian  utricles  in  vitro.  This  mechanism  could  not  be 
effected in adult utricles; the underlying mechanisms are currently unknown (Meyers 
and Corwin, 2007). However, in the adult utricles formation of lamellapodia was still 
observed that could potentially give rise to a slower mechanism for re-establishing the 
epithelial barrier.
In  the  mammalian  cochlea,  if hair  cells  are  lost,  an  epithelial  scar  is  formed  by 
support cells but the area is not repopulated with new hair cells (Forge, 1985; Chardin
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and  Romand,  1995;  Kelley  et  al.,  1995).  However,  there  is  evidence  that  a  small 
number  of new  hair  bundles  are  formed  after  hair  cell  damage  by  gentamicin  or 
neomycin  treatment  in  utricles  both  in  vivo  and  in  vitro.  Both  proliferation  of 
progenitors and the transformation of support cells give rise to the newly generated 
cells (Forge et al.,  1993; Warchol et al., 1993; Rubel et al.,  1995; Forge et al.,  1998). 
In  contrast,  a robust proliferative  response  is  observed  in  avian  hair  cell  epithelia 
following an insult that results in the repopulation of the epithelium with hair cells 
(Corwin and Cotanche, 1988; Ryals and Rubel, 1988). The cells that are stimulated to 
divide  and generate  new hair cells  are the  surrounding  support  cells  (Warchol  and 
Corwin,  1996). In avian utricular epithelial sheet cultures, when serum-withdrawal is 
used  as  the  insult,  phosphoinositol-3 kinase  (PI-3 kinase)  and  extracellularly 
regulated  kinases 1  and 2  (ERK 1/2)  were  found  to  be  critical  signalling  events 
upstream  of the  subsequent  proliferation  (Witte  et  al.,  2001).  In  a  similar  study, 
mammalian utricular epithelial sheet cultures induced to proliferate by recombinant 
human glial growth factor 2, did so in a PI-3 kinase- and ERK 1/2-dependent manner 
(Montcouquiol and Corwin, 2001). It is not known whether these signalling cascades 
are activated following aminoglycoside or noise damage in HC epithelia or whether 
they are critical for a robust regenerative response.
Cell-cell  interactive  signalling events between damaged HCs and their surrounding 
support  cells  likely  trigger  the  wound  closure  that  has  been  observed  in  order  to 
maintain an adequate physiological environment for surviving hair cells. Very little is 
known  about  the  signalling  cascades  that  initiate  and  regulate  the  wound  repair 
program  by  support  cells.  Therefore,  some  of  the  mechanisms  implicated  in 
damage-induced  signalling  in  other  systems  will  be  discussed  in  the  following 
sections  in  the  context  of  their  physiological  function  and  their  role  during 
pathophysiological  events.  Information  will  be  given,  where  appropriate  about the 
knowledge of these processes in HC epithelia.
1.2  Ca2+ function and dysfunction
Ca2+  is  a  second  messenger  that  regulates  many  cellular  processes  including 
metabolism,  proliferation,  differentiation  and  cell  death.  A  variety  of  agonists 
including  neurotransmitters  such  as  glutamate  and acetylcholine  as  well  as  growth
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factors  like  epithelial  growth  factor  (EGF)  elicit  intracellular  Ca2+  signals.  The 
signalling  events  and their  function  are  cell  type  specific.  Thus  in  the  subsequent 
section  aspects  of Ca2+  signalling  and  handling  will  be  discussed  in  the  light  of 
cochlear function. This will be followed by a summary of Ca2+ dysregulation during 
damage, toxicity and cell death.
1.2.1  Ca2+ homeostasis and function in the cochlea
The transduction of sound into neural cues is established at the interface of HCs and 
afferent neurons.  The  processes  that  accomplish  mechano-transduction  in  HCs  are 
regulated by Ca2+ at numerous stages. When stereocilia are displaced during exposure 
to sound mechano-electrical transduction channels open and facilitate the entry of K+  
and Ca2+ into the stereocilia and depolarisation of HCs. If the channels remain open, 
then adaptation and closure of the channels occurs enabled by the influx of Ca2+. In 
addition, sound-induced depolarisation of HCs leads to the opening of voltage-gated 
Ca2+ channels -  specifically Cav1.3 channels. The influx of extracellular Ca2+ through 
these  channels  mediates  vesicular  release  of  glutamate  which  acts  as  the 
neurotransmitter at the afferent synapse. HCs also express Ca2+ activated K+  channels 
-  the BK channels that establish efflux of K+ and thus are part of the regulatory unit 
that  maintains  the  K+  homeostasis.  Another  Ca2+  activated  K+  channel  -   the  SK 
channel  is  known  to  be  expressed by  mature  OHCs.  The  release  of acetylcholine 
(ACh) from efferent neurons projecting onto basal aspects of OHCs results in influx 
of Ca2+ into OHCs via nicotinic ACh receptors and subsequently causes the activation 
of SK channels. The subsequent K+  efflux results in hyperpolarisation of OHCs and is 
thought to be a protective mechanism (reviewed in Housley et al., 2006; reviewed in 
Mammano et al., 2007).
Mediators of Ca—  signalling events
The  previous  section  illustrated  that  Ca2+  is  crucial  at  various  stages  of  sound
transduction  and  to  HC  homeostasis.  Up  to  this  point  extracellular  Ca2+  was  the
21 primary source for the increase in intracellular Ca  . However, Ca  signalling events 
can also be established through the release of Ca2+ from intracellular stores.  Several 
mechanisms are known to trigger the release of Ca2+ from intracellular stores in other 
cellular systems. These include the generation of inositol-3-phosphate (IP3) or cyclic-
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ADP-ribose  (cADPR)  that  act  on  IP3  or  ryanodine  receptors  at  the  endoplasmic 
reticulum, respectively and facilitate Ca2+ release (reviewed in (Berridge et al., 2003). 
More recently,  nicotinic  acid dinucleotide phosphate  (NAADP)  was  also  shown to 
evoke intracellular Ca2+ release. The NAADP receptor has not yet been identified, but 
it has been suggested that it acts on lysosomes to mediate Ca2+ release (Churchill et 
al.,  2002;  Yamasaki  et  al.,  2004).  The  choice  of the  intracellular  elicitor  of Ca2+ 
events  and  thus  the  compartment  is  determined  by  the  agonist  (Yamasaki  et  al., 
2004).
Both  IP3  and ryanodine receptor expression  and  function have been  studied  in the 
cochlea.  RT-PCR  of microdissected pooled  rat  OHCs  and  Deiters’  cell  samples 
revealed the expression of the IP3 receptor subtypes IP3RI to IP3R3 (Lioudyno et al., 
2004).  The  presence  of  IP3  receptors  in  HCs  has  been  confirmed  with  an 
immunocytochemical  approach  in  adult  guinea  pigs  (Mammano  et  al.,  1999). 
Moreover, adenosine triphosphate- (ATP)-induced Ca2+ signals in HCs were reduced 
when  IP3  generation  or binding to  its receptors  were  compromised.  IP3  dependent 
signalling  has  also  been  described  in  cochlear  support  cells  including  Deiters’, 
Hensen and Claudius cells (Mammano et al., 1999; Lagostena et al., 2001; Lagostena 
and Mammano, 2001; Gale et al., 2004). Expression of ryanodine receptor subtypes 
RyRl and RyR3 but not RyR2 was observed in pooled microdissected samples of rat 
OHCs  and  Deiters’  cells  using  RT-PCR  (Lioudyno  et  al.,  2004). 
Immunohistochemical studies revealed the localisation of RyR in OHCs,  IHCs  and 
various  support  cell  subtypes  including  Deiters’  and  phalangeal  cells.  Moreover, 
ryanodine receptors were also detected in neurons (Grant et al., 2006; Morton-Jones 
et al., 2006). In contrast to the study by Lioudyno et al. (2004), an antibody against 
the RyR2  subtype revealed its expression in rat HCs,  Deiters’  and phalangeal cells 
(Morton-Jones et al., 2006). Functional studies also support the presence of ryanodine
I
receptors.  In IHCs, the depolarisation-induced rise of intracellular Ca  at the basal 
pole of the cell was significantly reduced in the presence of an inhibitory ryanodine 
concentration.  The  depolarisation-induced  increase  in  Ca2+  levels  was  abolished  in 
0 Ca2+,  suggesting  that  ryanodine  receptors  were  activated  by  the  influx  of 
extracellular  Ca2+  providing  an  example  for  Ca2+  induced  Ca2+  release  in  the 
mammalian  cochlea  (Kennedy  and  Meech,  2002).  Moreover,  the  ACh-evoked 
activation of SK channels in OHCs is also modulated by ryanodine (Lioudyno et al.,
23Chapter 1  -  Introduction
2004). In contrast to IP3 and ryanodine receptors, at present there is no evidence that 
Ca  release in the cochlea is attributed to the action of NAADP. Taken together, both 
IP3  and ryanodine receptor-mediated Ca2+ release mechanisms  are employed in the 
mammalian  cochlea.  However,  an  understanding  of  their  function  during 
physiological processes is still quite limited.
Regulation of cytoplasmic Ca~ concentrations
The concentration of cytoplasmic Ca2+ has to be tightly regulated in order to maintain 
the function of HCs and preserve their capacity to transduce sounds. As a result there 
have  been  a  number  of  investigations  into  the  mechanisms  that  regulate  Ca2+
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homeostasis  in HCs.  In  contrast,  Ca  signalling  and regulation  in  the  surrounding 
support cells are less well established.
In  HCs,  a  major  Ca2+  efflux  pathway  occurrs  via  the  plasma-membrane  Ca2+ 
ATPases 1-3  (PMCA1-3)  (Dumont  et  al.,  2001).  PMCA4  was  not  observed  in 
cochlear cells (Dumont et al., 2001). HCs are characterised by high expression of the 
PMCA2 at the tip of the stereocilia which coincides with increased efflux compared 
to the baso-lateral aspects of HCs (Yamoah et al.,  1998; Dumont et al., 2001).  The 
deafwaddler mouse exhibits a mutation in the gene for PMCA2 that results in hearing 
and balance impairment (Street et al.,  1998). Recently, this mutant gene and a newly 
identified mutation in the human gene were assessed for their Ca2+ removal properties 
when transfected into CHO cells. Both mutants showed similar peak Ca2+ responses 
to  the  wildtype  PMCA  when  challenged  with  the  P2  receptor  agonist  ATP.  The 
recovery  to  baseline  Ca2+  levels  was  compromised  in  both  mutants,  however  the 
deafwaddler mutant was affected to a greater extent (Ficarella et al., 2007). Beside the 
PMCAs  other  mechanisms  can  facilitate  the  removal  of intracellular  Ca2+.  These 
mechanisms  include  the  uptake  of Ca2+  by  mitochondria  or  into  the  endoplasmic 
reticulum through SERCA pumps (Rizzuto et al.,  ; Boitier et al.,  1999).  In addition 
the extrusion of Ca2+ has also been demonstrated to occur through the action of the 
Na+-Ca2+  exchanger  (reviewed  in  Ishida and Paul,  2005).  In  IHCs,  in  addition  to 
PMCAs,  mitochondria  and  the  endoplasmic  reticulum  have  been  demonstrated  to 
partially  regulate  the  uptake  of Ca2+.  However,  the  Na+-Ca2+  exchanger  did  not 
contribute  to  the  removal  of  Ca2+  following  a  depolarisation-induced  rise  in 
cytoplasmic Ca2+ levels (Kennedy, 2002).
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Ca2+ must not only be removed following signalling events, but depleted intracellular 
stores must also be replenished in order to facilitate subsequent events. The common 
transient  receptor  potential  (trpC)  channel  has  been  suggested  to  fulfil  this  task. 
TrpC3 was recently found to be expressed in guinea pig and rat cochleae; specifically 
in  IHCs  and  OHCs.  Store-operated  Ca2+  entry  occurred  when  the  extracellular 
solution  was  switched  from  Ca2+-free  to  1.5 mM  Ca2+  (Raybould  et  al.,  2007) 
demonstrating  that  these  mechanisms  are  engaged  in  HCs.  It  has  not  been 
investigated whether similar mechanisms act in cochlear support cells.
Ca~ binding proteins and their function in hair cells
The  homeostasis  and  the  function  of HCs  are  also  preserved  and  even  modulated 
through  the  action  of various  Ca2+  binding  proteins.  A  gradient  of Ca2+  buffering 
proteins has been observed along the length of the turtle cochlea when adaptation of 
the  mechano-electrical  transduction  current  was  compared  in  HCs  at  different 
cochlear locations (Ricci et al.,  1998). Recently, the calmodulin-like calcium-binding 
proteins  (CaBPs)  have  been  suggested  to  modulate  Cav1.3  channels  (Yang  et  al., 
2006).  These channels  show  strong  Ca  -dependent inhibition when expressed  in  a 
heterologous  expression  system.  However,  currents  mediated  in  HCs  by  these 
channels do not exhibit this feature. Co-expression of Cav1.3 channels and CaBPl  or 
CaBP4  in  HEK294  cells  abolished  the  Ca2+-dependent  inhibition,  suggesting  that 
HCs might utilise this mechanism (Yang et al., 2006). This hypothesis is supported by 
immuno-localisation studies. CaBPl was found to be expressed in Deiters’ and pillar 
cells as well as in the region of the cuticular plate of OHCs in the adult rat cochlea. 
CaBP4 was also observed localising to OHCs, IHCs, Deiters’ and pillar cells at P9. In 
contrast, at P28 the immuno-labelling was restricted to IHCs only (Yang et al., 2006). 
Other  Ca2+ binding  proteins  such  as  calbindin,  calretinin,  a-parvalbumin  and 
oncomodulin  (p-parvalbumin)  were  detected  in  HCs  of  the  mammalian  cochlea 
(Sakaguchi et al.,  1998; Yang et al., 2004a; Hackney et al., 2005). Deiters’ and outer 
pillar cells also express a-parvalbumin during the first postnatal days (Sakaguchi et 
al.,  1998;  Yang  et  al.,  2004a;  Hackney  et  al.,  2005)  and  these  cells  are  also 
characterised  by  the  abundance  of  the  Ca2+  binding  protein  S-100  (Pack  and 
Slepecky,  1995).  It is not known whether particular Ca2+ binding proteins perform 
specific roles within support cells.
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1.2.2  The role of Ca2+ during damage and cell death
Ca~ homeostasis during toxic events
Ca2+ has been implicated as a regulator in the execution of cell death in various cell 
types including neurons (reviewed in Bano and Nicotera, 2007; reviewed in Hara and 
Snyder, 2007). Dysregulation of Ca2+ concentrations resulting in raised Ca2+ levels in 
the cytoplasm or mitochondria but also those that cause low Ca2+ concentrations in 
the ER, lead to cellular death. Increased intracellular Ca2+ levels were found in cells 
of the  chick  hearing  organ  -   the  basilar  papilla  -   within  30 min  of exposure  to 
gentamicin  (Hirose  et  al.,  1999).  A  different  study  observed  a  similar  rise  in 
intracellular Ca2+  levels  in  response  to  1  mM  neomycin  in  cells  of chick utricular
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epithelial  cultures  (Matsui  et  al.,  2004).  In  addition,  a  substantially  larger  Ca 
response that lasted between 30 to 120 min was recorded after ~ 4 hrs of exposure to 
neomycin (Matsui et al., 2004). These studies did not directly address whether Ca2+ is 
the messenger that initiates the death signalling cascades in HCs. However, HC death 
was not prevented in gentamicin treated organ of Corti explants from guinea pigs that 
were  pre-incubated  with  the  Ca2+  chelator  Quin-2  AM  (Dehne  et  al.,  2002).  The 
simplest  explanation  is  that  Ca2+ is  not  involved  in  apoptosis;  however,  the  cells 
might not be protected for a number of reasons: i) the Ca2+ homeostasis of cells in the 
presence of a Ca2+ chelator is certainly impaired and ii) the Ca2+ buffering capacity by 
Quin-2 may have been overloaded. In the ear, increased intracellular Ca2+ levels have 
not been directly linked to the mechanisms that underlie HC death. In other cellular 
systems,  proteases  such  as  caspases  and  calpains  are  activated  and  facilitate 
breakdown  of proteins  during  cell  death.  Both  caspases  and  calpains  have  been 
implicated during aminoglycoside and cisplatin induced HC death (Ding et al., 2002; 
Cunningham et al.,  2004;  Matsui  et al.,  2004;  Wang et al.,  2004).  These proteases 
have been  shown to  cleave the  PMCA  and Na+-Ca2+  exchanger during  excitotoxic 
events in neurons resulting in dysfunction of these elements crucial for maintenance 
of  intracellular  Ca2+  homeostasis  (Schwab  et  al.,  2002;  Bano  et  al.,  2005). 
Consequently, cells experience elevated Ca2+ concentrations and undergo cell death. 
Increased  Ca2+  also  acts  on  various  other  enzymes  including  protein  phosphatases 
such as calcineurin.  Pharmacological studies  implicate a role  for calcineurin during 
noise-induced hearing loss (Minami  et al., 2004).  Calcineurin  is a phosphatase that 
among other roles mediates dephosphorylation of BAD -  a pro-apoptotic member of
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the Bel family. Dephosphorylation enables BAD to translocate from the cytoplasm to 
mitochondria where it promotes apoptosis (Wang et al., 1999). These are only a small 
number of examples  from the vast network of Ca2+ dependent processes occurring 
during cell death and more continue to be added.
Mechanical stimulation and Ca~ waves
Beside chemical damage, mechanical stimulation has also been shown to elicit a rise 
in intracellular Ca2+ that travels as an intercellular Ca2+ wave through cell layers in 
various cell culture models, including airway epithelial and glial cells (Sanderson et 
al.,  1990;  Charles et al.,  1991).  Ca2+ waves have also been described to propagate 
between glial cells in retinal organ preparations (Newman and Zahs,  1997; Newman,
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2001). The mechanically stimulated rise in intracellular Ca  was found to be initiated 
by the generation of IP3 and the subsequent release of Ca2+ from intracellular stores,
9-4-  9+ whereas extracellular Ca  was not required for Ca  wave propagation (Sanderson et 
al.,  1990;  Charles  et  al.,  1991;  Hansen  et  al.,  1995;  Newman  and  Zahs,  1997; 
Venance  et  al.,  1997;  Sung  et  al.,  2003).  Initially  the  mechanically  evoked  wave 
propagation was compared to that induced by exogenous application of ATP and was 
shown to be similar (Hansen et al.,  1993).  Subsequently, treatment with P2 receptor 
antagonists  or  the  ATP  degrading  enzyme  apyrase  revealed  that  release  of 
extracellular ATP triggers the formation of intercellular Ca2+ waves.  Measurements 
of ATP  released  following  mechanical  stimulation  showed  that  ATP-induced  P2 
receptor  activation  caused  the  release  of ATP  (Newman,  2001).  The  role  of gap 
junctions in the propagation of Ca2+ waves is controversial. Ca2+ waves in HepG liver 
cell monolayers and between glial cells in the retina were not reduced in the presence 
of uncoupling  agents  (Newman,  2001;  Sung  et  al.,  2003).  The  latter  study  rather
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found  an  increase  in  the  area  covered  by  the  Ca  wave  in  the  presence  of the 
uncoupling agent octanol (Newman, 2001). In contrast, gap junctions were suggested 
to participate in mechanically induced Ca2+ wave propagation across airway epithelial 
and astrocyte cell monolayers (Sanderson et al., 1990; Venance et al., 1997). In HeLa 
cells that express connexin 43, a Ca2+ wave propagated to nearby cells in the presence 
of  apyrase  following  mechanical  stimulation,  whereas  it  was  restricted  to  the 
stimulated cell only in control Hela cells (Paemeleire et al., 2000). This indicates that 
gap junctions  participate  in  the  propagation  of Ca2+  waves,  when  connexin  43  is 
expressed.  Moreover,  connexins  the  proteins  that  form  gap  junctions  have  been
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suggested to function as hemichannels that facilitate the release of ATP during Ca2+ 
wave propagation (Stout et al., 2002; Pearson et al., 2005).
In  mammalian  cochlear  explants  it  has  been  shown  that  damaging  a  single  HC 
triggered a rise in cytoplasmic Ca2+ that propagated initially to neighbouring cells and 
subsequently to  cells up to  160 pm from the  lesion site  in form of an intercellular 
Ca2+  wave  (Gale  et  al.,  2004).  The  Ca2+ wave  was  suggested  to  be  generated  by 
release of extracellular ATP as a result of the IP3  dependent increase in Ca2+ levels
*y  1
(Gale et al., 2004). The study focused on the propagation of the Ca  wave into the 
region  composed  of Claudius’  and  Hensen’s  cells.  However,  it  is  still  unknown
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whether the damage-induced Ca  wave also triggers changes in Ca  levels in the HC 
and  IS  cell  region  (IS)  of cochlear  explants.  Moreover,  the  exact  nature  of  P2 
receptors  that  elicit  the  damage-induced  Ca2+  wave  propagation  is  not known.  P2 
receptor  expression  and  function  in  the  mammalian  cochlea  will  be  discussed  in 
chapter  1.3.  The  signalling  mechanisms  downstream  of the  damage-induced  Ca2+  
wave  are  also  not  determined  yet.  A  potential  candidate  signalling  cascade  is  the 
mitogen activated protein kinase (MAPK),  specifically the  ERK signalling cascade 
which is introduced in chapter 1.4.
1.3  P2 receptors
1.3.1  P2 receptors -  general
The first evidence that signalling of ATP sensitive receptors -  P2 receptors -  might
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play  a  role  in  the  mammalian  cochlea  arose  from  patch-clamp  and  Ca  imaging 
experiments.  ATP-induced  inward  currents  were  recorded  from  isolated  hair  and 
support  cells,  including  Hensen  and  Deiters’  cells  of the  guinea pig  cochlea.  The 
currents  were  observed  to  coincide  with  intracellular  Ca2+  changes  (Ashmore  and 
Ohmori,  1990; Nakagawa et al.,  1990).  ATP acts  on a class of receptors  called P2 
receptors that are  subdivided into  ionotropic P2X and metabotropic  P2Y receptors. 
The P2X subfamily consists of seven members that are the P2Xi  to P2 X7 receptors. 
Similarly various P2Y receptor subtypes are known and include P2Yi,  P2 Y2, P2 Y4, 
P2Y6 and P2Yn  to P2Ym (reviewed in King and Townsend-Nicholson,  2003).  The
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receptor families and their subtypes exhibit distinct features which will be discussed 
briefly in the following paragraphs.
P2X receptors
The members of the P2X receptor family are non-selective cation channels that are 
almost exclusively activated by ATP.  The only receptor which represents a special 
case  is  the  P2 X3  receptor  subtype  which  is  in  addition  to  ATP  also  activated  by 
uridine triphosphate (UTP) and to a lesser extent by adenosine triphosphate (ADP) 
(Liu et al., 2001; Greenwood et al., 2007). The P2 receptor subtypes exhibit variable 
sensitivity to agonists and the timecourse of desensitisation also differs. The receptors 
that  are  more  sensitive  to  ATP  are  P2Xj  and  P2 X3  receptors.  These  are  also  the 
rapidly  desensitising  receptors,  whereas  P2 X2  and  P2 X4  desensitise  more  slowly 
(Bianchi et al.,  1999). P2 X2, P2 X4 and P2 X7 are also characterised by their potential 
to  allow passage  of dyes  during prolonged receptor  stimulation  (Surprenant et al., 
1996; Khakh et al., 1999a; Meyers et al., 2003). Proposed mechanisms are: i) dilation 
of the P2X pore or ii) coupling to a different channel. Recently it has been shown that 
the  P2 X7  receptor  recruits  pannexins  -   a  protein  with  similar  characteristics  to 
connexins. The interaction with pannexins facilitates the dye entry during prolonged 
ATP exposure (Pelegrin and Surprenant, 2006).
In addition to homomeric  P2X receptors,  heteromer formation has been described. 
P2 X2/3, P2 X4/6, P2Xj/5 and P2 X2/6 are known to form heteromeric channels (Le et al., 
1998;  Le  et  al.,  1999;  King  et al.,  2000;  Liu  et  al.,  2001).  Co-expression  of P2X 
receptors  renders  agonist  and  antagonist  specificity  as  well  as  the  timecourse  of 
desensitisation. In vivo several P2X receptors are simultaneously expressed resulting 
in a potential diversity of P2 receptor interactions and thus in an increased regulatory 
complexity  of signalling  processes.  Knowledge  is  quite  limited  in  regard  to  the 
interactions occurring between co-expressed P2X receptors in vivo.
P2Y receptors
The  P2Y  receptor  subtypes  couple  to  heterotrimeric  guanine-nucleotide  binding 
proteins  (G-proteins).  G-protein  coupled  receptors  are  characterised  by  seven 
transmembrane domains that are linked by three intracellular and three extracellular 
loops. The P2Y receptor subtypes exhibit different sensitivities to nucleotides. P2Yj,
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P2Yi2 and P2Yn receptors are activated by the adenosine-based nucleotides ADP and 
ATP  but  not by  UTP  or uridine  diphosphate  (UDP).  In  contrast  P2 Y2,  P2 Y4  and 
P2Yn  receptors are  sensitive to ATP  and UTP whereas their diphosphates  are  not 
sufficient to mediate signalling events through these receptors (Nicholas et al.,  1996; 
van der Weyden et al., 2000; White et al., 2003; Wildman et al., 2003). UDP acts in 
addition to UTP and ADP on the rat P2Y6 receptor (Nicholas et al., 1996). The P2YJ4 
receptor is subtype that is not activated by any of the common nucleotides mentioned 
above but by the UDP derivative UDP-glucose.  The  P2Yi,  P2 Y2,  P2Y4,  P2Y6  and 
P2Yn  receptor subtypes couple to Gq proteins that interact with the PLC signalling 
axis resulting in the release of Ca2+from intracellular stores.  P2 Y2, P2Y4, P2Y6 and 
P2Yn also interact with other G-proteins to facilitate the activation of other signalling 
pathways.  P2 Yi2  to  P2Yi4  receptors  mediate  the  formation  of  cAMP  through 
interaction  of Gi  proteins  with  adenocyclases  (reviewed  in  King  and  Townsend- 
Nicholson, 2003; reviewed in von Kugelgen, 2006).
Brief overview of P2 receptor antagonists
P2X and P2Y receptor mediated signalling events can be partially distinguished on 
the basis of the agonist profiles of P2Y receptors. Antagonists are not very specific 
and  act  on  various  P2X  and  P2Y  receptors.  Commonly  used  broad  spectrum 
antagonists  are PPADS  and suramin.  A  selective P2X receptor antagonist is TNP- 
ATP that only acts  on P2Y receptors  at millimolar concentrations  (Virginio  et al., 
1998; Wildman et al., 2003). The various P2X receptors are differentially sensitive. 
P2Xi, P2 X3 and P2 X2/3 receptors are inhibited by TNP-ATP in the nanomolar range 
whereas higher doses in the micromolar range are required to antagonize P2 X2, P2X* 
and P2 X7 receptor activation  (Virginio  et al.,  1998).  Brilliant BlueG  is  a selective 
antagonist  when  used  at  nM  concentrations  at  the  P2 X7  receptor,  but  other  P2X 
receptors are also sensitive at higher concentrations (Jiang et al., 2000). The potencies 
of the antagonists were determined using heterologous expression systems. In native 
tissue,  co-expression  of  receptors  occurs  and  this  has  been  shown  to  alter 
pharmacological  profiles  (Le  et  al.,  1998;  Liu  et  al.,  2001;  Gallagher  and  Salter,
2003).  Therefore,  the  half  maximal  effective  concentration  (EC50)  may  not  be 
applicable to complex tissues.
30Chapter 1  -  Introduction
ATP has been implicated in physiological and pathological events in various organs 
including the brain and the ear. The functions of P2 receptors are diverse and cover 
proliferation,  survival,  differentiation  and,  during  pathological  conditions,  also  cell 
death  (Neary  et al.,  2003;  Arthur  et  al.,  2005;  Pearson  et  al.,  2005;  Arthur  et  al., 
2006).  A  number  of  studies  have  been  carried  out  to  characterise  P2  receptor 
expression in the cochlea and to determine their function. In the subsequent sections 
the current knowledge of the expression pattern of P2 receptors in the cochlea will be 
summarised according to their subclasses. This will be followed by a discussion about 
their modulation and function.
1.3.2  P2 receptor expression in the cochlea
P2X receptor expression in the cochlea
The  expression  patterns  of P2X  receptors  in  the  mammalian  cochlea  are  better 
characterised than that of P2Y receptors. Although at present, data are not available 
for  all  of  the  known  P2X  receptor  subtypes.  The  results  of  various 
immunocytochemical  studies  are  summarised  in  Table 1.1 a-c.  P2Xi  to  P2 X3,  and 
P2 X7 receptors have been characterised in the mammalian cochlea at various stages 
during development. Immunocytochemical localisation of P2Xi receptors revealed its 
presence  in  spiral  ganglion neurons  of the  rat  cochlea between  embryonic  day  16 
(El6 )  and postnatal  day 6  (P6 ) whereas  P2Xi  mRNA  was  only  observed at P0  in 
these cells. Earlier timepoints were not studied using RT-PCR (Nikolic et al., 2001; 
Greenwood et al., 2007). In contrast, P2Xi was expressed in isolated OHCs of adult 
guinea pigs (Szucs et al., 2004). P2 X2 receptors are the most studied P2 receptors in 
the cochlea and expression is  observed in  stereocilial bundles  of HCs,  in Deiters’, 
border,  Hensen,  Claudius  cells  and  spiral  ganglion neurons  (Housley  et  al.,  1999; 
Xiang et al.,  1999; Jarlebark et al., 2000; Jarlebark et al., 2002;  Szucs et al., 2004). 
Furthermore, the existence of three splice variants P2 X2-1, P2 X2-2 and P2 X2-3 has been 
suggested (Brandle et al.,  1997;  Chen et al., 2000;  Greenwood et al., 2007).  These 
splice variants differ in their desensitisation rate as shown using oocytes or HEK293 
expression  systems.  P2 X2-3  is  distinguished  from  the  other  splice  variants  by  its 
decreased  sensitivity  to  ATP.  However,  these  studies  did  not  test  whether  co­
expression of these splice variants affect their pharmacological profile as shown for 
other P2X receptors (Brandle et al., 1997; Chen et al., 2000; Greenwood et al., 2007).
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Another type  of P2 X3  receptors  is  expressed  in  HCs  and  spiral  ganglion  neurons 
during early development from El8 to P6 depending on the cochlear region. HCs in 
the basal region discontinue  P2 X3  expression earlier than those of the more  apical 
regions  (Huang  et al.,  2005).  Co-expression of the  P2 X3  receptor  subtype  and the 
P2 X2-3 splice variant in Xenopus oocytes rendered the pharmacological characteristics 
of both receptors to a phenotype that more closely represents that of spiral ganglion 
neurons (Greenwood et al., 2007). In contrast to the developmental downregulation of 
P2 X3  receptors,  P2 X7  expression  is  initiated  and  increases  during  postnatal 
development.  P2 X7  receptors  are  present  in  IHCs  and  OHCs  from  P0-P6  and  are 
maintained  in  IHCs  into  adulthood.  Deiters’  and  phalangeal  cells  commence 
expression at P6 , whereas spiral ganglion neurons show immunoreactivity as early as 
E l8  (Nikolic  et  al.,  2003).  The  P2 X4,  P2Xs  and  P2X6  receptors  have  only  been 
studied  in  spiral  ganglion  neurons  where  expression  was  observed  using  both  an 
immunocytochemical approach and RT-PCR. The P2Xs receptor mRNA expression 
was  abolished  after  onset  of hearing  measured  at  PI4,  whereas  P2 X4  and  P2 X6 
receptors  were  maintained  (Xiang  et  al.,  1999;  Greenwood  et  al.,  2007).  P2 X4 
receptor expression was additionally demonstrated in isolated OHCs cells (Szucs et 
al., 2004).  Functional expression of P2X receptors has been demonstrated for HCs, 
Hensen,  Deiters’  cells  and  spiral  ganglion neurons.  ATP-mediated  inward currents 
have  been  recorded  in  these  cells  assessed  using  the  patch-clamp  techniques 
(Ashmore  and  Ohmori,  1990;  Nakagawa  et  al.,  1990;  Chen  and  Bobbin,  1998; 
Housley et al.,  1999; Mammano et al.,  1999; Lagostena et al., 2001; Lagostena and 
Mammano, 2001; Greenwood et al., 2007).
P2Y receptor expression:
The  expression profile  of P2Y receptors  is poorly characterised in the  mammalian 
cochlea. A study using RT PCR revealed the presence of P2Yj, P2 Y2, P2 Y4 and P2Y6 
in P2  rat cochleae (Gale et al., 2004). The stria vascularis was removed before RNA 
isolation  and  thus  did  not  contribute  to  the  results.  The  expression  of the  P2 Y2 
receptor was confirmed by immunocytochemical labelling of cochlear explants. P2 Y2 
was observed in Hensen cells and stereocilia of IHCs (Table  1.2).  In Claudius-like 
cells  and along the  HC  region the  labelling was  fainter.  The  cell  types  in the  HC 
region that contribute to the labelling were not identified (Gale et al., 2004).  P2Yi, 
P2 Y2 and P2 Y4 were observed in isolated OHCs of guinea pig cochleae. P2Yi was
32Tablel.la: Immunocytochemical localisation of P2X receptor expression in the mammalian cochlea, ap = apical, bs = basal,  gp = adult guinea pig,
n.p.d = not possible to determine, n.t. = not tested.
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Receptor IHC OHC Deiters’
cells
Phalangeal
cells
Pillar
cells
Hensen
cells
Claudius
cells
Spiral
ganglion
Species Antibody
Source
Reference
P2X1 E16-P6 
adult: n.t
rat Alomone Nikolic et 
al., 2 0 0 1
n.t. n.t. n.t. n.t. n.t. n.t. n.t. + rat In Lab Xiang et 
al., 1999
n.t. + n.t. n.t. n.t. n.t. n.t. n.t. gP Alomone Szucs et 
al., 2004
P2X2 n.t. n.t. n.t. n.t. n.t. n.t. n.t. + rat In Lab Xiang et 
al., 1999
Stereo-
cilia
Stereo-
cilia
+ n.p.d. n.p.d. n.p.d. n.p.d. + gP In Lab Housley 
et al., 
1999
Stereo-
cilia
+ But border 
cell
+ + + rat In Lab Jarlebark 
et al., 
2 0 0 0
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nTablel.lb: Immunocytochemical localisation of P2X receptor expression in the mammalian cochlea, ap -  apical, bs = basal,  gp = adult guinea pig,
n.p.d = not possible to determine, n.t. = not tested.
Receptor IHC OHC Deiters’
cells
Phalangeal
cells
Pillar
cells
Hensen
cells
Claudius
cells
Spiral
ganglion
Species Antibody
Source
Reference
P2X2 Stereocilia + + + + + mouse In Lab Jaerlebark 
et al., 
2 0 0 2
n.t. + n.t. n.t. n.t. n.t. n.t. n.t. gP Alomone Szucs et 
al., 2004
P2X3 n.t. n.t. n.t. n.t. n.t. n.t. n.t. + rat In Lab Xiang et 
al., 1999
E18-
P0/P3
bs/ap
E18-
P0/P6
bs/ap
- ■ “ “ “ E18-P6
tested
mouse Neuromics,
USA
Huang et 
al., 2005
P2Xi n.t. n.t. n.t. n.t. n.t. n.t. n.t. + rat In Lab Xiang et 
al., 1999
n.t. + n.t. n.t. n.t. n.t. n.t. n.t. gP Alomone Szucs et 
al., 2004
P2X5 n.t. n.t. n.t. n.t. n.t. n.t. n.t. + rat In Lab Xiang et 
al., 1999
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nTablel.lc: Immunocytochemical localisation of P2X receptor expression in the mammalian cochlea. a.n.p.d. = adult not possible to determine,
ap = apical, bs = basal, gp = adult guinea pig, n.p.d = not possible to determine, n.t. = not tested.
Receptor IHC OHC Deiters’ Phalangeal Pillar Hensen Claudius Spiral Species Antibody Reference
cells cells cells cells cells ganglion Source
P2X6 n.t. n.t. n.t. n.t. n.t. n.t. n.t. + rat In Lab Xiang et 
al., 1999
P2X7 P0- P0-P6 P6 -adult P2-adult P6 - P6 faint P6 faint E18- rat Alomone Nikolic et
adult adult:
negative
adult a.n.p.d a.n.p.d adult al, 2003
n.t.
+
n.t. n.t. n.t. n.t. n.t. n.t. gP Alomone Szucs et 
al., 2004Table 1.2: P2Y receptor expression in the mammalian cochlea. The P2Y6i u> 12, n,and u which are not listed in the table have not been investigated,  cc =
cochlear culture, gp = adult guinea pig, n.p.d -  not possible to determine, n.t. -  not tested.
Receptor IHC OHC Deiters’
cells
Phalangeal
cells
Pillar
cells
Hensen
cells
Claudius
cells
Spiral
ganglion
Species Antibody
Source
Reference
P2Y1 n.t. + n.t. n.t. n.t. n.t. n.t. n.t. gP Alomone Szucs et 
al., 2004
P2Y2 Stereocilia
P3
n.p.d. n.p.d. n.p.d. + n.p.d. rat cc Alomone Gale et 
al., 2004
n.t. + n.t. n.t. n.t. n.t. n.t. n.t. gP Alomone Szucs et 
al., 2004
P2Y4 n.t. n.t. n.t. n.t. n.t. n.t. n.t. gP Alomone Szucs et 
al., 2004
“ ” + * • + n.p.d n.t. gP Alomone Parker et 
al., 2003
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distributed homogenously in OHCs whereas P2 Y2  localised to more  apical aspects 
and P2 Y4 towards the basal end of OHCs (Szucs et al., 2004).  In contrast, a study 
examining  P2 Y4  receptor  expression  in  cryosections  of  guinea  pig  cochleae 
demonstrated labelling in Deiters’ cells but not HCs (Parker et al., 2003).
The application of agonists  such as UTP  and UDP that predominantly act on P2Y 
receptors supports the expression of these receptors in Hensen and Claudius-like cells 
(Gale et al., 2004; Piazza et al., 2007). Furthermore, in Hensen cells from the guinea 
pig ATP induced two inward currents -  a fast current that coincided with influx of 
extracellular Ca2+ and a slower one that was IP3-dependent (Lagostena et al., 2001). 
In Deiters’ cells ATP only elicited a fast current (Lagostena and Mammano, 2001). 
ATP-induced  Ca2+  changes  were  observed  in  Deiters’  cells.  Ca2+  release  from 
intracellular stores was suggested as the source; however, this was not directly tested 
(Dulon et al.,  1993; Lagostena and Mammano, 2001).  Intracellular Ca2+ changes in 
HCs  resulting  from  exogenous  application  of ATP  occurred  in  an  IP3-dependent 
manner  suggesting  a role  for P2Y  receptors  (Mammano  et  al.,  1999).  In  contrast, 
application of UTP  did not elicit currents  in  isolated guinea pig  OHCs  and  IHCs, 
which however does not exclude P2Y receptor function in HCs (Housley et al., 1999). 
These receptors might not couple to ion channels and thus measurements of agonist- 
induced Ca2+ changes are a more reliable technique to determine their presence and 
function.  Further  immunohistochemical  and  functional  studies  at  different  stages 
during development are necessary to identify the impact of P2Y receptors on cochlear 
development and function.
1.3.3  Modulation of P2 receptor responses in cochlear cells
P2 receptors are modulated by various external factors and physiological stimuli. P2X 
receptor  responses  are  dependent  on  extracellular  Ca2+,  Zn2+,  Cu2+,  and  H+ 
concentrations (Evans et al.,  1996;  King et al.,  1997; Ding and Sachs,  1999, 2000; 
Kanjhan et al., 2003).  The presence of divalent cations such as Ca2+ or Zn2+ in the 
extracellular  space  interferes  with  P2  receptor  function  and  decreases  resultant 
currents. Alkaline pH also inhibits P2X receptors whereas acidification results in the 
potentiation of P2 receptor currents in HCs and Deiters’ cells (Kanjhan et al., 2003). 
Beside the modulation by environmental factors P2 receptor-mediated events are also
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regulated by neurotransmitters as well as intracellular signalling cascades. ACh, the 
neurotransmitter  released  by  efferent  neurons,  has  been  shown  to  reduce  the 
ATP-induced  rise  in  intracellular  Ca2+  in  OHCs  (Ashmore  and  Ohmori,  1990; 
Wikstrom et al.,  1998). Intracellular cascades that have been demonstrated to affect 
P2  receptors  in  cochlear  cells  are  the  cyclic guanosine monophosphate 
(cGMP)-protein  kinase G  (PKG)  and  cyclic  adenosine  monophosphate  (cAMP)- 
protein  kinase A  (PKA)  signalling  axis.  ATP  has  been  observed  to  stimulate  the 
production  of  nitric  oxide  in  IHCs  and  OHCs  that  subsequently  regulates  the 
simultaneously occurring intracellular Ca2+ events. Although, the effect which nitric 
oxide exerts, differs according to the type of HC. In IHCs nitric oxide decreases the 
ATP-induced elevated Ca2+ levels whereas it provokes the opposite effect in OHCs 
(Shen et al., 2005; Shen et al., 2006). In addition the cAMP analogue  8 -Br-cAMP or 
other agents that induce the generation of cAMP decrease P2X mediated currents in 
isolated  Deiters’  cells  (Chen  and  Bobbin,  1998).  Taken  together  P2  receptors  are 
modulated at various levels presenting a basis for controlling physiological events.
The expression of ectonucleotidases -  the enzymes that hydrolyse ATP -  offers a yet 
additional  mechanism  to  control  P2  receptor  mediated  signalling  cascades.  The 
ecto-nucleotidase  triphosphate  diphosphohydrolases  (NTPD)  1,  2  and  3  have been 
reported to be expressed in the rat cochlea (Vlajkovic et al., 2002a, b). This implies 
that a physiological function is attributed to controlled P2 receptor signalling in the 
cochlea.
1.3.4  P2 receptor function in the cochlea
P2 receptor function and hearing
P2X  receptors  are  proposed  to  modulate  sound transduction  on  the  basis  of their 
expression in sensory HCs and their afferent neurons (Housley et al.,  1999). In vivo 
experiments  give  some  indication  that  ATP  can  play  a  modulatory  role  in  the 
mammalian  cochlea.  Enhanced  electrically-evoked otoacoustic  emissions  measured 
when  ATP  was  applied to  the  scala media,  provide  evidence  that ATP  can  affect 
OHC activity (Kirk and Yates, 1998). Furthermore, ATP injected into the scala media 
reduced the endocochlear potential that was restored to baseline levels in the presence 
of PPADS  (Thome  et al.,  2004).  It has been  suggested that a  shunt current  is  the
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mechanism  underlying  altered  endocochlear  resistance  resulting  in  decreased  HC 
sensitivity to sounds. This shunt is however not mediated by HCs as their loss did not 
affect the ATP-induced changes of the endocochlear potential (Thome et al., 2004). 
Thus the change in endocochlear potential is predominantly carried by other cochlear 
cells that express P2 receptors. Application of the purinergic agonist ATP-y-S to the 
scala tympani resulted in a transient threshold shift of the compound action potential 
and the frequency tuning curves of single neurons (Sueta et al., 2003). At present, the 
cellular  mechanisms  underlying  these  threshold  shifts  are  unidentified.  Taken 
together  P2  receptor  function  has  been  implicated  in  sound  transduction  but 
knowledge of its specific action is quite limited.
P2 receptors during development
The transient expression of P2Xi, P2 X3 and P2Xs receptors implicates a role during 
development. A recent study addressed the question whether the transient expression 
of P2 X3 receptors in spiral ganglion neurons during early postnatal days is related to 
neuronal  development.  Spiral  ganglion  neurons  cultured  in  the  presence  of brain- 
derived  neurotrophic  factor  (BDNF)  and  the  purinergic  agonist  ATPyS  exhibited 
fewer and shorter neurites than those grown in BDNF alone (Greenwood et al., 2007). 
This suggests that P2 receptors might be involved in pruning of neurons and thereby 
establishing the correct number of contacts with HCs. During retinal development P2 
receptors have also been shown to regulate mitosis (Pearson et al., 2005). Knowledge 
of the function of P2 receptors during development of the mammalian cochlea is very 
limited.
P2 receptors signal damage
Noise  overexposure  has  been  shown  to  result  in  the  accumulation  of  ATP  in 
endolymphatic and perilymphatic spaces (Munoz et al., 2001). This is accompanied 
by the upregulation of P2 X2 receptors (Wang et al., 2003b). These data suggest that 
ATP  plays  a role  under pathological  conditions  in  the  cochlea.  Recently,  in  vitro 
experiments  demonstrated  that  damage  of  single  HCs  leads  to  the  release  of 
extracellular ATP that triggers the propagation of an intercellular Ca2+ wave.  Thus 
ATP  is  a  molecule  that  signals  the  impaired  integrity  of damaged  HCs  to  their 
neighbouring cells.  At present, the P2 receptor subtypes that facilitate the damage-
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induced propagation  of the  Ca2+ wave  are  not  identified.  It is  established that  IP3 
generation and thus P2Y receptors contribute to the Ca2+ wave formation (Gale et al., 
2004; Piazza et al., 2007). Knowledge is also lacking about the downstream targets of 
increased intracellular Ca2+ and their subsequent signalling events during damage.
1.4  ERK1/2
1.4.1  Mitogen activated protein kinases -  an overview
Cellular processes are tightly regulated and among other protein kinases, the family 
of MAPKs are highly responsive to external stimuli.  The MAPK family comprises 
several subclasses -  ERK 1  to 5 and 8 , JNK 1-3 and p38 kinases a, J3, y and 5. A wide 
range of receptors, including those for EGF, neuronal growth factor (NGF), glutamate 
and purinergic agonists are coupled to the MAPK signalling cascade (Cowley et al., 
1994; Traverse et al.,  1994; Neary et al.,  1999; Yang et al., 2004c). The presence or 
absence  of agonists  is  sensed  and  can  result  in  the  activation  or  deactivation  of 
MAPKs initiating distinct cellular programs. The activation or deactivation of one of 
these members can positively or negatively influence other members of the MAPK 
family;  for  example  ERK1 and 2  activation  concurrently  negatively  regulates  the 
activity of JNK, or vice versa JNK activation results in deactivation of ERK 1/2 (Xia 
et  al.,  1995;  Lavoie  et  al.,  1996).  Thus  the  equilibrium  between  activated  and 
deactivated states of these kinases at a certain point in time can determine the cellular 
responses and fate.
The  different  MAPKs  are  similarly  activated by  a  MAPK  signalling  cascade  that 
involves  the hierarchical phosphorylation  of several  intermediate  kinases  (Fig 1.2). 
Receptor  activation  initiates  the  phosphorylation  of  the  MAPK  kinase  kinase 
(MAPKKK) followed by the MAPK kinase that then phosphorylates and activates the 
MAPK.  The  kinase  cascades  differ  between  MAPK  subclasses.  For  example, 
ERK 1  and 2  (ERK 1/2)  activation  is  accomplished  by  one  of  the  following 
MAPKKKs:  A-Raf,  B-Raf  or  c-Raf  (also  called  Raf-1).  One  of  these  kinases 
phosphorylates  MEK1  or  2  (MEK1/2),  the  MAPKKs  for  ERK1/2.  The  ERK1/2 
signalling cascade has been associated with tumour growth and invasion. Mutations
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Stimulus: growth factors, stress
I I
MAPKKK: e.g. A, B, C-Raf
MAPKK: MEK1/2
I I
MAPK: ERK1/2
Fig 1.2 MAPK activation cascade
Left panel: hierarchical activation of MAPKs by the MAPK signalling cascade and 
Right panel: ERK1/2 activation as an example.
in  B-RAF  or  its  upstream  activator  the  small  G-protein  Ras  were  found  to 
continuously  activate  ERK1/2  and  thereby  induce  proliferation  and  tumour 
succession (reviewed in Dhillon et al., 2007).
Originally  distinct functions  were  associated with the  different MAPK  subclasses. 
ERK1/2  activation  was  thought  to  be  crucial  for  cellular  survival,  proliferation, 
tumour formation as well as  differentiation, whereas JNKs and p38 kinases where 
thought to respond exclusively to cellular stress and to mediate signalling towards cell 
death.  Hence  JNKs  were  formerly  called stress  activated protein kinases  (SAPK). 
More recently it has emerged that the functions of these kinases cannot be separated 
in such a clear-cut fashion. JNKs might be the death mediating kinases in one cellular 
system and yet in another they promote cell survival whereas the role in promoting 
cell death is been taken by ERK1/2. In order to accomplish their functions MAPKs 
either phosphorylate targets in the cytoplasm or are transferred to the nucleus where 
they affect gene transcription.
In the subsequent section the focus will be  specifically turned to the  activation of 
ERK 1/2 and in particular its function during damage.
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1.4.2  ERK1/2 -  activation
ERK 1/2  activation  can  be  modulated via  several  signalling pathways  upstream  of 
MAPKKKs. Extracellular stimuli activate receptors that couple to heterotrimeric G- 
proteins.  Inhibition  of  the  pertussis-toxin  sensitive  subunit  Gj  reduces  ERK 1/2 
activation (Soltoff et al., 1998; Neary et al., 1999; Neary et al., 2003). G-proteins can 
activate various enzymes including PLC or adenylyl cyclases that can result in the 
activation of ERK1/2 (Vossler et al.,  1997; Corbit et al., 2000; Werry et al., 2005). 
Conversely, adenylyl cyclases that generate cAMP that subsequently activates PKA, 
are  also  reported  to  counteract  ERK1/2  activation  (Cook  and  McCormick,  1993; 
Stork and Schmitt, 2002). Another signalling event leading to ERK 1/2 activation is 
the  PLC  mediated generation of IP3  and  diacylglycerol  (DAG)  that act on protein 
kinase C (PKC). DAG is a direct effector at PKC, whereas IP3 mediates its actions in 
an indirect manner via the release of Ca2+ (Schonwasser et al.,  1998;  Corbit et al., 
2000;  Goldsmith  and  Dhanasekaran,  2007).  Choline-specific  PLC  has  also  been 
suggested to result in the activation of ERK1/2 (Neary et al., 1999). In addition to G- 
protein coupled receptors, phosphotyrosine kinases can activate ERK 1/2 via GTPases 
such as Ras. These activate Raf s -  the MAPKKK’s and thus link, together with their 
adaptor proteins, phophotyrosine kinase receptors to the ERK 1/2 signalling cascade 
(Marshall,  1995). These are only a few examples of the vast number of intracellular 
effectors  of  ERK 1/2  activation.  The  entire  network  of  molecules  involved  in 
signalling  towards  ERK 1/2  cannot be  discussed  in  full  detail  in  the  scope  of this 
introduction (for further information see Werry et al., 2005).  Instead, as damage of 
hair cell  epithelia has  been  shown  to  result in  elevated Ca2+  levels  (Hirose  et  al., 
1999; Gale et al., 2004; Matsui et al., 2004) the focus here will be specifically turned 
towards the regulation of ERK 1/2 by Ca2+.
ERK activation/deactivation in a Ca— -dependent manner
The phosphorylation  of ERK1/2  has been  shown to  depend on  Ca2+ (Neary et al., 
2003;  Paul  et  al.,  2003;  Kupzig  et  al.,  2005)  but  it  can  also  occur  independently 
(Cook et al.,  1997;  Yang et al.,  2004c).  The cell type and the  extracellular stimuli 
determine the necessity for Ca2+ to  activate ERK 1/2.  The activation of ERK 1/2  in 
striatal  neurons  stimulated by  50 pM NMDA  occurs  in  a  Ca2+-dependent  manner, 
whereas the sub-threshold concentration of NMDA (1 pM, N-methyl-D-aspartic acid)
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together with the metabotropic glutamate receptors (mGluR) agonist DHPG (3 pM, 
S-3,5-Dihydroxyphenylglycine)  result  in  ERK1/2  activation  independently  of Ca2+ 
(Yang  et  al.,  2004c).  Ca2+  can  act  through  different mechanisms  that  include  the 
activation of a calmodulin  dependent kinase (Schmitt et al.,  2004)  or of Ras-GRF 
(guanosine nucleotide releasing factors, (Farnsworth et al., 1995).
Three  classes  of  phosphatases  regulate  the  dephosphorylation  and  thus  the 
deactivation  of  ERK 1/2:  i)  dual  specificity  phosphatases,  ii)  serine/threonine 
phosphatases and iii) tyrosine phosphatases (reviewed in Raman et al., 2007). In some 
cells  Ca2+  is  required  for  the  deactivation  of ERK 1/2.  Mitogen  activated  protein 
kinase  phosphatase  (MKP)  is  newly  synthesised  upon  activation  of ERK 1/2.  The 
absence  of Ca2+  during  the  induction  of MKP  expression  results  in  the  failure  to 
dephosphorylate  ERK 1/2  and  thereby  ERK 1/2  activation  sustained  (Cook  et  al., 
1997). Another specific neuronal phosphatase STEP (striatal enriched protein tyrosine 
phosphatase) that deactivates ERK 1/2 requires Ca2+ in order to be dephosphorylated 
and  switched  to  its  active  conformation  (Paul  et  al.,  2003).  In  addition  to  the 
dephosphorylation  of ERK 1/2,  the  inactivation  of the  upstream  signalling  cascade 
leads  also to the  abrogation of ERK 1/2  signalling.  CAPRI,  a Ca2+-dependent Ras- 
GTPase activating protein induces Ras to hydrolyse the bound GTP and thereby Ras 
is transferred into its inactive form that is not sufficient to activate ERK 1/2 (Lockyer 
etal.,2 0 0 1 ).
1.4.3  ERK1/2 activation during damage and cell death
Many processes/steps during and following injury or oxidative stress are regulated by 
one  or  several  members  of the  MAPK  family.  The  members  most  studied  during 
cytotoxic  events  are  JNKs,  p38  kinases  and  ERK 1/2  and  all  of them  have  been 
implicated  in  stress-induced  signalling.  As  discussed  above  the  functions  of these 
kinases are diverse and differ depending on cell types. Oxidative stress is a key player 
during  HC  damage  and  death  following  noise  exposure  and  ototoxic  insults. 
Therefore, the function of damage- or oxidative stress-induced activation of ERK 1/2 
will be discussed in more detail.
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Acute  damage  such  as  mechanical  strain  was  observed  to  activate  ERK 1/2 
immediately within minutes following the insult (Neary et al., 2003; Matsubayashi et 
al., 2004). This activation has been shown to be mediated by damage-induced release 
of ATP. Chemical mediators including H2O2 and cisplatin can induce a delayed onset 
of ERK 1/2  activation  several  hours  after  the  initial  exposure  dependent  on  their 
concentration and mode of action (Wang et al., 2000).  The function and targets of 
activated ERK 1/2 during stress signalling are not only diverse but also opposing. In 
one cellular system activated ERK 1/2 is critical for cell survival, whereas in another it 
promotes  cell  death  (Xia  et  al.,  1995;  Nowak,  2002;  Sperandio  et  al.,  2004; 
Subramaniam et al., 2004; Chen et al., 2005; Arthur et al., 2006). Adding a further 
level of complexity, in a lung carcinoma cell line (A549) the type of toxic stimulus 
determines whether ERK 1/2 promote cell survival or cell death.  Cisplatin, a drug that 
is also ototoxic induces ERK 1/2 mediated cell death in A549 lung carcinoma cells, 
whereas during oxidative stress following exposure to H2O2 or doxorubicin ERK 1/2 
act  as  survival  factors  (Wang  et  al.,  2000).  The  downstream  signalling  events  of 
activated ERK 1/2 that lead to the execution of either survival or cell death are only 
beginning  to  be  unravelled  and  some  are  discussed  in  more  detail  below. 
Subsequently, the function of ERK1/2 in re-establishing the integrity of damaged cell 
monolayers or organs will be outlined.
ERK 1/2 -  damage and survival signalling
Survival  signalling  was  originally  considered  to  be  one  of the  main  functions  of 
ERK 1/2 during pathological events. Xia et al. (1995) provided the first evidence that 
ERK 1/2  activation resulting from overexpression  of the MAP kinase kinase MKK 
can oppose apoptosis in PC-12 cells induced by withdrawal of neuronal growth factor 
(NGF).  Subsequently,  further  research  confirmed  a  role  of activated  ERK 1/2  in 
survival signalling.
The potential mechanisms that ERK 1/2 exploit to sustain the survival status can be 
divided  into  two  wider  categories  -   one  is  the  phosphorylation  of  pro-  and 
anti-apoptotic  cytoplasmic  targets  and  the  second  is  the  positive  or  negative 
regulation  of  transcription  factors  that  are  anti-  and  pro-apoptotic,  respectively. 
ERK 1/2 have been described to interact with pro-apoptotic proteins that are located in 
the  cytoplasm.  It  has  been  suggested  that  activated  ERK 1/2  can  phosphorylate
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caspase-9  at  threonine  residue 125  and  that  this  modulation  inhibits  caspase-9’s 
ability to  auto-cleave and thereby activate itself.  Thus the proteolytic  activation of 
caspase-3 and the execution of the death signalling cascade are discontinued (Allan et 
al.,  2003).  This  mechanism  could potentially also  sense  trophic  factor  withdrawal 
leading  to  reduced  ERK1/2  activation  including  decreased  phosphorylation  of 
caspase-9 that then permits the initiation of the apoptotic signalling cascade.
Another mechanism that has been proposed to be crucial for cellular survival is the 
ERK 1/2  induced  phosphorylation  of BAD,  a  pro-apoptotic  member  of the  Bcl-2 
family  (Bonni  et  al.,  1999).  The  dephosphorylated  form  of  BAD  binds  to 
mitochondrial  Bcl-2  proteins  to  trigger  apoptosis,  but  upon  phosphorylation  BAD 
dissociates  resulting  in  survival.  Moreover,  XAIP,  a  member  of  the  apoptosis 
inhibiting protein  family  (AIP)  that  interacts  with  caspases  and  thereby maintains 
them in their inactive form, has also been shown to be regulated by ERK 1/2 (Gardai 
et al., 2004). Whether ERK 1/2 activation resulted in the stabilisation of XAIP or in 
sustained expression was not investigated.
Activated ERK 1/2 not only modulate cytoplasmic target proteins, but also alter gene 
expression profiles through the regulation of transcription factors, thereby influencing 
cell  survival.  Phosphorylation  of the  transcription  factor  CREB  (cAMP  response 
element binding-protein) mediated by activated ERK 1/2 can lead to the expression of 
survival  genes  such  as  Bcl-2  (Bonni  et al.,  1999;  Wang  et  al.,  2006a).  Moreover, 
ERK1  has  been  shown  to  positively  regulate  Nrf-2-induced  gene  expression  in 
CIO murine alveolar type II-like epithelial cell line during hyperoxia (Papaiahgari et 
al., 2004).  Nrf-2 is a transcription factor that regulates the expression of genes such 
as  glutathione-S-transferase,  y-glutamylcysteine  synthetase  and  heme  oxygenase- 1 
that maintain the redox-balance of cells exposed to oxidative stress (Chan et al., 2001; 
Braun et al., 2002). To summarise: the activation of ERK1/2 together with the action 
of another survival  kinase  the  PI-3  kinase  could result in  a concerted response  in 
order to preserve cellular function and survival during damaging stimuli.  The exact 
mechanisms  that  are  employed  downstream  of  ERK 1/2  activation  to  facilitate 
survival  and those that integrate  survival  and death  signalling events  remain to be 
determined.
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ERK 1/2 activation promotes cell death
The tumour suppressor p53 is crucial for cell survival. Activation of p53 by oxidative 
stress can either lead to cell cycle arrest or apoptosis. One of the downstream events 
of activated  ERK1/2  is  the  activation  and  upregulation  of p53  that  subsequently 
initiates  cleavage  of procaspase-3  (Wang  et  al.,  2000;  Li  et  al.,  2005).  Activated 
ERK 1/2  are  demonstrated  in  a  different  report  to  exert  their  action  on 
phospholipase A2  (PLA2) that produces  arachidonic  acid which  in turn  favours the 
release  of  mitochondrial  cytochrome c,  the  activation  of  caspase-3  and  its 
downstream  target  poly(ADP-ribose)  polymerase  (PARP)  (Kim  et  al.,  2003). 
Arachidonic acid was observed to bind to the NADPH-oxidase (Pessach et al., 2001) 
resulting in the formation of ROS, that could then trigger the execution of apoptosis. 
Moreover, ROS formation was also observed when aminoglycosides that are ototoxic, 
were exposed to  arachidonic acid and NADH in a cell free non-enzymatic system 
(Sha and Schacht,  1999). ROS have also been shown to induce ERK1/2 activation. 
Thus ERK 1/2 induced ROS generation could result in a feedback loop that maintains 
ERK1/2 in an activated state. ROS scavengers or overexpression of the copper/zinc 
superoxide dismutase 1   are sufficient to inhibit ERK 1/2 activation and attenuate cell 
death (Wang et al., 2000; Noshita et al., 2001). ERK1/2 activation by ROS could be 
accomplished  directly  through  manipulation  of  the  ERK 1/2  activating  cascade. 
However, recent data suggest that oxidative stress  results in the inactivation of the 
ERK 1/2  deactivating  phosphatases  and  thereby  indirectly  increases  ERK 1/2 
activation (Levinthal and Defranco, 2005). Hence, ERK1/2 activation by ROS could 
be a result of the action of two potential mechanisms i) modulation of the ERK 1/2 
activating  cascade  or  ii)  impairment  of the  function  of the  ERK 1/2  deactivating 
phosphatases. These mechanisms could act independently but also mutually.
Calpains are calcium-dependent intracellular cysteine proteases that have also been 
implicated in the execution of cell death in response to oxidative stress. Knock-down 
of the  regulatory  subunit  of calpain  that  is  encoded  by  the  gene  capn4  has  been 
observed  to  attenuate  cell  death  induced  by  UV-irradiation  or  other  mediators  of 
oxidative  stress  (Tan  et  al.,  2006).  Cleavage  of  caspases  and  the  release  of 
mitochondrial cytochrome-c are involved in calpain-mediated apoptosis. As calpains 
can be directly targeted and activated by ERK1/2 (Glading et al., 2004;  Tan et al.,
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2006),  it is possible that this  is  an additional mechanism by which ERK 1/2  might 
promote cell death.
The  death-associated  protein  kinase  (DAPK)  has  been  implicated  in  triggering 
cleavage  of  caspase-3  and  its  substrate  PARP  but  also  in  the  activation  and 
upregulation  of the  transcription  factor p53  and  thereby  to  induce  apoptosis.  The 
activation  of DAPK requires the phosphorylation of its death domain by activated 
ERK1/2  (Wang et al., 2002a;  Chen et al., 2005;  Stevens et al., 2007).  Conversely, 
exposure  to  phorbol  ester  PMA  or  EGF  reduced  DAPK-induced  apoptosis  in  an 
ERK 1/2 dependent manner. In that study ribosomal S6  kinase  1   (RSK-1), one of the 
downstream targets of ERK 1/2, was shown to phosphorylate DAPK at its calmodulin- 
binding domain resulting in the attenuation of apoptosis (Anjum et al., 2005).  The 
phosphorylation  sites  described  in  those  reports  differ  suggesting  that  activated 
ERK 1/2 could have a dual role. DAPK also functions as an ERK 1/2 binding protein 
and  thereby  sequesters  ERK 1/2  in  the  cytoplasm  disabling  its  performance  in  the 
nucleus (Chen et al., 2005).  Similarly, the retention of activated ERK1/2 by DAPK 
could  interfere  with  the  phosphorylation  of  RSK-1.  Thus  DAPK  cannot  be 
phosphorylated at its calmodulin-binding domain resulting in its release to exert its 
pro-apoptotic effect. Thus, cell fate is potentially determined according to the balance 
of phosphorylation between the two sites.
To summarise, ERK 1/2 acts on a variety of targets through which it exerts its pro- 
apoptotic effect. The actions of ERK 1/2 during cell death and the mechanisms of how 
single downstream events interact in the signalling network continue to be unravelled.
ERK 1/2 -  a role in wound repair
Damage repair is crucial to the continued survival and function of tissues and organs. 
Repair can be  accomplished as  a result of migratory wound closure which  can be 
followed by proliferation to replace damaged or dead cells.  Cells neighbouring the 
damaged  area  gain  migratory  competence  due  to  the  action  of MAPKs  including 
ERK1/2,  that  are  activated  following  the  damaging  insult.  Both,  pharmacological 
inhibition  of ERK1/2  activation  and  expression  of dominant-negative  mutants  of 
ERK1  or ERK2  reduces the  capacity to  close wounds  (Matsubayashi  et al.,  2004; 
Providence and Higgins, 2004). A proliferative response subsequent to damage and
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wound  closure  often  requires  the  dedifferentiation  of cells.  Schwann  cells  can  be 
driven to dedifferentiate in a Raf-l/MEKl/2 dependent fashion. However, these cells 
were  not  able  to  re-enter  the  cell  cycle  and  proliferate  (Harrisingh  et  al.,  2004). 
Following brain injury,  the activation of the protease-activated receptor-1   (PAR-1) 
contributes  to  astrogliosis,  measured  by  an  increase  in  the  number  of astrocytes 
positive for glial  fibrillary acidic protein.  Exposure  of astrocytes  in vitro  or in the 
striatum  to  a PAR-1  agonist promotes  proliferation that requires  the  activation  of 
ERK 1/2 (Nicole et al., 2005). In order to initiate cell cycle entry, activated ERK 1/2 
control the transcriptional upregulation of proliferative effectors such cyclin D 1  and 
the  downregulation  of  antiproliferative  gene  products  including  JunD,  Gadd45a 
(growth  arrest  and  DNA  damage-inducible 45 a)  and  Sox6   (SRY  box  containing 
gene 6 , (Lavoie et al.,  1996; Harrisingh et al., 2004; Yamamoto et al., 2006). Taken 
together this  indicates that ERK 1/2  can play crucial roles  at various  stages  during 
wound repair that depending on the types of cell and organs.
1.4.4  MAPKs and the inner ear
In the inner ear knowledge about the functions of the various MAPKs is quite limited. 
The  focus  of research  has  mainly  been  upon  the  role  of JNKs,  which  have  been 
shown  to  be  activated  in  HCs  during  exposure  to  aminoglycosides  and  following 
acoustic  overstimulation  (Pirvola  et  al.,  2000;  Ylikoski  et  al.,  2002;  Wang  et  al., 
2003a; Matsui et al., 2004; Sugahara et al., 2006; Wang et al., 2006b). During both 
noise damage and aminoglycoside-induced ototoxicity inhibition of JNK activation 
preserves the function of HCs (Pirvola et al., 2000; Wang et al., 2003a; Matsui et al., 
2004;  Wang  et  al.,  2006b).  In  contrast,  cisplatin-induced  hearing  loss  was  not 
prevented using the JNK inhibitor D-JNKI-1  (Wang et al., 2004). The role of another 
MAPK member -  the p38 kinase -  during HC damage is controversial. In rat cochlear 
explants p38 kinases have been suggested to promote HC death during exposure to 
gentamicin (Wei et al., 2005), whereas in murine utricles HCs die independently of 
p38 kinases (Sugahara et al., 2006). Activated ERK1/2 has been shown to be a pro­
survival  signal  in  HCs  (Battaglia  et  al.,  2003).  Moreover,  proliferation  in  chick 
utricular  epithelial  sheet  cultures  stimulated  by  serum  occurred  partially  in  an 
ERK 1/2 dependent manner (Witte et al., 2001).  Exposure of rat utricular epithelial 
cultures to recombinant human glial growth factor 2  triggered cells of this epithelium
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to also proliferate.  The ERK1/2 pathway is one of a number of signalling cascades 
engaged to  facilitate that proliferative response  (Montcouquiol  and  Corwin,  2001). 
With respect to damage signalling, studies using immortalised HC lines implicate a 
role  for ERK 1/2  during  gentamicin-  and  cisplatin-induced toxicity  (Kalinec  et al., 
2005;  Previati  et  al.,  2007;  So  et al.,  2007).  However,  the  study by Previati  et al. 
(2007)  showed that application of the ERK inhibitor PD 98059 resulted in reduced 
cell death in the presence of cisplatin, whereas, using Western blot analysis activated 
ERK1/2 were only reduced in the presence of PD 98059 at 16 hrs but not at 10 hrs or 
24 hrs  of cisplatin exposure.  So  et al.  (2007)  demonstrated that ERK1/2  inhibitors 
reduced  the  release  of  pro-inflammatory  cytokines  during  cisplatin-induced  cell 
death. However, these results have to be taken with caution as immortalised HC lines 
do  not  express  all  features  of functional  HCs  and  therefore  the  signalling  events 
activated  by  ototoxic  drugs  are  likely  to  differ.  In  cochlear  explants  treated  with 
gentamicin HC death was enhanced when ERK1/2 activation was inhibited (Battaglia 
et al., 2003) suggesting that ERK1/2 are key players in HC survival.  Despite these 
investigations  it  has  not  been  determined  whether  ERK 1/2  are  activated  in  HC 
epithelia following damage of HCs.
1.5  Aims
Cell to cell communication and in particular that between hair and support cells must 
occur during traumatic events in order to trigger wound repair, re-establishment of 
the physiological environment for surviving cells and in some cases a proliferative 
response.  As  outlined  in  this  introduction  such  signalling  mechanisms  are  only 
poorly understood.  An  intercellular Ca2+  wave  has  been  described to travel  in  an 
ATP-dependent manner  into  the  outer  sulcus  (OS)  region  as  a result  of hair  cell 
damage (Gale et al., 2004). The aim of this thesis was to investigate, whether damage 
also triggers changes in intracellular Ca2+ levels in the HC and inner sulcus regions 
and  to  further  the  understanding  of the  mechanisms  underlying  the  Ca2+  wave 
formation.  This  included investigations  to  the  source  of Ca2+  and the propagation 
mechanisms; in particular the roles of ATP and gap junctions were examined as these 
have been shown to be crucial  in other cellular systems.  The function of the  Ca2+ 
wave described by Gale et al. (2004) has not been studied.
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One of the signalling cascades that is not only activated by Ca2+ but also reported to 
mediate wound closure, is the ERK1/2 signalling cascade (Matsubayashi et al., 2004; 
Kupzig et al.,  2005).  Therefore,  it was tested in this thesis whether i) mechanical 
damage also triggers the activation of ERK1/2 and ii) whether the same mechanisms 
that underlie the formation of the damage-induced Ca2+ wave result in activation of 
ERK1/2.  Hair  cells  presented  with  toxic  stimuli  such  as  aminoglycosides  or 
neoplastic  drugs  become  damaged  and  die.  Therefore,  the  question  was  raised 
whether ERK1/2 play a role during such toxic events.
ATP has been shown to be increased in the endolymph following hair cell damage 
and has been suggested as a damage signalling molecule (Munoz et al., 2001; Gale et 
al., 2004). However, the exact nature of the P2 receptors activated during damage is 
currently  not  known.  In  this  thesis,  pharmacological,  immunohistochemical  and 
electrophysiological  approaches  were  used  to  further  this  knowledge.
50Chapter 2 -  Material and Methods
2. Material and Methods
2.1 Chemicals and solutions
2.1.1 Materials
Fluorescent-labelled  substances  were  obtained  from  Molecular  probes  and  all 
chemicals were from Sigma unless otherwise specified.
U0126,  U0124 and BAPTA-AM  (l,2-bis-(o-Aminnophenoxy)-ethane-N, N, N \ N’- 
tetraacetic  acid  tetraacetotoxy-Methyl  ester)  were  obtained  from  Cell  signalling. 
U73122,  Raf kinase  inhibitor I  and  U0126  were  obtained  from  Calbiochem  and 
PPADS (Pyridoxal phosphate-6-azo(benzene-2,4-disulfonic) acid) from Tocris.
The sources of primary antibodies are given in Table 2.6.
2.1.2 External and internal solutions
External solutions
The  constituents  of external  solutions  used  are  given  in  Table  2.1.  The  pH  of 
hepes-buffered Hank’s balanced salt solution (HB-HBSS) was adjusted to  7.4  and 
those of ACSF (artificial cerebrospinal fluid) and patch ringer were 7.3. In a subset 
of  experiments  1  mM Ca2+  in  HB-HBSS  was  replaced  with  1  mM Mg2+  and 
additionally  chelated with  1  mM  EGTA  (ethylene  glycol-bis(p-aminoethyl  ether)- 
N,N,N’,N’,-tetraacetic acid). The conditions in which this external solution was used 
will be referred to as 0 Ca2+ throughout this thesis.
Internal patch solution
Constituents  of the  internal  patch  solution  used  are  given  in  Table  2.2.  In  some 
experiments ATP and GTP were omitted. The pH was adjusted to 7.30 with KOH 
and osmolarity to 290 mOsm by diluting the solution. Aliquots were stored at -20 °C.
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substance Molecular 
weight [g/mol]
Concentration [mM]
HB-HBSS ACSF Patch ringer
NaCl 58.44 137 119 119
KC1 74.56 5.37 2.5 2.5
MgCl2x6 H20 203.3 1 1.3 1.3
CaCl2 x 2 H20 147.02 1 2.5 2.5
NaH2P04 x H20 137.99 0.65 1 1
NaHCOa 84.01 - 26.2 -
k h2po4 136.9 0.44 - -
Hepes 238.30 1 0 - 2 0
Glucose 180.16 5.5 1 1 1 1
Table 2.2 Composition of internal patch solution.
Substance Molecular weight 
[g/mol]
Concentration
[mM]
Methanesulfonate 96.1 131.1
EGTA (KOH) 380.4 0 . 2
Hepes 238.3 2 0
MgCl2 203.3 1
Na-ATP 551.1 2
Na-GTP 523.2 0 . 2
2.1.3  Stock solutions of drugs
All  stock  solutions  were  prepared  and  stored  at  -20 °C in  aliquots  to  avoid 
freeze-thawing  unless  otherwise  specified.  U0126,  U0124,  cRAFl  inhibitor 1, 
U73122, and carbenoxolone (CBX) were dissolved in dimethylsulfoxide (DMSO) to 
make a lOOOx stock except for CBX. CBX was prepared as a 50 mM stock in DMSO
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and then further diluted in  18 MQ nanopure water to  give a 5 mM stock solution. 
The  final  concentration  used  was  75 pM.  Octanol  was  dissolved  to  a  final 
concentration  of  1  mM  in  ACSF  that  was  supplemented  with  1:1400  DMSO 
(10 mM).  B  APT  A-AM was dissolved in 10 % pluronic in DMSO to obtain a lOOOx 
stock.  PPADS  and  suramin were  dissolved in  18 MQ nanopure  water to  obtain  a 
50 mM or a  lOOOx  stock, respectively.  Lyophilised apyrase mixed with potassium 
succinate  salts  were  reconstituted  at  400 U/ml  in  MilliQ  water.  Neomycin  was 
dissolved in Dulbecco’s Modified Eagle’s medium with F12 (DMEM/F12, Gibco). 
Neomycin, suramin, CBX and octanol were prepared on the day of the experiment.
2.2  Isolation and culture of cochlear explants
Cochleae were isolated from neonatal Sprague Dawley rats between PI  and P3.  In 
detail,  rats  were  sacrificed  by  rapid  cervical  dislocation  according  to  schedule  1 
procedure and then decapitated. The head was sterilized in 70 % ethanol for 5 -  10 
min  in  order to  avoid bacterial  contamination during the  isolation procedure.  The 
head was cut along the midline and separated into two halves. Following removal of 
the  brain,  connective  tissue  and  surrounding  bone,  the  cochlear  bullae  were 
transferred into Medium  199 (Ml99, Gibco, UK) supplemented with penicillin and 
fungizone (10 U/ml; 25 ng/ml). In order to access the cochlea, the bulla was opened 
and  freed  from  the  surrounding  cartilage.  The  stria  vascularis  and  Reissner’s 
membrane were removed and the cochlea cut into its basal to apical turns. For most 
of the  experiments,  unless  otherwise  indicated,  only  basal  and middle  turns  were 
cultured.  The cochlea turns were transferred onto MatTek® dishes (USA)  that had 
been coated with Celltak® (BD Biosciences, UK). For coating, Celltak® was diluted 
in 0.1 mM NaHC0 3  to a concentration of 73 pg/ml and 30 pi was spread across the 
coverslip of the MatTek®  dish. The dishes were incubated at room temperature for at 
least  1  hr.  Prior to plating the cochlear coils  Celltak® was removed and the dishes 
were  rinsed  four  times  in  Dulbecco’s  Modified  Eagle’s  medium  with  F12 
(DMEM/F12, Gibco, UK) that was supplemented with 5 % fetal bovine serum (FBS, 
Gibco,  UK).  Cochlear turns were cultured in DMEM/F12  containing  5 % FBS  at 
37 °C in a 5 % C(V95 % air atmosphere. Cochlear explants were used after one day 
in vitro for all experiments except for the patch clamp studies.
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2.2.2  Isolation of cochlear explants without culture
The  isolation procedure  of cochlear coils  designated for patch  clamp  experiments 
differed only in two aspects: i) isolation was carried out in ACSF (see 2.1) saturated 
with 95 % O2 /5 % CO2 and ii)  isolated cochlear coils were used on the  same  day. 
Cochleae were cut into basal and middle turns and held down using a platinum harp.
2.3  Damage paradigms
2.3.1  Cochlear damage models
Several models have been employed to study cochlear pathology. These include in 
vivo studies in mature animals or in vitro studies, using either postnatal explants or 
immortalised cochlear cell lines (OC-2, HEI-OC1) (Richardson and Russell,  1991; 
Wang et al., 2002b; Nicotera et al., 2003; Wang et al., 2003a;  So et al., 2007).  In 
vivo models are advantageous as mature animals are used to investigate both toxic 
and traumatic events. However, studies of dynamic signalling processes especially of 
short-lasting  events  are  very  difficult  to  undertake  in  vivo.  Postnatal  cochlear 
explants  offer the possibility to examine  such processes while the  structure of the 
organ of Corti is maintained. At present explants are only possible to culture during 
the early postnatal period. However, the onset of hearing in rats occurs at around P12 
(Geal-Dor et al., 1993; Freeman et al., 1999). There are many developmental changes 
still occurring in cochlear cells during the first postnatal weeks.  These include e.g. 
changes  in  the  expression  patterns  of ion  channels/  currents  in  hair  cells  and  of 
connexins in support cells to only name a few (Jagger and Forge, 2006; reviewed in 
Housley et al., 2006).
In  this  PhD  thesis  in  order  to  study  dynamic  signalling  events  occurring  during 
damage of the mammalian cochlea, postnatal cochlear explants were chosen as the 
model. Culture of these explants allows cells to recover from the traumatic isolation 
procedure.  In  addition,  cochlear  explant  cultures  offer  the  opportunity  to  study 
processes over several days.
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2.3.2 Laser damage
Laser damage was used to investigate the time course and mechanism of damage- 
induced activation of ERK1/2. The lesions were induced using a Micropoint system 
(Photonic Instruments Inc., USA). Briefly, the technique is based on a nitrogen laser 
(Laser Science Inc.) emitting energy of a wavelength at 337 nm (70 kW peak output, 
70 ns). UV-light is transmitted via a fibre optic into a dye cell containing Coumarin. 
The dye cell is crucial to re-establish coherence of the beam that is lost during the 
transmission  along the  fibre optic.  The  dye  emits  a 440 nm beam onto  steering 
mirrors that are used to align and focus the beam through the lens onto the specimen. 
The intensity of the emitted light and thus the size of the lesions were adjusted with a 
graded neutral density attenuator plate.
In detail, the laser beam was focused through a 40x  1.3 N.A. Zeiss Fluar objective 
(oil immersion) onto the specimen. The cochlear culture was placed so that a 2nd row 
OHC  was  centred  in  the  path  of the  laser  beam.  Damage  was  introduced  while 
focusing  from  the  apical  surface  of the  cochlear  coil  to  its  basal  aspect.  Several 
pulses were sufficient to induce a lesion once the focal plane of the laser beam was 
reached.
2.3.3 Needle damage
In  order  to  image  a  larger  area  of the  cochlear  cultures  a  20x  0.75 Zeiss  Fluar 
objective  was  used  The  laser  ablation  technique  was  not  effective  with  lower 
magnification/N.A.  lenses.  Therefore mechanical trauma was  implemented using a 
microneedle. The tip of the microneedle was positioned 15 pm above the focal plane 
of the hair bundle of the second row of OHCs. Damage was induced by lowering the 
microneedle  -60 pm  using  the  remote  controlled  piezoelectric  manipulator 
(Burleigh) where  it was held for two  seconds and returned to its original position 
above the tissue. For the majority of experiments the microneedle was positioned in 
the centre of the field of view.
The needle damage technique was also applied in experiments investigating damage- 
induced currents. For these experiments the microneedle was placed 94 pm above a 
cell  situated  five  cells  away  from  the  patch-clamped  Deiters’  cell  (same  row, 
Fig 5.1 A).  This technique was  chosen to  avoid disruption of the  seal between the
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electrode and the patched cell. The microneedle was lowered by  110 pm to induce 
the first lesion and after two seconds it was placed back to its original position. The 
procedure was repeated at the site of the first lesion 30 min later but the second time 
the microneedle was lowered 125 pm.
2.3.4 Neomycin-induced HC damage
Neomycin was used as a damage paradigm to investigate ERK1/2 signalling when 
HCs were targeted specifically.  Neomycin (1 mM with 1:1000 DMSO vehicle) with 
the addition of 10 pM U0126 (in DMSO) or its inactive analogue U0124 (10 pM, in 
DMSO) was applied to cochlear cultures.  To assess whether U0126 alone was HC 
toxic it was applied to cochlear cultures in the absence of neomycin. Test solutions 
were  placed  at  37 °C  (5 % CO2)  for  20 min prior  to  use.  Cochlear  cultures  were 
washed  four  times  in  test  solution  before  incubating  them  at  37 °C  in  a 
5 % CO2 /9 5 % air atmosphere for 8 or 24 hrs (Fig 2.1). In some experiments cultures 
were exposed to neomycin for 8 hrs after which they were switched into DMEM/F12 
containing  vehicle  control,  U0126  or U0124  without  neomycin  for  further  16 hrs 
(Fig 2.1). Culture media were changed at 4, 8 and 20 hrs to avoid breakdown of test 
substances.  Following  the  mentioned  incubation  paradigms  cultures  were  fixed 
(fixation  details  see  2.7.1)  and  immunocytochemically  labelled  for  activated 
ERK1/2, chromatin and filamentous actin following the various incubation times (see 
2.7.2).
2.4 Local application of nucleotides
The  responsiveness  of cochlear cells  to  different purine  nucleotides  was  assessed 
using  i)  voltage  clamp  studies,  ii)  Ca  imaging  and  iii)  activation  of ERK1/2. 
Nucleotides were prepared as 100 mM stock solutions in 18 MQ nanopure water and 
were  diluted  to  their  final  concentrations  in  HB-HBSS  for  Ca2+  imaging  and  for 
ERK1/2  activation  experiments.  Solutions  were  applied  locally  by  a  micropipette 
picospritzer (puff application). In order to avoid blockage of micropipettes the
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neomycin  +  U0126 U0126
Neomycin +  U0124 U0124
Fig 2.1 Overview of experimental set up.
Most  upper  panel  indicates  the time  scale  of the  experiment.  ‘Change’  indicates 
the  time  point  of renewal  of test  medium  and  ‘fix’  that  of fixation.  Below  are the 
different conditions tested.
nucleotide  solution was  sterile  filtered and then filled into micropipettes  (2 pm tip 
diameter) that were pulled using a two step electrode puller (Narashige, Japan).
The micropipette was placed 2 pm above the focal plane of the 1st row of OHCs but 
positioned above the outgrowing Claudius-like cells approximately 20 pm from the 
edge of 3rd row OHCs. Nucleotides were locally applied with a pressure of six psi 
which did not activate mechanically-induced Ca2+  signals.  100 pM ATP  and UTP 
were applied for 10 s, whereas  100 pM ADP, UDP and AMP were applied for 20 s. 
The onset of nucleotide application was noted.
In patch clamp experiments the nucleotides were diluted in patch ringer (Table 2.1). 
Micropipettes  prepared  for patch  clamp  experiments  were  also  used to puff apply
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nucleotides (see 2.8.1). The puff micropipette was placed in parallel with the three 
rows of OHCs opposite to the patch electrode. It was positioned slightly above the 
HC epithelium at the site of the Deiters’ cell that neighboured the patched cell in the 
same row.  The nucleotides were applied locally at sixpsi for  10 milliseconds (ms) 
using a pressure application system (Toohey Company, USA). Timing information 
from  the  puff  application  system  was  sent  to  the  computer  via  AD  converter 
Digidata 2000  and  combined  with  electrophysiological  recording  in  pClamp 9.2 
software.
2.5  Calcium imaging
2.5.1  Fura-2 Ca2+ measurement and protocol
Changes in the cytoplasmic Ca2+ concentrations were measured in cochlear cultures 
using  the  ratiometric  Ca2+  sensitive  dye  l-[6-Amino-2-(5-carboxy-2-oxazolyl)-5- 
benzofuranyloxy]-2-(2-amino-5-methylphenoxy)ethane-N,N,N',N,-tetraacetic  acid 
(Fura-2). Fura-2-AM, which has an acetotoxy methyl group attached to make it cell 
permeable,  was  dissolved  in  10%  pluronic  in  DMSO  to  a  3 mM  stock  solution. 
Cultures  were  loaded  with  3  pM  Fura-2-AM  in  DMEM/F12  for 40  to 50 min  at 
37 °C in a 5% CO2 /9 5 % air atmosphere, washed four times in HB-HBSS and then 
placed at 25 °C for 20 min to allow esterases to cleave the AM groups. Experiments 
were carried out at room temperature (20 -  23 °C) in HB-HBSS.
Fura-2  was  alternatively  excited  at  340 nm  and  380 nm  using  a  monochromator 
(Kinetic Imaging Ltd.).  Epifluorescent light was passed through a 505 nm dichroic 
mirror and a 510 nm long pass filter and images were captured on a  12-bit cooled 
CCD  1280 x 1024  pixel  sensicam  camera  (PCO,  Germany).  AQM/IQ  software 
(Kinetic Imaging Ltd./Andor Imaging Inc) controlled the specimen illumination and 
image capture. Routinely, the protocol comprised of 200 frames of 256 x 300 pixel 
images  (4x4  pixel  binning)  and  both  channels  were  exposed  for  500 ms.  Needle 
damage  was  induced  after  collecting  baseline  data  for  approximately  20 s.  Puff 
application of nucleotides was also initiated after a similar baseline recording. The 
time of damage and nucleotide application were noted.
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In most cases the cochlear coils were large enough to perform at least three lesions. 
The distance between lesions was at least 300  pm.  The first damage stimulus was 
always carried out in HB-HBSS containing the vehicle that the drugs were dissolved 
in. The second and third damage stimuli were induced following a 30 min incubation 
period  in  HB-HBSS  supplemented  with  the  drug  or  its  vehicle  except  for 
BAPTA-AM which was pre-applied for 90 min. An interval of approximately 5 to 7 
min separated the second and third damage stimuli as re-positioning and re-focussing 
of the microneedle was required. Similarly, nucleotides were applied at two spatially 
separated sites  (at least 500 pm)  along the  cochlear turn.  The  cultures were  fixed 
5 min after the last insult or puff application (see 2.7.1) and a subset was included 
into the ERK1/2 study.
2.5.2  Analysis of Ca2+ measurements
The 340/380 ratios (R) are proportional to the cytoplasmic Ca2+ concentrations and 
the changes in the ratio (AR) reflect changes in cytoplasmic Ca2+ levels [Ca2+]c.  340 
and  380  intensity  levels  were  determined  using  Metamorph  software  (Molecular 
Devices  Inc.)  and  exported  into  Microsoft  Excel,  where  baseline  levels  were 
subtracted (F340: 108; F380:  135 grey levels, range from 0 to 4095 grey levels) and 
ARs were calculated:
F340 -  baseline^ 0
R —-----------------------
F380 -  baselinem
AR = R-R0
Regions of interest
In  order  to  assess  the  formation  of the  Ca2+  wave  the  analysis  was  subdivided 
according to the distinct regions of cochlear cultures that are the OS, the HC and the 
IS.  In  the  OS  region  regions  of interests  (ROIs,  20 x 20 pm)  were  positioned  at 
45 ° angle to the HC rows  in both directions  from the  lesion site at the  following 
distances:  42-70 pm,  98-126 pm,  154-182 pm  and  210-238 pm  (Fig 4.2 A).  ROIs
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were  positioned  at  40-60 pm,  80-100 pm  and  120-140 pm  to  both  sites  from  the 
lesion site longitudinally along the rows of HCs (Fig4.2C).  In the IS region ROIs 
were placed at 60-80 pm,  100-120 pm and 140-160 pm horizontally from the lesion 
site (Fig 4.IE). The data were extracted and calculated as described above. If there 
were more than one ROI at the same distance the intensities were averaged.
In  a  subset  of experiments  the  microneedle  was  placed  at  the  top  of the  image 
allowing  20 x 20 pm  ROIs  to  be  positioned  from  30 pm  up  to  270 pm  from  the 
lesion  site along the HC rows.  The ROIs for the  IS  and OS regions were kept as 
described above  with the  exception that Ca2+  levels  were  determined in only  one 
diagonal array of ROIs in the OS region.
Determination of maximum changes in cytoplasmic Ca—
Peak Ca2+ changes were determined using Microsoft Excel for comparison between 
control and drug treatment. The two consecutive lesions in the presence of the drug 
were pooled together as were the initial control lesions and the 2/3 lesions performed 
in a small number of all control experiments. This method was verified on the basis 
that no differences in peak Ca2+ changes were observed between the two consecutive 
lesions in drug treated cultures.  In the case of 0 Ca2+ for the OS region the peak Ca2+ 
changes of the 2nd lesion in 0 Ca2+ was reduced compared to the 1st; most likely as a 
result of depletion of Ca2+ stores. Therefore, only the  1st lesion was included in the 
comparison. Statistical analysis was carried out using unpaired, two-tailed Student’s 
/-tests. In addition, the apyrase + CBX and U73122 + 0 Ca2+ data sets were subjected 
to ANOVA.
Changes in resting cytoplasmic calcium concentration (Rn values)
To check whether drugs affected baseline Ca2+ concentration the Fura-2 ratios at time 
zero  (R o)  were  determined  for  each  R O I  in  the  distinct  cochlear  region. 
Measurements of Ro were taken before and after drug exposure for comparison with 
controls (Tables 2.3 -  2.5). Ro values were significantly increased in the presence of 
U73122 in the OS but not the HC or IS regions. Suramin increased Ro values in all 
regions whereas 0 Ca2+ reduced Ro in the HC region only.
60Table 2.3: RO values in the OS and IS region. *P < 0.05, /-Test
Os
OS region IS region
Distance from 
lesion [fim] 42-70 98-126 154-182 210-238 60-80 100-120 140-160
Control: 0 Cai+/ 
U73122/PPADS
0.54 ± 0.011 0.50 + 0.011 0.48 ± 0.008 0.49 + 0.011 0.50 + 0.012 0.47 + 0.018 0.44 ± 0.036
OCa2 0.50 ± 0.022 0.48 ± 0.022 0.47 + 0.021 0.42 + 
0.007*
0.46 + 
0 .0 1 1 *
0.43 + 0.019 0.38 ± 0.022
U73122 0 . 6 8  + 
0.009*
0.64 + 
0.019*
0.64 + 
0.023*
0.61 + 
0.024*
0.49 + 0.014 0.45 + 0.016 0.44 ± 0.075
0 Ca2+ + U73122 0.64 ± 
0.017*
0.60 + 
0.026*
0.57 + 
0.016*
0.52 + 0.015 0.50 ± 0.005 0.45 ± 0.006 0.39 ± 0.006
control
APY+CBX
1.18 ± 0.057 1.18 + 0.067 1.16 + 0.037 1.34 + 0.122 1.10 + 0.056 1.11+0.045 1.18 + 0.043
APY 1.13 ± 0.046 1.17 + 0.045 1.17 + 0.041 1.16 + 0.087 1.18 + 0.042 1.2 + 0.034 1.24 + 0.026
APY+CBX 1.15 + 0.052 1.14 + 0.049 1.13 + 0.059 1.20 + 0.069 1.29 + 0.038 1.23 + 0.036 1.15 + 0.052
CBX 1 .2 + 0.062 1.17 + 0.051 1.15 + 0.067 1.5 + 0.164 1.31 + 
0.043*
1.26 + 
0.039*
1.22 + 0.051
control suramin 0.96 + 0.015 0.89 + 0.019 0.80 + 0.014 0.79 + 0.011 0.86 ± 0.023 0.88 + 0.014 1.01+0.017
suramin 1.02 + 0.019 0.94 + 
0.027*
0.85 + 
0.016*
0.90 + 
0.025*
0.92 + 
0.009*
0.96 + 
0.015*
1.06 + 
0.018*
PPADS 0.52 + 0.018 0.47 ± 0.026 0.47 ± 0.023 0.40 + 0.019 0.51+0.01 0.50 + 0.01 0.50 ± 0.008
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sTable 2.4: RO values in HC region for the data set investigating the source of Ca2+. *P < 0.05, t-Test
O n to
Distance from 
lesion [jam] 30-50 50-70 70-90 90-
110
110-
130
130-
150
150-
170
170-
190
190-
210
210-
230
230-
250
250-
270
Control: 0.56 0.55 0.56 0.55 0.55 0.56 0.55 0.57 0.58 0.58 0.57 0.56
0Ca27U73122 ± dh dh ± ± ± ± ± ± d b ± ±
/PPADS 0.009 0.009 0.007 0.009 0.007 0.008 0 .0 1 0.007 0.04 0.004 0.006 0.006
OCa2 0.49 0.50 0.51 0.50 0.50 0.51 0.51 0.52 0.54 0.55 0.55 0.54
± ± d: ± d b ± ± ± ± ± ± ±
0.009* 0 .0 1 * 0.008* 0.013* 0 .0 1 2 * 0.016* 0.017* 0 .0 1 1 * 0 .0 1 2 * 0.013* 0.013 0.009*
U73122 0.56 0.55 0.55 0.56 0.56 0.58 0.59 0.58 0.58 0.59 0.60 0.58
± ± ± ± ± ± ± ± ± ± ± ±
0.008 0.008 0.004 0.009 0 .0 1 1 0.016 0.023 0.007 0.006 0 .0 1 0.004* 0.005
0 Ca2 + 0.54 0.52 0.52 0.53 0.54 0.53 0.55 0.54 0.56 0.54 0.53 0.53
U73122 ± ± ± ± ± ± ± ± ± ± ± ±
0.016 0.015* 0.007* 0.009 0.009 0.015* 0.018 0.005* 0 .0 0 2 * 0 .0 1 * 0.008* 0.005*
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Table 2.5: RO values in the HC region. *P < 0.05, /-Test
HC region
Distance from 
lesion [pm] 40-60 80-100 120-140
Control 1.25 ±0.037 1.29 ±0.045 1.36 ±0.045
APY 1.26 ±0.05 1.32 ±0.043 1.29 ±0.055
APY + CBX 1.15 ±0.052 1.14 ±0.049 1.13 ±0.059
CBX 1.34 ±0.048 1.44 ±0.064* 1.48 ±0.05
Control suramin 0.94 ±0.023 0.92 ±0.031 0.92 ±0.015
Suramin 1.01 ±0.024 1.0 ±0.037 1.01 ±0.05*
PPADS 0.53 ±0.008 0.52 ±0.013 0.50 ±0.020
All  other  treatments  did  not  significantly  affect  baseline  or  resting  calcium 
concentrations.
Measurement of Ca~ wave velocity
The velocities  of the  damage-induced  Ca2+ waves were  determined  along the  HC 
region using data obtained when the needle was positioned at the top of the image in 
order to have the maximum length of the organ in the image.  The differential ratio 
(8 R) signal was derived from mean ratio values by calculating ratio derivative, where 
5R = Rt -  Rt+l.  8 Rmax reliably represented the onset of the calcium signal and so for
each  ROI  the  time  to  5Rm ax  was  calculated  for each  ROI.  ROIs  were  placed  at 
different distances from the damage site and that distance was plotted as a function 
of the time to  8 Rm ax. The data were fit with a linear regression in Microsoft Excel 
(y = mx + c ) where the slope was equal to dxl dt  or the wave velocity. This method 
was used to determine the velocity of the slow wave between ROIs at 50 -  70 pm to 
up  to  150-  170 pm.  As  a  result  of  the  velocity  of  the  fast  Ca2+  wave  and 
image-acquisition settings there was  a limited number of time points available for
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curve fitting. Therefore, in this case an “instantaneous” velocity was calculated using 
dx/dt for one ROI using time zero (to) for the onset of the stimulus and time to ARm ax.
Purinergic agonists
In this case, when purinergic nucleotides ATP, UTP, ADP and UDP were applied 
with a micropipette the same ROI template was used to analyse changes in AR as 
described for the microneedle damage. Peak ARs were determined and then averaged 
for all the ROIs  in the distinct cochlear regions to give one  single value  for each 
region.
2.5.3  Data presentation
Fura-2 ratio images presented in this thesis are of two types, either time series AR 
images  that  are  averages  of  two  consecutive  images  or  in  the  case  of  drug 
applications,  averages  of  15  frames  of AR  images  were  made  from  the  start  of 
damage, equivalent to approximately 20 s of imaging. The latter images provide not 
only  an  average  of Ca2+  concentrations  over  20 s  but  also  indicate  the  extent  of 
spread of the Ca2+ signal.
2.6  ERK1/2 activation
Damage-induced  ERK1/2  activation  was  studied  with  an  immunocytochemical 
approach  using  an  antibody  against  the  dually  phosphorylated  form  of ERK1/2 
(pERK,  see  2.7.2).  In  order  to  study  the  spatio-temporal  aspects  of  ERK1/2 
activation  cultures  were  subjected  to  laser  damage  and  fixed  for 
immunocytochemistry at the following time points:  1, 2,  5,  10, 20,  30 and 60 min 
post damage. Basal, middle and apical turns were included in this study.
To  study  the  mechanism  of damage-induced  ERK1/2  activation  only  basal  and 
middle  turn  cochlear  cultures  were  used.  Comparisons  were  performed  between 
control and drug-treated cultures fixed 5 min and in some cases also 10 min after the 
damage.  The cultures were pre-incubated with drugs for 30 min and maintained in
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their  presence  throughout  the  experiment  except  for  B  APT  A-AM,  which  was 
pre-incubated for 90 min instead.
2.7  Immimocytochemistry
2.7.1 Fixation
Paraformaldehyde (PFA) was used as an agent to crosslink cellular components such 
protein  structures  of cells.  A  commercially  available  stock  of  16% PFA  (Agar 
Scientific, USA) was diluted in 0.1 M phosphate buffered saline (PBS) to 4 % PFA. 
Cochlear cultures were incubated at room temperature with 4 % PFA that had been 
kept  at  4 °C.  Following  an  incubation  of 30 - 60 min  in  4 % PFA  cultures  were 
washed three times for 15 min in 0.1 M PBS. After the final wash they were changed 
into 0.1 M PBS supplemented with 0.05 % (w/v) NaN3 in order to prevent bacterial 
contamination  and  stored  at  4 °C  until  they  were  used  for  immunocytochemical 
investigations.
Cultures  used  to  study  P2  receptor  expression  were  fixed  after  one  day  in  vitro. 
Fixation  time  points  of  cochlear  cultures  included  in  the  ERK1/2  study  were 
discussed earlier (see chapter 2.3.3 and 2.6).
2.7.2 Immuno-labelling
After fixation cultures were  incubated in blocking  solution to reduce non-specific 
binding of antibodies. Triton-XlOO (0.1 %) was included to the blocking solution to 
permeabilise lipid membranes and to permit access of antibodies to their intracellular 
antigen. When using the monoclonal anti-pERK antibody, specimens were incubated 
in  blocking  solution  containing  10%  goat  serum  and  0.1 % Triton-XlOO  in 
0.1 M PBS  for  one  hr  at  room  temperature  while  agitating.  Goat  serum  was 
substituted  by  horse  serum  when  P2  receptor  antibodies  were  used.  Primary  and 
secondary antibodies were diluted in blocking solution according to the experiment 
and primary antibody dilutions are summarized in Table 2.6.  Following overnight 
incubation in primary antibody at 4 °C  specimens were washed three  times  for  at 
least 15 min in 0.1 M PBS. Alexa Fluor-488 goat anti-mouse or goat anti-rabbit
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Table 2.6: Overview of primary antibodies and their dilutions
Antibody
(Ab)
Supplier Species Ab stock 
concentration
Dilution Peptide
dilution
anti
P2Y2
Alomone
labs
rabbit polyclonal 0 . 8  pg/pl 1:1 0 0 ,
1:500
1  Pg/ 
lpg Ab
anti
P2Y4
Alomone
labs
rabbit polyclonal 0 . 8  pg/pl 1:1 0 0 ,
1:500
1 Pg/ 
lpg Ab
anti
P2Y„
Alomone
labs
rabbit polyclonal 0 . 8  pg/pl 1:1 0 0 ,
1:500
1  Pg/ 
lpg Ab
anti
P2X2
Alomone
labs
rabbit polyclonal 0 . 8  pg/pl 1:1 0 0 ,
1:500
1  Pg/ 
lpg Ab
anti
P2X3
Alomone
labs
rabbit polyclonal 0 . 8  pg/pl 1:1 0 0 ,
1:500
1  Pg/ 
lpg Ab
anti
P2X4
Alomone
labs
rabbit polyclonal 0 . 8  pg/pl 1:1 0 0 ,
1:500
1  Pg/ 
lpg Ab
anti
pERKl/2
Sigma mouse monoclonal 1 : 1 0 0 0
secondary  antibodies  were  diluted  1:1000  for  pERK  and  1:500  for  P2  receptor 
antibodies, respectively. In order to avoid photo bleaching cultures were kept in the 
dark throughout the  subsequent procedures.  Cultures were  incubated  in  secondary 
antibody  for  two hrs  at  room  temperature  and  then  washed  in  0.1 M PBS  as 
described  above.  Routinely,  cultures  were  counter  stained  with  the  DNA 
intercalating  dye  diamidinophenolindole  (DAPI,  1  pM)  for  1  hr  in  PBS  at  room 
temperature.  In  some  cases,  specimens  were  also  labelled  with  the  actin  binding 
toxin phalloidin conjugated to Alexa-546 or -633 (1:200). If both counter stains were 
used they were applied together for one hr at room temperature and then washed as 
described earlier.
In  order  to  check  whether  the  secondary  antibodies  adhere  non-specifically  to 
cochlear  cells  the  primary  antibody  was  omitted  and  cultures  were  treated  as 
described above.  Anti-P2 receptor antibodies were pre-adsorbed by incubation  for
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30 min  at  room  temperature  with  the  specific  peptides  they  were  raised  against 
concentrations:  see  Table  2.6).  Immunocytochemical  labelling  was  carried  out  as 
described above using the antibody-antigen mix instead of the primary antibody.
2.7.4 Confocal imaging
Images of immunolabelled specimens were acquired using a Zeiss LSM510 confocal 
microscope.  The  confocal  head  was  attached  to  the  side-port  of  an  inverted 
microscope (Zeiss Axiovert 200M).  The following laser lines were used: 405 diode 
(DAPI excitation); the argon-krypton 488 nm line (Alexa-488), the helium-neon 543 
or 633 nm lines (Alexa-546 and Alexa-633 respectively). The images were acquired 
using  the  following  lenses:  Plan-Apochromat/20x/0.75  dry  lens,
Plan-Neofluar/40x/1.3 or Plan-Apochromat 63x/ 1.4 oil lenses
Z-stack  images  were  acquired through  the thickness  of the  sensory  region  of the 
epithelium.  For comparative  studies  the  acquisition  settings  of the Zeiss  LSM510 
were kept the same for cultures that were labelled simultaneously i.e.  in the same 
labelling batches.  Between batches of specimens the settings were kept as close as 
possible.
2.7.5 Image analysis
ERK1/2 activation
To quantify the  spread of damage-induced ERK1/2  activation along the OHC  and 
IHC  region  a  line  scan  analysis  was  performed using  Metamorph  software.  Line 
widths of 30 (= 38 pm) and 20 pixels (= 25 pm) were applied for the OHC and IHC 
regions, respectively.  Line scan intensity data were exported into Microsoft Excel 
and then an average intensity and standard deviation was determined from 2 0  pixels 
along the line in two non-responding region.  Then this  average background value 
plus  10 times the standard deviation was used to set a threshold for the data. Pixels 
above the threshold value after subtraction were > 0  and these were considered to be 
positive  (sites  of activation).  At  the  edges  of the  activation  regions  the  signals 
dropped close below  0 for a few pixels and then rose above the threshold again at 
greater  distances.  In  order  to  treat  all  images  equally  the  following  rules  were
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applied: pixels below background (negative pixels) were included when three or less 
were  followed  by  any  number  of pixels  above  background  (positive  pixels;  see 
Table 2.7). If between 3 and 12 negative pixels were recorded, then there needed to 
be at least > 6 positive pixels for those negative regions to be included. If a run of 12 
negative pixels was observed ( ~ 2  cell widths) then this was considered the end of the 
spread and any further positive pixels were not included.  The distance in  pm was 
determined as the length between the first positive pixel at the lesion site and the last 
positive pixel that met the criteria described above. For the OHC region the extent of 
ERK1/2  activation  was  measured  on  both  sides  of the  lesion  and  averaged.  The 
spread along the IHC region was continuous (not separated by a lesion site), as the 
lesion was induced in the OHC region. Thus in order to make a comparison between 
the  IHC  and OHC  regions,  the  distance  measure  was  divided by two.  Data were 
statistically  evaluated  using  Students  f-test  and  where  necessary  using  one-way 
ANOVA.
Table 2.7: Rules that describe the handling of negative pixels for measuring activated ERK1/2 
spread.
No. of neg. pixels Rules (included, if...)
<3 any number of positive pixel follow
4-12 6 connected positive pixels follow
>  1 2 not included
Neomvcin-induced hair cell nvknosis
In this thesis the pyknotic nature of the nucleus  is used as  a measure of hair cell 
death.  The  number of pyknotic  and healthy nuclei  were  determined using  DAPI- 
labelled confocal z-stack images throughout the thickness of the cochlear epithelium. 
Nuclei  with  condensed  morphology  and  increased  intensity  were  counted  as 
pyknotic. The pyknotic nuclei count also included nuclei of extruded cells.
Signal noise of images was reduced by subjecting them to x-y pixel averaging and 
then  averaging  of two  adjacent  z-plane  images  (running  average)  using  Lucida
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imaging  software  (Andor,  UK).  DAPI-labelled  nuclei  were  binned  pyknotic  and 
morphologically  healthy  appearing  nuclei  for  the  IHC  and  OHC  regions  in 
460 x 230 pm images. In the OHC region morphologically healthy appearing nuclei 
were estimated from 1st row counts. Two to three 460 x 230 pm regions were imaged 
per  cochlear  culture  and  averaged  to  obtain  one  value.  Data  are  expressed  as 
pyknotic or total number of nuclei, comprised of healthy and pyknotic, per  1 0 0 pm. 
Two-tailed Student’s /-tests were used to evaluate statistical significances between 
groups.
2.7.6 Image presentation
Lucida,  Zeiss  LSM 5  (Zeiss,  UK)  and  Adobe  Photoshop  were  used  to  produce 
images for data presentation.
Averages of confocal z-stack images were prepared using Lucida (Andor, UK). For 
comparative studies the depth of the z-stack was kept the  same.  Zeiss LSM 5  was 
used  to  prepare  3-D  reconstructions  and  x-z  projections.  Five  consecutive  x-z 
projections  were  averaged  for  P2  receptor  presentation  using  Lucida  software. 
Images presented in this thesis were assembled in Adobe Photoshop.
2.8  Patch clamp
2.8.1  Electrode preparation
Glass  capillaries without filaments  (WPI, USA) were cleaned with  100% ethanol. 
Electrodes were pulled using a two step electrode puller (Narashige, Japan). Puller 
settings  were  chosen  to  obtain  electrode  resistances  between  3.0  and  4.0 MQ. 
Electrodes  were  front  and  back  filled  with  filtered  internal  solution  (Table  2.2). 
When recordings of purinergic agonist-induced currents were made, ATP and GTP 
were omitted from the internal solution. In all other cases the internal contained ATP 
and GTP as it was found that they improved the stability of recordings.
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2.8.3 Protocol
Acutely  isolated  cochlear turns  (see  2.2)  were  continuously  perfused  with  ACSF 
(Table  2.1)  which  was  saturated  with  9 5 %C> 2/5 %C0 2 .  Recordings  were  made  at 
room  temperature  from  Deiters’  cells  that  were  maintained  in  their  support  cell 
syncytium unless otherwise  stated.  Cochlear turns were visualised with an upright 
microscope  (Axioskop  2  FS,  Zeiss)  using  a  40x  Achroplan  water-immersion 
objective lens and differential interference contrast optics.  Currents were measured 
using a Multiclamp 700A amplifier and digitised using Digidata 2000  analogue to 
digital interface (Molecular Devices Inc, USA).
2.8.4 Seal formation
Positive pressure was applied to the electrode during micromanipulation to the level 
of the stereocilial bundles of hair cells using an automatic manipulator (Siskiyou Inc, 
USA).  When  the  electrode  entered  the  buffer  the  offset  current  due  to  slight 
differences between the electrode and bath potentials was  adjusted to zero.  Under 
visual  control  the  electrode  was  positioned  between  stereocilial  hair  bundles  and 
simultaneously lowered and brought forward to break through the reticular lamina at 
cell-cell junctions. Once in the epithelium the electrode was lowered to the level of 
Deiters’ cell nuclei. When an indent in the cell membrane due to the positive pipette 
pressure was observed, the pressure was released and slight suction applied to form a 
tight Giga-ohm seal. Whole-cell recordings were obtained by breaking into the cell 
using  negative  pressure.  Seal  formation  was  assessed  using  the  Clampex  9.2 
(Molecular  Devices  Inc,  USA)  seal  test  option  (10 mV  steps).  After  forming  a 
Giga-Ohm seal the capacitative transients were minimised using digital controls.
2.8.5 Whole cell recording protocols
Lesion protocol
In  order  to  record  damage-induced  currents  recordings  of whole-cell  or  whole- 
syncytium currents were made for -20 min from Deiters’ cells held at -90 mV prior 
to stimulation. Gap free recordings of 5 min lengths were made intercalated with a
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10 mV voltage step protocol to control for access and syncytial resistance (Rsync). At 
~23 min  a  lesion  was  induced  and  recorded  and  this  was  followed  by  a  further 
30 min of recording at which point a second lesion was made at the same site. In a 
subset of experiments  150 pM PPADS was applied 10 min before the second lesion 
was induced. Recordings were filtered at 1  khz and sampled at a frequency of 50 khz.
Puff protocol
The nucleotides ATP, ADP, UTP and UDP were puff applied to cochlear cultures as 
described earlier (see 2.4). Again, ionic currents were recorded from Deiters’  cells 
that were coupled to the support cell syncytium and held at -90 mV.
In a subset of experiments Deiters’ cells were subjected to octanol (1 mM) to record 
from  single  Deiters’  cells.  When  cells  had  been  uncoupled,  then  voltage  clamp 
protocols  could  be  applied.  The  current-voltage  relationship  (I-V)  of 
nucleotide-activated  currents  were  determined  for  spontaneously  or  octanol 
uncoupled Deiters’ cells by applying voltage-commands in a range from -100 mV to 
+60 mV in 40 mV increments. The voltage was stepped and 0.2 s afterwards the puff 
was automatically applied for 10 ms. In the same Deiters’ cell the voltage-activated 
currents were recorded in the absence of ATP application. Recordings were filtered 
at 1  khz and sampled at a frequency of 50 khz.
2.8.6  Analysis
Data analysis was performed using Clampfit 9.2 (Molecular Devices Inc, USA) and 
Microsoft  Excel.  For  presentation  purposes  the  current  traces  were  prepared  in 
Origin (Origin Lab Corp, USA).
Determination of syncytial Resistance (R^nr)
The  syncytial  resistance  (Rsync)  is  an  estimate  of  the  number  of  cells  in  the 
syncytium.  R Sync was estimated using a 10 mV voltage-step-protocol. The change in 
the steady-state current resulting from the voltage step was measured and R sync was 
determined using Ohms Law. The pre-lesion R sync  was compared to the post-lesion 
RS ync  following  the  5  min  recording.  Rsync  was  also  determined before  nucleotide 
applications.
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Determination of peak current and charge
The peak current was determined manually for damage-induced currents by placing 
the cursor over that point in the recording. The amount of charge moved during the 
onset and decline of the current was quantified using a specific Clampfit 9.2 function 
that measures the area between two cursors placed at the onset and at the point where 
the current had recovered to baseline. To assess the effect of PPADS the peak current 
and charge transferred were analysed for the second lesion in recordings made from 
control  and PPADS-exposed  cochlear  turns.  It was  found that  Rsync  was  different 
between  control  and  PPADS  data  sets  and  thus  consequently  the  magnitudes  of 
currents would be expected to differ. In order to normalise for the differences it was 
assumed that the peak current and Rsync relationship is approximately linear. Thus the 
values  obtained  for the  peak  current  and  charge  transferred  were  divided  by  the 
conductance  Gsync  (/„orm   = 11Gsync)  and  the  resulting  values  were  subjected  to
statistical analysis using Student’s /-test.
For  the  nucleotide-induced  currents  the  peak  current  and  total  charge  transferred 
were determined as described above except that specific Clampfit 9.2 functions were 
applied to obtain the peak currents in this case. Based on the biphasic response of the 
ATP-induced  current,  the  peak  currents  were  determined  for  the  initial  500 ms 
measured from the midpoint of the puff application and during the following 5.5 s. 
Two measures  of charge transfer were made.  The  first was measured for the  first 
500 ms and the second for 6 s from the onset of the current (this included the initial 
peak  current).  Subtraction  of the  charge  transferred  during  the  initial  peak  (first 
500 ms) from that of the 6 s response provides a measure of the charge transferred by 
the second current.
For the comparison of charge transferred during damage and in response to ATP the 
charge transfer was measured between the onset and the point at which the currents 
recovered to baseline in both cases.
Determination of the I-V relationship
In  order  to  resolve  the  ATP-activated  currents,  Deiters’  cell  currents  recorded  at 
various  voltages  in  the  absence  of ATP  application  were  subtracted  from  those
72Chapter 2 -  Material and Methods
recorded when ATP was applied. The peak of the ATP-activated current was plotted 
as a function of the applied voltage.
2.9  Sample numbers and statistical analysis
Experiments were performed on at least three cochlear cultures from three different 
animals. The experiments were conducted on at least two different days. N-numbers 
are  indicated  in  the  figure  legends.  All  data  are  presented  as  mean ± S.E.M. 
Statistical analysis was carried out using Student’s /-tests, unless otherwise stated.
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3.  The  mechanism  of  the  damage-induced  Ca2+ -wave 
formation
Damage of various kinds has been shown to elicit changes in intracellular Ca2+ in HC 
epithelia (Hirose  et al.,  1999;  Gale  et al.,  2004;  Matsui  et al.,  2004;  Piazza et al., 
2007). Both Gale et al. (2004) and Piazza et al. (2007) described the formation of an 
intercellular Ca2+ wave triggered by damage to a single HC in cochlear explants using
a  microelectrode  or  oscillating  probe.  The  intercellular  Ca2+ wave  was  shown  to
•  •  ? 1  
propagate  in  an  extracellular ATP-dependent  fashion  requiring the  release  of Ca
from intracellular HVsensitive stores. These studies focused on the propagation of the
Ca2+  wave  outwards  from  the  OHC  region  into  the  outer  sulcus  (OS)  region  of
cochlear explants. In this chapter it was investigated whether the Ca2+ wave induced
by  damage  to  the  HC  epithelium  also  propagates  into  other  regions  of cochlear
explants -  namely the HC region itself and inwards to the inner sulcus (IS region). In
this  study  a  larger  damage  stimulus  was  used  to  investigate  the  mechanisms
underlying  the  Ca2+  wave  propagation  induced  by  HC  damage.  Specifically,  the
source of Ca2+ necessary to constitute the damage-induced Ca2+ wave and the role of
P2 receptor activation were determined for the distinct cochlear regions. In addition
the  involvement  of gap junctions  in  the  propagation  of the  damage-induced  Ca2+
wave was assessed.
3.1  Damage elicits the propagation of an intercellular Ca2+ wave
To examine whether the Ca2+ wave propagates into the distinct cochlear regions, a 
cluster of cells were damaged in the HC region using a microneedle (Fig 3.1 A, C). 
Intracellular changes in  [Ca2+]  were monitored using the ratiometric  Ca2+ indicator 
Fura-2. Selected AR images from a time series data set reveal the propagation of the 
Ca2+ wave  (Fig 3.IB,  movie  1).  In agreement with previous reports  (Gale  et al., 
2004;  Piazza  et  al.,  2007)  damage  triggered  the  rise  in  intracellular  Ca2+  in  cells 
immediate to the lesion site. This rise subsequently travelled as an intercellular wave 
of cytoplasmic Ca2+ to further distances into the OS region comprised of Hensen and 
Claudius-like cells (Fig 3. IB).  In addition, it was observed that the Ca2+ wave also 
propagated in the IS and HC region (Fig 3.IB). ARs changes in the IS and HC region
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were  smaller than those  in the  OS  region.  Detailed examination of the  Ca2+ wave 
propagating in the HC region revealed two temporally distinct components -  in effect 
two waves. The first wave spread faster with a velocity of 40.7 ±5.4 pm/s (n = 11) 
and appeared to occur in a subset of cells in the HC region. The second slower wave 
seemed to involve all cells and travelled with a velocity of 13.7 ± 0.5 pm/s (n = 16), 
similar to that described for the OS region (Gale et al., 2004). The faster Ca2+ wave 
was not observed in the OS or IS region. The decline of intracellular Ca2+ to baseline 
levels was faster in the HC and IS region than in the OS region and occurred within 
90 s  following  the  insult.  In  contrast,  Ca2+  levels  in  the  OS  region  did  not  fully 
recover during the time course of the recording (150 s).
In  order  to  quantify  the  propagation  of  the  intercellular  Ca2+  wave  ARs  were 
determined in 20 x 20 pm ROIs placed at various distances from the lesion site (see 
Fig 3.2A, C, E and chapter 2.5.2). Fig 3.2B shows ARs as a function of time for the 
ROIs  displayed  in  Fig  3.2A.  The  graph  depicts  that the  Ca2+ wave  propagates  to 
distances up to at least 154- 168 pm from the lesion site and that the wave reaches 
the furthest ROI with a delay. The Ca2+ waves in the HC and IS region propagated to 
distances up to  120 -140 and  140- 160 pm from the lesion site, respectively.  The 
Ca2+ waves were characterised by a decrease in peak Ca2+ changes as a function of 
distance.  The magnitude of the Ca2+ changes in the HC and IS region were similar 
whereas those in the OS region were several magnitudes higher.
3.2  The  source  of  Ca2+  required  for  damage-induced  Ca2+  wave 
signals
Various  mechanisms  can  result  in  the  elevation  of intracellular  Ca2+  levels.  Two 
major mechanisms are the release of Ca2+ from intracellular stores via generation of 
IP3 or influx of extracellular Ca2+ facilitated by the opening of various types of Ca2+ 
channels in the plasma membrane. These Ca2+ sources were tested for their potential 
to  mediate  the  damage-induced  rise  in  intracellular  Ca2+  levels.  In  this  subset  of 
experiments half of the Ca2+ wave was imaged in order to maximise the  extent of 
Ca2+ wave propagation along the HC rows. Averages of the first 15 AR images from 
the time of the insult are compared in the presence of Ca2+ (Fig 3.3 A, movie 2) and in
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0 Ca2+  conditions  (Fig 3.3B,  movie 3).  Switching  to  0 Ca2+  significantly  reduced 
baseline Ca2+ levels (Ro) in the HC region but not in the OS or IS region (Table 2.3, 
2.5). In the OS region Ca2+ wave propagation was unaffected by 0 Ca2+ (Fig 3.3A, B). 
ARs expressed as a function of time shown at 154-182 pm confirmed that the extent 
of the Ca2+ wave propagation was not dependent on extracellular Ca2+ (Fig 3.4A). In 
contrast,  when  U73122,  a  PLC  inhibitor  was  used  to  prevent  release  from 
IP3-sensitive intracellular stores, Ca2+ wave propagation in the OS region was blocked 
(Fig 3.3C, Fig 3.4B, movie 4). A small rise in intracellular Ca2+ was observed at sites 
close to the lesion. When U73122 treatment was combined with 0 Ca2+ conditions the 
Ca2+  wave  in  the  OS  region  was  completely  abolished  (Fig  3.3D,  movie 5).  The 
damage-induced peak Ca2+ changes expressed as a function of the distance from the 
lesion site are shown in Fig 3.4D. The graph reiterates that in the OS region release of 
Ca2+ from IP3-sensitive intracellular stores was the key mechanism mediating Ca2+ 
wave propagation.
Propagation of the damage-induced Ca2+ wave into the IS region was not reduced in 
0 Ca2+ or by inhibition of PLC with U73122 (Fig 3.3A-C, Fig 3.5A, B). Assessing the 
damage-induced  peak  Ca2+  changes  gave  further  evidence  (Fig  3.5D,  Table 3.1). 
Application  of  U73122  in  0Ca2+  was  sufficient  to  significantly  decrease  the 
propagation of the Ca2+ wave at  100-120 and  140-160 pm but not at 60 -  80 pm 
from the lesion site into the IS region (Fig 3.5C, D, Table 3.1).
In order to examine the propagation of the Ca2+ wave along the HC rows AR images 
were  cropped to  only  show this  region  (Fig 3.6A-D).  As  described  earlier,  in  this 
region Ca2+ wave spread was characterised by two distinct waves. The fast Ca2+ wave 
was observed to spread at least 280 pm from the lesion site (Fig 3.6A). The slower 
Ca2+ wave did not reach such distances. 20 x 20 pm ROIs placed along the HC region 
(see Fig 3.8A) were used to determine the peak Ca2+ changes. Along the length of the 
HC  region  peak  Ca2+  changes  decreased  considerably  at  distances  > ~180 pm  at 
which the propagation was  only  facilitated by the  fast  Ca2+  wave  (Fig 3.6,  arrow; 
Fig 3.8B).  The  peak  Ca2+  changes  associated  with  the  fast  Ca2+  component  were 
maintained  at  a  small  but  consistent  level  at  distances  from  ~ 180 up  to  at 
least 260 pm (Fig 3.8B). In 0 Ca2+ the fast Ca2+ wave was abolished (Fig 3.6B). The
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damage-induced  rise  in  intracellular  Ca2+  was  attenuated  at  90-110 pm  and 
abolished at 190-210 pm from the lesion site (Fig 3.7A, B). The peak Ca2+ change 
was  significantly  reduced  in  0 Ca2+  at  all  distances  measured.  The  PLC  inhibitor 
U73122  reduced  the  magnitude  of  the  slow  Ca2+  wave  but  not  the  fast  wave 
(Fig 3.6C). U73122 significantly decreased the peak Ca2+ levels at distances between 
100  and  180 pm  from the  lesion  site  (Fig 3.7C,  D).  In 0 Ca2+ and the presence  of 
U73122,  propagation  of the Ca2+ wave was  limited to up  to  ~ 100 pm  in  the  HC 
region (Fig 3.6C, Fig 3.8  B).  Table 3.2 presents the  statistical  significances for the 
various conditions tested.
3.3  The  Ca2+ wave  spreads  in  an  ATP  dependent  manner  and  is 
sensitive to the gap junction inhibitor CBX
The damage-induced Ca2+ wave in the OS region was modulated by the release of 
extracellular ATP (Gale et al., 2004). In some systems, gap junctions are thought to 
mediate Ca2+ wave propagation (Sanderson et al.,  1990; Venance et al.,  1997). Here, 
it was  investigated whether  extracellular ATP  and  gap junctions  contribute  to  the 
propagation of the damage-induced Ca2+ wave into the distinct regions of the cochlear 
explant.
3.3.1 The effect of apyrase
In order to determine a role for extracellular ATP in mediating damage-induced rises 
in intracellular Ca2+, cochlear explants were exposed to the ATP-hydrolysing enzyme 
apyrase (40 U/ml).  Apyrase reduced the propagation of the Ca2+ wave into the OS 
region (Fig 3.9B, Fig 3.10A). In the presence of apyrase damage-induced peak Ca2+ 
changes  were  significantly  decreased  in  all  ROIs  in  the  distinct  cochlear  regions 
(Fig 3.9A, B; Fig 3.10A, D; Fig 3.11A, D; Fig 3.12A, D).
3.3.2 The effect of CBX
To examine whether gap junctions participate in the formation of the damage-induced 
Ca2+ wave, CBX (75 pM) -  an inhibitor of gap junctions -  was used. CBX reduced 
the  spread  of the  damage-induced  Ca2+  wave  into  the  OS  region  (Fig 3.9C).  A
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significant reduction in peak Ca2+ was observed at 98-126 and 154-182 pm from the 
lesion site (Fig 3.1 OB, E). In the IS region CBX affected Ca2+ wave propagation to a 
lesser degree (Fig 3.9C). A significant decrease in peak Ca2+ was only observed at 
100-120 pm from the lesion site (Fig 3.1 OB, E). In the HC region CBX reduced the 
spread of the Ca2+ wave (Fig 3.9C). In close proximity to the lesion site the peak Ca2+ 
changes were not modulated by CBX whereas at further distances of 80-100 and 120- 
140 pm they were significantly reduced by 23 and 30 % respectively (Fig 3.12B, E). 
However,  it  is  worth  noting  that  CBX  increased  Ro  values.  To  summarise  CBX 
attenuates the damage-induced Ca2+ wave in the distinct cochlear regions.
3.3.1 The effect of the combined treatment of apyrase and CBX
To investigate whether extracellular ATP and gap junctions act in parallel to facilitate 
the generation of the damage-induced Ca2+ wave, apyrase and CBX application was 
combined. Propagation of the damage-induced Ca2+ wave into the OS region in the 
presence of apyrase and CBX was attenuated to a greater extent than observed with 
either treatment alone (Fig 3.9D). Combining CBX and apyrase significantly reduced 
the  peak  Ca2+  levels  at  98-126 and  154-182 pm  from  the  lesion  site  compared  to 
apyrase  alone  (Fig 3.10C,  D).  In  contrast,  in  the  IS  and  HC  region  combined 
treatment  did  not  impose  an  additional  effect  to  that  of apyrase  alone  (Fig 3.9D; 
Fig 3.11C, D; Fig3.12C, E).
3.4  Purinergic mechanism of Ca2+ wave formation
3.4.1 Exogenous application of ATP elicits a Ca2+ wave
The experiments in the previous sections and those by Gale et al. (2004) suggest that 
ATP  is  a  mediator  of the  damage-induced  Ca2+  wave.  In  order  to  investigate  the 
presence of P2 receptors, ATP was locally puff-applied for 10 s in close proximity to 
the HC region of cochlear explants (Fig 3.13A).  Peak changes in intracellular Ca2+ 
were measured in ROIs as indicated in Fig 3.2A,  C  and E and used to  analyse the 
response of cells in the different cochlear regions. Cells in all regions showed a dose 
dependent  increase  in  Ca2+  (Fig 3.13).  Cells  recovered  to  baseline  within  ~ 60 s 
following  exogenous  application  of 1  pM ATP.  At higher concentrations  recovery
80Chapter 3 - Results
was slowed. In the OS region  100 pM ATP resulted in sustained elevation of Ca2+ 
(Fig 3.13B).
3.4.2  Ca2+ wave formation stimulated by other nucleotides
P2Y receptor subtypes are not only activated by ATP but also by other nucleotides 
and this knowledge can be used to establish a P2Y receptor expression profile. Here, 
UTP, UDP and ADP were investigated for their ability to elevate intracellular Ca2+ in 
the distinct cochlear regions.  AMP was used to test whether conversion of ATP to 
adenosine that acts on PI  receptors contributed to the rise in intracellular Ca2+. The 
nucleotides  (100 pM)  were  puff-applied  locally  and  analysis  was  carried  out  as 
described for application of ATP. The graph in Fig 3.14A depicts ARs as a function 
of time triggered by application of UTP (10 s), UDP (20 s), ADP (20 s) and AMP (20 
s) in the OS region. UTP elicited a rise in intracellular Ca2+ in the OS region that had 
not fully recovered to baseline  levels  150 s after application.  ADP  and UDP  were 
both sufficient to trigger an increase in Ca2+ levels; however the magnitude was less 
than  that  induced by  UTP  (Fig  3.14A, B).  AMP  did  not  cause  global  changes  in 
intracellular  Ca2+  levels.  However,  in  3/5  experiments  a  few  single  OS  cells 
responded with  a rise  in  Ca2+  during the  later phase  of the  time  course  (data not 
shown).  The  maximum  Ca2+changes  triggered  by  the  various  nucleotides  are 
summarised in Fig 3.14B. OS cells were characterised by P2Y receptors that are most 
sensitive  to  UTP  followed  by  the  rank  order ATP» UDP > ADP  to  trigger  an 
increase in intracellular Ca2+.
In the IS region, the rank was UTP > ATP »  ADP > UDP (Fig 3.15A, B). UDP was 
the least potent P2 receptor agonist in the IS region. AMP was not sufficient to induce 
changes in intracellular Ca2+ levels at any time in the IS region. Ca2+ responses to all 
nucleotides returned to baseline within 150 s (Fig 3.15A).
In the HC region ATP and UTP were similarly potent. The rank order of potency was 
ATP  = UTP > ADP = UDP  (Fig 3.16).  Again,  AMP  did  not  induce  a  rise  in 
intracellular Ca2+ at any time in the HC region. The Ca2+ responses to UTP, ADP and 
UDP recovered to baseline levels within 150 s (Fig 3.16A).
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3.5  Damage-induced  Ca2+  wave  propagation  is  sensitive  to  P2 
receptor antagonists
Previous  sections  of this  chapter  showed that  the  ATP-degrading  enzyme  apyrase 
significantly decreased the propagation of the damage-induced Ca2+ wave. Moreover, 
purinergic agonists triggered Ca2+ changes in distinct cochlear regions.  Here, it was 
investigated whether the broad spectrum P2 receptor antagonists PPADS and suramin 
affected  the  damage-induced  Ca2+  wave.  When  used  at  10 pM,  suramin  did  not 
decrease the damage-induced peak Ca2+ changes in any of the cochlear regions (data 
not shown).  However,  100 pM  suramin reduced the propagation  of the  Ca2+ wave 
into the OS, IS and HC region (Fig 3.17A, B). Peak Ca2+ changes were significantly 
reduced by suramin in the OS region at 98-126 and 154-182 pm, but not close to the 
lesion  site  (42-70 pm,  Fig  3.18A,  B)  and  at  all  distances  in  the  IS  region  (Fig 
3.19A, B).  In  the  HC  region  propagation  of the  slow  Ca2+  wave  appeared  to  be 
restricted whereas the fast Ca2+ wave was still observed in the presence of suramin 
(Fig  3.17B).  Peak Ca2+  levels  were  only  significantly  affected by  suramin  at  120- 
MO pm but not at distances closer to the lesion site (Fig 3.20A, B).
PPADS, another P2 receptor antagonist was not sufficient to reduce the propagation 
of the damage-induced Ca2+ wave when used at a concentration of 10 pM. In contrast, 
150 pM PPADS significantly restricted the propagation of the intercellular Ca2+ wave 
into  the  distinct  regions  of the  cochlear  explant  (Fig  3.17C,  D).  Quantification
^ I
revealed that PPADS  significantly decreased the peak Ca  changes at all distances 
into the OS, IS and along the HC region (Fig 3.18C, D -  3.20C, D, respectively).  As 
demonstrated for suramin, the fast Ca2+ wave was not abolished in the presence of 
PPADS (Fig 3.17D).
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3.6 Discussion
Characterisation of the Ca~ wave propagation
Damaging a cluster of cells in the HC region with a microneedle triggered a rise in 
intracellular Ca2+ in the cells surrounding the lesion site. The increase in intracellular 
Ca2+ propagated to neighbouring cells as an intercellular Ca2+ wave that travelled into 
all regions of the organ.  Propagation properties of the Ca2+ wave in the OS region 
were described previously (Gale et al., 2004; Piazza et al., 2007) and confirmed here. 
However, propagation of the Ca2+ wave in the HC region was markedly different in 
that it was formed by two waves. A faster wave reached distances of at least 280 pm 
and required entry of Ca2+ from outside the cell. It was followed by a slower wave 
that  spread over distances  of ~ 180 pm and was mediated by release  of Ca2+  from 
IP3-sensitive  stores.  Zero  Ca2+  conditions  or U73122  allowed the  isolation  of two 
waves  in  the  HC  region  and might  suggest that  different  cell  types  i.e.  HCs  and 
Deiters’ cells form the distinct waves.
The velocity and the source of Ca2+ that constituted the slower wave in the HC region 
were similar to that reported previously for the OS region (Gale et al., 2004).  In the 
IS region, the Ca2+ wave travelled with a similar velocity to that observed for the OS 
and the slow wave along the HC region. However, only the combined inhibition of 
IP3 production in 0 Ca2+ moderately reduced the spread of the Ca2+ wave in the IS 
region.  The  epithelium  in  this  region  is  relatively  thick  and  tightly  packed.  It  is 
therefore possible that the inhibitor as well as the chelator did not reach the target 
region and that residual Ca2+ was trapped between the cells. Assuming that there was 
good access for the solutions, then the simplest explanation is that the Ca2+ wave in 
the IS region depends upon a third mechanism. A wave was still observed in the HC 
region when 0 Ca2+ and U73122 were combined and perhaps this also depends on a 
third unknown mechanism. A variety of other mediators are reported in the literature 
to  induce  local  Ca2+  changes.  These  include  NAADP  that  releases  Ca2+  from 
lysosomal compartments, cyclic ADP ribose (cADPR) acting on ryanodine-sensitive 
stores as well as sphingosine-1  phosphate (SIP) (Berridge et al., 2003).  Ryanodine 
receptors are documented to be expressed in the cochlea and could therefore account 
for the third mechanism (Lioudyno et al., 2004; Grant et al., 2006; Morton-Jones et 
al., 2006).
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Recovery of the damage-induced Ca~ wave in the distinct regions 
The  kinetics  of recovery  of intracellular  Ca2+  was  also  different  in  the  distinct 
cochlear  regions.  In  the  OS  region,  prolonged  Ca2+  increases  were  observed 
compared with those in the IS or HC regions; the latter exhibited similar recovery 
kinetics. The mechanisms that trigger elevated intracellular Ca2+ levels and those that 
result in their removal determine the recovery kinetics. In the OS region the signals 
mediating the release of Ca2+ from intracellular stores might be maintained over an 
extended period compared to that in the HC and IS region; thus resulting in prolonged 
elevated  Ca2+  levels.  However,  these  results  could  also  reflect  the  engagement  of 
different  Ca2+  removal  mechanisms  in  the  OS  and  IS/HC  region.  The  Ca2+ 
homeostasis  of a  cell  can  be  re-established  via  various  mechanisms  that  include 
uptake into mitochondria or the endoplasmic reticulum (Rizzuto et al.,  1998; Boitier 
et al.,  1999). Also, the PMCA or the Na+-Ca2+ exchanger can facilitate extrusion of 
Ca2+  and  thus  accomplish  return  to  baseline  Ca2+  levels  (Ishida  and  Paul,  2005; 
Ficarella et al., 2007). In IHCs it has been shown that the PMCA, mitochondria and 
the endoplasmic reticulum are involved in re-establishment of Ca2+ levels following 
depolarization-induced Ca2+ changes  (Kennedy,  2002).  The mechanisms that act in 
the various cochlear support cell types are currently unknown.
In addition to the mechanisms discussed above, the activation of distinct signalling 
cascades might also modulate the recovery rate. Recently, it has been demonstrated 
that PKC activation mediates an increased removal rate of Ca2+ through a mechanism 
that  modulates  both  the  PMCA4  and  the  SERCA  pump  (Usachev  et  al.,  2006). 
Although  there  is  no  evidence  for  the  expression  of PMCA4  in  the  mammalian 
cochlea similar mechanisms could act at other PMCA subtypes (Dumont et al., 2001). 
It is possible that,  as  the  signalling cascades  activated by  damage  can vary  in the 
distinct cochlear regions  (see  chapter 4)  these may  consequently  alter the rates  of 
cytoplasmic Ca  removal.
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Ca~ wave propagation in an ATP dependent manner
The propagation of the damage-induced Ca2+ wave into the distinct regions  of the 
cochlea  was  mediated  by  the  release  of extracellular  ATP.  Data  presented  here 
confirm the results of Gale et al. (2004) for the OS region. In both HCs and Deiters’
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cells  exogenous  application  of  ATP  has  been  reported  to  trigger  increases  in 
intracellular Ca2+. HCs increased Ca2+ levels in an IP3 dependent fashion and removal 
of extracellular Ca2+ resulted in an increased Ca2+ response (Mammano et al.,  1999). 
This  phenomenon  showing  elevated  intracellular  Ca2+  levels  in  0 Ca2+  was  not 
documented during damage-induced signalling in the whole organ preparation in this 
thesis. ATP-induced elevations of intracellular Ca2+ in Deiters’  cells have also been 
proposed  to  require  intracellular  Ca2+  stores  (Dulon  et  al.,  1993;  Lagostena  and 
Mammano, 2001). Both reports describe that ATP induces Ca2+ changes in 0 Ca2+ but 
the levels were not quantified. Therefore, it is not possible to estimate any possible 
contribution of extracellular Ca2+ in their work. Hensen cells are reported to respond 
with a biphasic rise of intracellular Ca2+ composed of a faster and slower component 
when exposed to exogenous ATP (Lagostena et al., 2001). The faster component was 
similar to that observed here  dependent on  extracellular Ca2+,  whereas  the  second 
more  slowly  developing  rise  in  intracellular  Ca2+  resulted  from  the  opening  of 
IP3-sensitive stores, again similar to that shown here (Lagostena et al., 2001).  The 
faster rise coincided temporally with an initial fast inward current, suggesting a role 
for P2X receptors. Here, the absence of the fast damage-induced Ca2+ wave along the 
HC region in 0 Ca2+ suggests that it is mediated through activation of P2X receptors 
whereas the slower HVdependent wave, inhibited by U73122, was triggered through 
P2Y receptor activation.
Interpretation of Ca~ wave formation on the basis of the nurinergic agonist profile 
A P2 receptor activation profile was established for the distinct cochlear regions using 
various  purinergic  agonists.  The  distinct  cochlear  regions  were  characterised  by 
increased sensitivity to UTP and ATP over their dinucleotides. This profile suggests 
that the damage-induced Ca2+ wave was predominantly carried by UTP-sensitive P2 
receptors that are also characterised by sensitivity to ATP.  The receptors that meet 
these conditions are P2 Y2, P2 Y4 and P2Yn receptors (Nicholas et al., 1996; White et 
al., 2003; Wildman et al., 2003). Based on their sensitivities to UDP and ADP, the 
UDP sensitive receptor P2Y6 and ADP sensitive receptors might play a minor role in 
the formation of the damage-induced Ca2+ wave. However, it cannot be excluded that 
Ca2+ changes elicited by ADP and UDP result from contamination with ATP or UTP, 
respectively. The profiles do not exclude activation of P2X receptors which are likely
85Chapter 3 - Discussion
contribute to the Ca2+ wave in the HC and IS region as the combination of U73122 
with 0 Ca2+ reduced the damage-induced rise in intracellular Ca2+. In contrast, only 
IP3-sensitive stores mediated Ca2+ wave propagation in the OS region; thus indicating 
that P2Y receptors are activated exclusively.
Some differences were observed in the rank orders for the individual regions. In the 
OS region, cells were most sensitive to UTP followed by the rank order ATP »  UDP 
> ADP. By contrast, in the IS region cells were least sensitive to UDP suggesting that 
the involvement P2Y6 receptors is negligible in this region.  In the HC region ATP 
and UTP elicited equivalent changes in intracellular Ca2+.
In summary, all cochlear regions are characterised by a dominance of UTP-sensitive 
P2 receptors suggesting that the propagation of the damage-induced slow Ca2+ wave 
might be facilitated in the different regions by the same receptor subtype. In addition, 
P2X receptor activation is implicated to occur in the HC and possibly to some extent 
in the IS region.
P2 receptor classification -  based on the action of PPADS and suramin 
The P2 receptor antagonists PPADS and suramin reduced Ca2+ wave propagation in 
the distinct regions of cochlear explants, providing further support that ATP acts on 
P2 receptors  to  trigger  and propagate  the  damage-induced  Ca2+ wave.  PPADS  and 
suramin both decreased the spread of the slow wave but did not affect the fast Ca2+ 
wave along the HC region. Moreover, the HC region was less  sensitive to suramin 
compared to  the  OS  or IS  region which  suggests  the  involvement  of different  P2 
receptor  subtypes.  As  described  previously,  based  on  the  agonist  profiles  UTP- 
sensitive  P2  receptors  are  likely  the  main  carrier  of  the  damage-induced  slow 
Ca2+ wave into the distinct cochlear regions. P2 Y2 and P2Yn but not P2 Y4 receptors 
are  sensitive  to  suramin  (Communi  et  al.,  1999;  van  der  Weyden  et  al.,  2000; 
Wildman et al., 2003).  Thus, combining agonist properties with suramin sensitivity 
P2 Y2  and  P2Yn  receptor  subtypes  are potential  mediators  of the  damage-induced 
Ca2+ wave into the OS and IS regions. In contrast, a reduced action of suramin in the 
HC region suggests that P2 Y2 and/or P2Yn receptors are less involved than in the OS 
and IS region.
86Chapter 3 - Discussion
PPADS is not a potent antagonist at either P2Y2, P2 Y4 or P2Yn receptors (Communi 
et al.,  1999;  van der Weyden et al., 2000;  Wildman et al.,  2003).  Thus a different 
PPADS-sensitive  P2Y  receptor is  likely to  be  involved  in  mediating  the  damage- 
induced Ca2+ wave.  P2Yi and P2Y6 are sensitive to PPADS and could therefore play 
a role in the OS and HC region (King and Townsend-Nicholson, 2003). In contrast, 
only  P2Yj  but  not  P2Y6  according  to  the  agonist  profile  of the  IS  region  might 
participate in the formation of the Ca2+ wave in this region. Data are only available 
for the human P2Yn  receptor and therefore the profile of a rat P2Yn-like receptor 
could differ to that of the human analogue. P2 Y4 cannot be excluded as a candidate as 
suramin and PPADS are not active at this receptor subtype, and both antagonists were 
only sufficient to reduce, but not abolish the slow Ca2+ wave.
The  fast  wave’s  requirement  for  extracellular  Ca2+  suggests  involvement  of ion 
channels,  possibly  P2X  receptors.  However,  both  suramin  and  PPADS  are 
documented to inhibit various P2X receptors at concentrations lower than those used 
here (King and Townsend-Nicholson, 2003) (Rassendren et al.,  1997; Chessell et al., 
1998;  King  and Townsend-Nicholson,  2003).  The receptor that is  less  sensitive to 
both PPADS and suramin is the  P2 X4 receptor (Jones  et al.,  2000).  Therefore,  the 
only likely P2X receptor candidate in mediating the damage-induced fast Ca2+ wave 
is P2 X4.
Extrapolating the nature of P2 receptor subtypes that mediated the damage-induced 
Ca2+  wave  from  the  data  obtained  with  PPADS  and  suramin  is  challenging. 
Pharmacological  profiles  for  the  various  P2  receptors  were  determined  in 
heterologous  expression  systems  and  therefore  the  pharmacology  might  differ  for 
native  tissues.  In  addition,  coexpression  of P2Y  receptor  subtypes  and  heteromer 
formation of P2X receptors are likely to occur in a native tissue such as the cochlea 
and this can alter pharmacological profiles (Le et al., 1998; Liu et al., 2001; Gallagher 
and Salter, 2003).
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Fast Ca~ wave propagation -  other possible mechanisms
The  fast  Ca2+  wave  could  potentially  also  be  formed  through  the  action  of other 
mechanisms. Assuming that the fast Ca2+ wave occurs in Deiters’ cells ATP-induced 
depolarisation  could  be  transmitted  via  gap junctions  to  neighbouring  cells.  This 
could mediate depolarisation-induced activation of voltage-gated Ca2+ channels and 
Ca2+ influx. Voltage-gated Ca2+ channels have been extensively characterised in HCs 
(Platzer et al., 2000; Brandt et al., 2005), but only one report suggests their expression 
during early postnatal development in Deiters’ cells (Hafidi and Dulon, 2004).
Another possibility is that HCs are the mediators of the fast Ca2+ wave and this could 
be  accomplished  through  mechano-transduction  in  response  to  needle,  and  thus 
reticular lamina and fluid movement. However, if this were the case, a simultaneous 
response rather than a wave would be expected to occur and thus it is unlikely that 
this mechanism can account for the generation of the  fast Ca2+ wave.  HCs are not 
coupled by gap junctions.  Therefore, it can be excluded that this pathway mediates 
the fast damage-induced Ca2+ wave between HCs.
Considering aspects of in vivo setting
In  the  guinea pig,  it  has  been  demonstrated  that  ATP  levels  are  increased  in  the 
endolymph  following  exposure  to  noise  (Munoz  et  al.,  2001).  Thus,  the
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damage-induced Ca  waves described in this chapter are likely to also arise in vivo.
Reviewing these data in the context of in vivo settings modulation of the Ca2+ wave 
might occur for the following reason. Apical and baso-lateral sites of cochlear cells 
are  exposed  to  endolymph  and  perilymph,  respectively.  Both  Ca2+  and  K+  -  
constituents  that  differ  in  these  extracellular  fluids  have  been  demonstrated  to 
modulate  P2X  and  P2Y  receptor  responses,  respectively  (Ding  and  Sachs,  1999, 
2000; Kanjhan et al., 2003; Pitt et al., 2005). The experimental medium used, is most 
similar to  perilymph.  Therefore,  if ATP  were  released  into  endolymph  containing 
high K+ and low Ca2+ it is likely that a reduced fast Ca2+ wave might occur due to the 
lower Ca2+ concentration and thus reduced Ca2+  influx.  However,  in hair cells  the 
IP3-mediated intracellular Ca2+ changes were shown to be increased (Mammano  et 
al., 1999). In addition, the P2Y mediated response that can be modulated by increased
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K+ might increase in this environment enriched in K+ (Pitt et al., 2005). Thus, in vivo 
the ratio of the two mechanisms involved in the formation of the Ca2+ waves might be 
altered  and  consequently,  downstream  events  might  also  be  affected.  The  ion 
concentrations  of the  experimental  setting  described  in  this  chapter  more  closely 
represent those of the perilymph.  Thus, if ATP were released to the perilymphatic 
space, the Ca2+ waves triggered are likely similar to those described here.
To  summarise,  UTP  sensitive  P2Y2,  P2 Y4  and  P2Yn  receptors  are  the  main 
candidates for mediation of the damage-induced slow Ca2+ wave, but other PPADS 
sensitive receptors such as P2Y]  or P2Y6 cannot be completely excluded. The only 
P2X receptor likely to mediate the fast Ca2+ wave is the P2 X4 receptor subtype based 
on  its  insensitivity  to  PPADS  and  suramin.  Although,  other  Ca2+  permeable  ion 
channels might mediate the fast Ca2+ wave and cannot therefore be excluded.
The role of gap junctions
The involvement of gap junctions in mediating Ca2+ wave propagation is dependent 
on the cell or organ type investigated with some reports demonstrating a role whereas 
in  other cases  agents  that uncouple  gap junctions  had no  effect  (Sanderson  et  al., 
1990;  Venance  et  al.,  1997;  Newman,  2001;  Sung  et  al.,  2003).  Expression  and 
functional coupling of connexins has been demonstrated in the organ of Corti (Forge 
et al., 2003; Jagger and Forge, 2006). In this chapter, the gap junction inhibitor CBX 
reduced Ca2+ wave propagation  in  the  OS  and HC  region.  In  contrast,  Ca2+ wave 
spread in the IS region was reduced to a much lesser extent. This suggests that gap 
junctions might participate in the propagation of the Ca2+ wave into the OS region 
and along the HC region. IP3 induced Ca2+ wave propagation between OS cells has 
been suggested to require gap junctions (Beltramello et al., 2005; Zhang et al., 2005).
Besides functioning as gap junctions, connexins can also form hemichannels and their 
opening has been implicated in the release of extracellular ATP (Stout et al., 2002; 
Pearson et al., 2005). In the mammalian cochlea ATP release has been demonstrated 
following mechanical stimulation that was sensitive to CBX (Zhao et al., 2005). Thus 
ATP  release  through  hemichannels  might mediate  the  damage-induced  Ca2+  wave 
propagation described in this chapter.  However, CBX was recently found to inhibit
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P2 X7 receptors (Suadicani et al., 2006) and voltage-gated Ca2+ channels (Vessey et 
al., 2004). On the basis of the data presented here, P2 X7 receptors were thought not to 
be  involved  in  the  propagation  of the  damage-induced  Ca2+  wave  based  on  the 
antagonist profile and are therefore unlikely the target of CBX. In contrast, inhibition 
of voltage-gated Ca2+ channels by CBX cannot be excluded.
In  the  OS  region,  the  combined  application  of apyrase  and  CBX  resulted  in  an 
additional decrease in the Ca2+ wave compared to apyrase alone, suggesting that these 
mechanisms act synergistically. In contrast, the combined treatment with apyrase and 
CBX did not differ from exposure to apyrase alone in the HC region. This indicates 
that the underlying mechanisms might be the  same.  Both apyrase  and CBX might 
interfere with the presence of extracellular ATP -  apyrase hydrolysing ATP and CBX 
inhibiting ATP release.
Previous  work has  focussed  on  damage-induced  Ca2+  signalling  events  in  the  OS 
region of the mammalian cochlea (Gale et al., 2004; Piazza et al., 2007).  This chapter 
extended these  studies  by  investigating the properties  of the  damage-induced  Ca2+ 
wave spread in the HC and IS regions. The mechanisms underlying the formation and 
propagation  of the  damage-induced  Ca2+  wave  were  found  to  be  different  in  the 
distinct  cochlear  regions.  However,  a  key  mediator  for  the  damage-induced  Ca2+ 
wave in the entire cochlear explant was ATP. Propagation of the Ca2+ wave was also 
likely modulated by  connexins.  In  the  following  chapter  of this  thesis  one  of the 
downstream signalling targets of the damage-induced Ca2+ wave will be investigated.
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Fig 3.1 Time-series of a damage-induced Ca2+ wave.
A) Brightfield image of a cochlear culture focused at the level of the stereocilial hair bundles depicting the microneedle that was used to damage 
the HC epithelium. The cochlear culture is comprised of HC,  IS and OS.
B) Series of AR images showing the propagation of a damage-induced Ca2+ wave.
C) Brightfield  image of the same cochlear culture following damage.
The dotted  line indicates the lesion site.
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Fig  3.2  Properties  of  the  damage-induced  Ca2+  wave  in  the  distinct  regions  of 
cochlear explants.
A, C, E) Averages of 10 consecutive baseline subtracted AR images starting at the time of 
damage  merged  with  the  corresponding  brightfield  image  before  the  onset  of  the 
experiment. The white lines outline the HC region.
ROIs were placed at the following distances from the lesion site:
A)  42-70, 98-126 and  154-182 pm  in the OS region;
C)  40-60, 80-100,  120-140 pm  in the HC region and
E) 60-80,  100-120,  140-160 pm  in the  IS region.
B,  D,  F) The graphs  depict the ARs  as a function  of time for the  regions  of interest  in  the
(B)  OS  region,  (D)  HC  region  and  (F)  IS  region.  The  arrow  head  marks  the  time  of 
damage.  For the OS and  HC  region the AR were averaged for the two ROIs placed  at the 
same distance from the lesion site.
Scale bars 50 pm
— 42-70
—  98-126
—  154-182
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Fig  3.3  Characterisation  of  the  source  of  Ca2+  required  for  the  formation  of  the 
damage-induced Ca2+ wave.
A-D) Time  averages  (15 frames)  AR  images show the extent of Ca2+ wave  spread  in  (A) 
control, (B) 0 Ca2+, (C)  10 pM  U73122, (D) U73122 + 0 Ca2+.
Arrows  point  on  the  area  of the  HC  region  occupied  by  the  fast  Ca2+ wave,  n  £  3;  scale 
bar, 50 pm.
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Fig 3.4 The propagation of the damage-induced Ca2+ wave in the OS region.
A-C) In the OS  region: control (black) and treated  (grey) ARs as a function of time at  154- 
182  pm from the lesion  site showing  in  (A)  0  Ca2+,  (B)  U73122  and  (C)  U73122  +  0
Ca2+. Arrowheads indicate the time of damage.
D)  Peak  Ca2+  changes  as  a  function  of distance  from  the  lesion  site  for  control  (black), 
0 Ca2+ (red),  U73122 (grey),  U73122 + 0 Ca2+ (blue).
Mean ± S.E.M., n = 16 (control), n = 4 (0 Ca2+), n = 6 (U73122), n = 5 (U73122 + 0 Ca2+).
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Fig 3.5 The propagation of the damage-induced Ca2+ wave in the IS region.
(A-C)  In the  IS  region:  control  (black) and treated  (grey) ARs as a function of time at  100- 
120  pm  from  the  lesion  site  showing  in  (A)  0  Ca2+,  (B)  U73122  and  (C)  U73122  +  0
Ca2+. Arrowheads indicate the time of damage.
D)  Peak  Ca2+  changes  as  a  function  of distance  from  the  lesion  site  for  control  (black), 
0 Ca2+ (red),  U73122 (grey),  U73122 + 0 Ca2+ (blue).
Mean ± S.E.M., n = 16 (control), n = 4 (0 Ca2+) , n = 6 (U73122), n = 5 (U73122 + 0 Ca2+).
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Fig 3.6 Damage-induced Ca2+ wave propagation in the HC region.
A-D)  Time  series  of  AR  images  showing  the  damage-induced  Ca2+  wave  propagation 
along the HC region in (A) control, (B) 0 Ca2+, (C) U73122 and (D) U73122 + 0 Ca2+
Arrows indicate the region of the fast Ca2+ wave,  n £ 3; scale bar,  50 pm.
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Fig 3.7 Kinetics of two distinct Ca2+ waves in the HC region.
(A-F) In the HC region control (black) and treated (grey) ARs as a function of time at (A, C, 
E) 90-110 and  (B, D, F)  190-210  pm from the lesion  site  in  (A,  B) 0 Ca2+,  (C,  D)  U73122 
(E, F) U73122 + 0 Ca2+.
Arrowheads indicate the time of damage,  n =  16 (control),  n = 4 (0 Ca2+) ,  n = 6  (U73122), 
n = 5 (U73122 + 0 Ca2+).
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Fig 3.8 Two distinct Ca2+ sources are required for wave propagation in the HC region
A)  Image  illustrates the distribution  of 20 x 20  pm  ROIs  along  the  HC  for which  peak  Ca2+ 
changes were determined.  Merged brightfield and AR image as described in Fig 3.2.
B)  Peak  Ca2+  changes  expressed  as  a function  of distance  from  the  lesion  site  for  control 
conditions (black), 0 Ca2+(red),  U73122 (grey) and U73122 + 0 Ca2+ (blue).
n =  16 (control), n = 4 (0 Ca2+) ,  n = 6 (U73122), n = 5 (U73122 + 0 Ca2+).
98Chapter 3 -  Figures
control
apyrase + 
CBX
Fig  3.9  The  damage-induced  Ca2+  wave  is  modulated  by  extracellular  ATP  and 
require gap junctions.
A-D) Time  R  images  (15 frames from  damage  start)  in  (A)  control,  (B)  40  U/ml  apyrase,
(C)  75 pM CBX and  (D) apyrase combined with CBX.
Scale bar, 50 pm.
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Fig 3.10 Ca2+ wave propagation is sensitive to apyrase and CBX in the OS region.
A-C)  Control  (black) and treated  (grey) ARs  as  a function  of time at 154-182 pm from the 
lesion  site for explants exposed to  (A) 40 U/ml  apyrase,  (B) 75 pM  CBX and  (C)  apyrase 
and CBX combined. Arrowheads indicate the time of damage.
D, E) Peak Ca2+ changes as a function of distance from the lesion site in the OS region for 
(D) apyrase (APY) and combined with CBX and (E) CBX alone.
Mean  ±  S.E.M.,  n  =  19  (control/CBX),  n  =  11  (CBX),  n  =  21  (control/apyrase),  n =  9 
(apyrase),  n  =  11  (apyrase  +  CBX),  *  indicates  P  <  0.05  between  treated  and  control,  + 
indicates P < 0.05 between apyrase and apyrase + CBX, ANOVA + Student’s f-test.
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Fig 3.11 Apyrase and CBX modulate the damage-induced Ca2+ wave in the IS region.
A-C)  Control  (black) and treated  (grey) ARs  as  a function  of time at  100-120  pm from the 
lesion site for explants exposed to (A) 40  U/ml apyrase,  (B) 75  pM  carbenoxonlone  (CBX) 
and (C) apyrase and CBX combined. Arrowheads indicate the time of damage.
D, E)  Peak Ca2+ changes as a function of distance from the lesion site  in  the  IS  region for 
(D) apyrase (APY) and combined with CBX and (E) CBX alone.
Mean  ±  S.E.M.,  n  =  19  (control/CBX),  n  =  11  (CBX),  n  =  21  (control/apyrase),  n  =  9
(apyrase),  n  =  11  (apyrase  +  CBX),  *  indicates  P  <  0.05  between  treated  and  control, 
ANOVA + Student’s f-test.
101Chapter 3 -  Figures
A
o
00
£0
©
CO
o
00
CO
©
CO
2  - 
1.5  - 
1   -  
0.5  - 
0
apyrase
— i--------1 --------1 --------1 —
30  60  90  120
time [s]
B CBX
o
00
CO
©
co
LL_
0.5  -
0  30  60  90  120
time [s]
apyrase +CBX
2
1.5
1
0.5
0
30 60  90
time [s]
120
D
□  control 
0.6 
0.5  -
APY  ■  APY + CBX
x re
E
§   0.4
re
*   0.2
"
*  ^   *
i
_ r _
*   * _ x
*   *
■ L - 1 ^ J L .
40-60  80-100  120-140
distance from lesion [pm]
control  CBX
40-60  80-100  120-140
distance from lesion [pm]
Fig 3.12 Apyrase and CBX modulate the Ca2+ wave in the HC region.
A-C) Control  (black) and  treated  (grey) ARs  as  a function  of time at  120-140  pm from the 
lesion site for explants exposed to (A) 40  U/ml  apyrase  (APY),  (B) 75  pM  carbenoxonlone 
(CBX) and (C) apyrase and CBX combined. Arrowheads indicate the time of damage.
D, E) Peak Ca2+ changes as a function of distance from the lesion site in the HC region for
(D)  apyrase and combined with CBX and (E) CBX alone.
Mean  ±  S.E.M.,  n  =  19  (control/carbnexolone),  n  =  11  (CBX),  n  =  21  (control/apyrase), 
n =  9  (apyrase),  n  =  11  (apyrase  +  CBX),  *  indicates  P  <  0.05  between  treated  and 
control, ANOVA + Student’s f-test.
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Fig 3.13 Ca2+ changes triggered by exogenous application of ATP
A)  Schematic diagram illustrating puff application protocol.
B-D) ARs as a function of time in response to  1  (blue),  10 (red) and  100 pM ATP (black) in the 
(B) OS, (C) IS and (D) HC region. The solid black bar indicates duration of application.
E)  Peak Ca2+ changes for 1,10 and  100 pM ATP for the distinct regions of cochlear explants.
n £ 3 for each concentration.
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Fig  3.14  Purinergic  agonist-dependent  changes  in  intracellular  Ca2+  in  the  OS  region.
A)  Fura-2 ARs  as a function of time in response to application of 100 pM  UTP,  UDP, ADP and 
AMP  in  the OS  region.  Black  (10  s) and  blue  bar (20  s)  indicate the  duration  for  UTP  and  for 
UDP, ADP and AMP applications, respectively.
B) Peak Ca2+ changes induced by 100 pM ATP, ADP, AMP,  UTP and  UDP.
Mean ± S.E.M., n £ 3
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Fig 3.15 Purinergic agonist-dependent changes in intracellular Ca2+ in the IS region.
A)  Fura-2 ARs as a function of time in  response to application of 100  pM  UTP,  UDP, ADP and 
AMP  in the  IS  region.  Black (10 s) and  blue  (20  s)  bars  indicate the duration  for  UTP  and  for 
UDP, ADP and AMP applications, respectively.
B) Peak Ca2+ changes induced by 100 pM ATP, ADP, AMP,  UTP and UDP.
Mean ± S.E.M, n £ 3
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Fig  3.16  Purinergic  agonist-dependent  changes  in  intracellular Ca2+  in  the  HC  region.
A)  Fura-2 ARs as a function of time in response to application of 100  pM  UTP,  UDP, ADP and 
AMP to the HC region.  The black (10 s) and the blue (20 s) bars indicate the duration for UTP 
and for UDP, ADP and AMP applications, respectively.
B) Peak Ca2+ changes induced by 100 pM ATP, ADP, AMP,  UTP and UDP.
Mean ± S.E.M, n > 3
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Fig 3.17 P2 receptor antagonists suramin and PPADS reduce the damage-induced  Ca2+ 
wave.
(A-D) Time/AR averages  (15 frames from  start of damage) for (A) control  matched to  (B)  100 
pM suramin, (C) control matched to (D) 150 pM  PPADS.
Arrows indicate the fast Ca2+ wave in the HC region. Scale bar, 50 pm.
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Fig  3.18  The  effect  of  P2  receptor  antagonists  suramin  and  PPADS  on  the  damage- 
induced Ca2+wave in the OS region.
A,  C)  Control  (black)  and  treated  (grey)  ARs  as  a  function  of time  at  154-182  pm  from  the 
lesion  site  for  (A)  suramin  and  (C)  PPADS  exposed  explants.  Arrows  indicate  the  time  of 
damage.
B,  D)  Peak  Ca2+  changes  at  various  distances  from  the  lesion  site  for  control  (black)  and 
treated (grey) for (B) suramin and (D) PPADS.
Mean  ±  S.E.M.,  n  =  11  (suramin),  n  =  5  (PPADS),  n  =  7  (control/PPADS), 
*P < 0.05, Student’s f-test.
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Fig  3.19  P2  receptor  antagonists  suramin  and  PPADS  reduce  the  propagation  of  the 
damage-induced Ca2+wave into the IS region.
(A,  C)  Control  (black)  and  treated  (grey)  ARs  as  a  function  of time  at  100-120  pm  from  the 
lesion  site  for  (A)  suramin  and  (C)  PPADS  exposed  explants.  Arrows  indicate  the  time  of 
damage.
B,  D)  Peak  Ca2+  changes  at  various  distances  from  the  lesion  site  for  control  (black)  and 
treated (grey) for (B) suramin and (D) PPADS.
Mean  ±  S.E.M,  n  =  11 
*P < 0.05, Student’s  f-test.
(suramin),  n  =  5  (PPADS),  n  =  7  (control/PPADS),
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Fig  3.20  The  effect  of  P2  receptor  antagonists  suramin  and  PPADS  on  the  damage- 
induced Ca2+wave in the HC region.
(A,  C)  Control  (black)  and  treated  (grey)  ARs  as  a  function  of time  at  120-140  pm  from  the 
lesion  site  for  suramin  (A)  and  (C)  PPADS  exposed  explants.  Arrows  indicate  the  time  of 
damage.
B,  D)  Peak  Ca2+  changes  at  various  distances  from  the  lesion  site  for  control  (black)  and 
treated (grey) for (B) suramin and (D) PPADS.
Mean  ±  S.E.M,  n  =  11  (suramin),  n  =  5  (PPADS),  n  =  7  (control/PPADS), 
*P < 0.05, Student’s  f-test.
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4.  Mechanism  and  downstream  effect  of  damage-induced 
ERK1/2 activation
One of the signalling pathways activated as a result of toxic and mechanical insults is 
the MAPK signalling cascade leading to the phosphorylation,  i.e.  the activation,  of 
ERK1/2 (Nowak, 2002; Neary et al., 2003; Matsubayashi et al., 2004; Subramaniam 
et  al.,  2004).  Both  pro-survival  and  pro-death  signalling  are  suggested  to  be 
downstream  of ERK1/2  (Xia  et  al.,  1995;  Nowak,  2002;  Sperandio  et  al.,  2004; 
Subramaniam  et  al.,  2004;  Chen  et  al.,  2005;  Arthur  et  al.,  2006).  This  chapter 
examines whether ERK1/2 are activated in neonatal rat cochlear explants as a result 
of mechanical  damage  induced with  a N2-laser  or a microneedle.  Both techniques 
allowed  precise  timing  of the  onset  of damage.  An  antibody  against  the  dually 
phosphorylated i.e. the activated form of ERK1/2 was used to determine the spatio- 
temporal activation pattern, the cellular and subcellular distribution, and to study the 
mechanism leading to ERK1/2 activation. In a subset of experiments HCs in cochlear 
explants  were  targeted  by  exposure  to  the  ototoxic  aminoglycoside  antibiotic 
neomycin in order to determine whether toxic compared to traumatic stimuli trigger 
the  activation  of ERK1/2.  Subsequently,  this model was  used to  study the  role  of 
ERK1/2 during aminoglycoside toxicity.
4.1 Mechanical damage induces ERK1/2 activation
4.1.1 Spatio-temporal aspects of N2-laser induced ERK1/2 activation
To investigate whether signalling via the ERK1/2 pathway occurs as a consequence 
of  damage  to  the  mammalian  cochlea,  the  HC  epithelium  of neonatal  cochlear 
explants was damaged using a N2-laser. A typical lesion site at 1  min post damage is 
displayed in Fig 4.1.1 A where the actin-rich stereocilia of hair bundles are displaced 
or absent. Fig 4.1. IB is a representative image of the cochlear HC epithelium at 1  min 
post damage showing sporadic activation of ERK1/2 in a small number of cells in the 
epithelium. The pattern was not particularly coordinated with the lesion site. On the 
contrary, at 10 min post damage (Fig 4.1.2C) strong ERK1/2 activation was observed 
around  the  lesion  site.  The  spatial  pattern  was  non-uniform  with  activation 
predominantly along the HC rows (Fig 4.1.2C).  Within 30 min the spread of ERK1/2
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activation had retracted to cells in close proximity to the lesion site (Fig 4.1.ID) and 
signals returned to baseline levels 60 min post damage (Fig 4.1.IE).
The distance that activated ERK1/2 spread along the sensory region of the cochlear 
turn was quantified by performing a linescan analysis. Specifically, lines were placed 
separately along the OHC and IHC regions (Fig 4.1.IF). Both regions are comprised 
of sensory HCs and their non-sensory support cells (see  1.1). Fig 4.1.1G shows the 
spread of activated ERK1/2 as a function of time after damage. In the OHC region, 
ERK1/2 were first observed to be activated 2 min after damage at which point the 
signal had already spread 27 ± 12 pm (n = 9) from the lesion site.  Over the following 
minutes  the  spread of activated ERK1/2  increased reaching  a peak  at  10 min post 
damage of 130 ± 19 pm (n = 5).  The spread then declined resulting in ERK1/2 being 
activated only in cells lining the lesion site 30 min post damage (17 ± 7 pm, n = 4, 
Fig 4.1.ID, G) and by 60 min post damage ERK1/2 activation returned to baseline 
levels (1  ± 1  pm, n = 4, Fig 4.1.IE, G). The timecourse of ERK1/2 activation in the 
IHC region was similar to that in the OHC region with it first being observed at 2 min 
post damage (47 ± 13 pm, n = 9). In contrast to the OHC region the maximum spread 
of 92 ± 10 pm (n = 21) was detected at 5 min post damage after which the spread of 
ERK1/2 activation decreased to only cells in immediate proximity to the lesion site 
(22 ± 13 pm at 30 min post damage, n = 4, Fig 4.1.ID, G). At 60 min post damage 
ERK1/2 activation also returned to baseline in the IHC region.
4.1.2  Cellular and subcellular localisation of ERK1/2
The spatial pattern of ERK1/2 activation shown in Fig 4.1.1C suggested a cell-type 
specific activation. 3-D reconstructions (Fig 4.1.2A, B, movie 6) and orthogonal x-z 
projections of confocal z-stack images (Fig 4.1.2C-E) confirmed that ERK1/2 were 
activated in a cell-specific manner.  ERK1/2  activation was observed in cell bodies 
and phalangeal processes of Deiters’  cells (Fig 4.1.2A, E) that line the baso-lateral 
sites of OHCs (Fig 4.1.2A, E; see introduction Fig  1.1). Activated ERK1/2 was not 
detected  in  OHCs.  Similarly,  phalangeal  cells  also  exhibited  ERK1/2  activation 
(Fig 4.1.2B, E). Again, IHCs situated in the “cups” of phalangeal cells did not exhibit 
ERK1/2 activation. A few pillar cells (Fig 4.1.2A, B) activated ERK1/2 as a result of 
damage. In contrast to the spread of ERK1/2 activation along the rows of Deiters’ and
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phalangeal cells the activation in pillar cells remained restricted to the proximity of 
the lesion site.
The  subcellular distribution of ERK1/2  is  crucial  for it to  initiate  specific  cellular 
programs.  The  orthogonal projection  of activated  ERK1/2  counterstained  with  the 
nuclear marker DAPI (Fig 4.1.2C-E) revealed that in Deiters’ cells it was localised to 
the nucleus and cytoplasm of Deiters’ cells.
4.1.3  ERK1/2 activation occurs in a classical manner via the activation of c-RAF 
and MEK1/2
The ‘textbook’ mechanism of ERK1/2 activation occurs following stimulation of cell 
surface receptors that initiate the activation cascade via MAPKKKs  such as  RAFs 
that subsequently phosphorylate MEK1/2. MEK1/2  then dually phosphorylates and 
activates  ERK1/2.  Here,  it was  determined whether  damage-induced  activation  of 
ERK1/2  was  also  mediated  through  the  classical  activation  cascade  using  a  cell- 
permeant inhibitor that targets cRAFl (Lackey et al., 2000) and U0126 which inhibits 
MEK1/2  (Favata  et al.,  1998).  The  application  of the  cRAFl  inhibitor  elicited  an 
increase in basal levels of ERK1/2 activation in the cytoplasm both of HCs and of 
support cells in undamaged areas.  In support cells nuclear localisation of activated 
ERK1/2 was also observed (Fig 4.1.3B, b). In the presence of the c-RAFl  inhibitor 
the damage-induced increase in activated ERK1/2 appeared to be restricted to only a 
few support cells lining the lesion site (Fig 4.1.3 A, B).
Application  of the  MEK1/2  inhibitor  U0126  abolished  basal  and  damage-induced 
activation of ERK1/2  (Fig 4.1.3C).  To  confirm that a lesion was  introduced to the 
sensory epithelium the corresponding image  labelled for actin rich  stereocilial hair 
bundles  is  shown  in  Fig  4.1.3D  and  displays  a  typical  lesion  site  at  5 min  post 
damage.  Taken  together,  these  data  show  that  the  damage-induced  activation  of 
ERK1/2 occurred via the classical Raf and MEK1/2 dependent activation cascade.
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4.1.4  ERK1/2  activation  depends  on  the  release  of extracellular  ATP  and  is 
sensitive to CBX
Recently  and  in  the  previous  chapter,  it was  shown  that  HC  damage  triggers  the 
formation  of  a  Ca2+-wave  in  cochlear  explants  that  depends  on  the  release  of 
extracellular  ATP  (Gale  et  al.,  2004).  The  release  of extracellular  ATP  and  its 
subsequent  action  on  P2  receptors  have  been  suggested  to  elicit  stretch-induced 
activation of ERK1/2 in astrocytes (Neary et al., 2003). Therefore it was tested here 
whether extracellular ATP released as a result of HC damage activates ERK1/2  in 
cochlear explants. In order to investigate this potential mechanism explants were pre­
incubated  for  30 min  and  then  maintained  in  the  ATP  degrading  enzyme  apyrase 
(40 U/ml). The spread of activated ERK1/2 was determined using line scan analysis 
along the OHC and IHC rows as described earlier. Apyrase significantly reduced the 
damage-induced spread of ERK1/2 along the Deiters’ cells in the OHC region from 
148 ± 18 pm (n = 9; Fig 4.1.4A) to 58 ± 7 pm (n = 4) 5 min after damage (Fig 4.1.4B,
E). Along the phalangeal cells in the IHC region apyrase also decreased the spread of 
activated ERK1/2, however this was not statistically significant (97.1 ± 9 pm, n = 9 to
69.6  ±2. lpm ,  n = 4,  P = 0.074,  Fig  4.1.4B,  E).  Although  apyrase  reduced  the 
magnitude  of  activated  ERK1/2  spread  it  did  not  completely  abolish  ERK1/2 
activation. One potential reason could be an inefficiency of the enzyme to eliminate 
an excess  of released ATP.  However,  it could also  suggest the  involvement of an 
ATP-independent  mechanism.  To  reemphasise,  activated  ERK1/2  spread 
preferentially along Deiters’ and phalangeal cells, the cells that are known to possess 
extensive gap junctional plaques and to efficiently couple to one another (Forge et al., 
2003; Jagger and Forge, 2006). To investigate whether a signal that passes through 
gap  junctions  mediates  the  damage-induced  spread  of  ERK1/2  activation  CBX 
(75 pM) -  a gap junction blocker -  was used. CBX significantly reduced the spread 
of activated  ERK1/2  both  along  Deiters’  (23 ± 7 pm,  n = 4)  and  phalangeal  cells 
(19.3 ± 10.9 pm,  n = 4;  Fig 4.1.4C, E)  suggesting  a  role  for  gap  junctions  in 
mediating  spread of the  signal  activity  of ERK1/2.  When  apyrase  and  CBX  were 
applied together ERK1/2 activation was almost completely abolished (Fig 4.1.4D). In 
a few cases it was observed that ERK1/2 was activated and spread along Hensen cells 
(Fig  4.1.4D).  Comparing  ERK1/2  spread  in  explants  damaged  in  the  presence  of 
apyrase to those treated with apyrase and CBX revealed a significant effect for both
114Chapter 4 - Results
the IHC and the OHC region (Fig 4.1.4E). The statistical significance of the spread in 
explants that were exposed to CBX alone compared to those that were additionally 
treated with apyrase was  statistically  different only  for the  OHC  region  (P < 0.05, 
whereas for IHC P = 0.27).
4.1.5  Purinergic activation of ERK1/2
4.1.5.1 Activation of ERK1/2 by local application of ATP
Reduction of ERK1/2  spread in the presence  of apyrase  suggests that extracellular 
ATP is a mediator of damage-induced activation of ERK1/2.  If ATP is essential to 
facilitate the  damage-induced activation of ERK1/2  exogenous  application  of ATP 
should  be  sufficient  to  induce  ERK1/2  activation.  ATP  was  locally  applied  to 
cochlear explants using a micropipette. Exogenous ATP resulted in the activation of 
ERK1/2  in a concentration-dependent manner.  1  pM ATP applied for  10 s was not 
sufficient to induce ERK1/2 activation (Fig 4.1.5A). However, as observed in chapter 
3,  1  pM  ATP  for  10 s  was  able  to  activate  P2 receptors  and  trigger  increases  in 
intracellular Ca2+. Application of 10 pM ATP (10 s) elicited ERK1/2 activation local 
to  the  puff  site  (Fig4.1.5B).  In  contrast, 100 pM  ATP  (Fig4.1.5C)  applied  for 
10 s resulted  in  a  strong  cell-specific non-uniform  activation  of ERK1/2  along the 
length  of the  cochlea.  Orthogonal  projections  of confocal  z-stack  images  reveal 
ERK1/2 activation in Deiters’ and inner phalangeal cells but not in HCs (Fig 4.1.5c). 
In Claudius-like cells ERK1/2 activation was minimal. The cellular distribution and 
spread  of activated  ERK1/2  in  response  to  100 pM  ATP  was  very  similar  to  that 
observed following damage.
4.1.5.2 Profiling P2Y-receptor responses with UTP, UDP and ADP
Only a few specific pharmacological antagonists are available in order to distinguish 
between different receptor subtypes. However, agonists such as UTP, UDP and ADP 
are  widely  used  to  differentiate  between  various  P2Y  receptor  subtypes  (see 
section 1.3). Therefore application of different purinergic agonists was used to profile 
receptor expression. Local application of 100 pM UTP for 10 s elicited the activation 
of ERK1/2 in Deiters’ cells but not in pillar, phalangeal or HCs (Fig 4.1.5D, d). The 
activation of ERK1/2 occurred along the length of Deiters’  cell rows. The intensity
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levels of ERK1/2 activation for UTP were lower compared to ATP in pairs matched 
for laser and acquisition settings Fig 4.1.5C, D). UDP (Fig 4.1.5E) and 100 pM ADP 
(Fig4.1.5F) applied for 20 s  each were not sufficient to activate ERK1/2,  although 
these agonists were shown to trigger a rise in intracellular Ca2+ levels but to a lesser 
degree than ATP or UTP (see chapter 3.5.2). Taken together, only ATP and UTP are 
potent to induce ERK1/2 activation.
4.1.6  ERK1/2  spread  is  insensitive  to  the  P2  receptor  antagonist  PPADS  and 
suramin
The reduction of damage-induced ERK1/2 spread in response to the degradation of 
ATP  by  apyrase  suggests  an  ATP-dependent  mechanism.  Moreover,  exogenous 
application of ATP and UTP were sufficient to mimic the damage-induced ERK1/2 
activation  pattern  thus  suggesting  that  P2  receptors  are  the  likely  mediators  of 
ERK1/2 activation. To investigate the involvement of P2 receptors in the activation of 
ERK1/2,  two  common  P2  receptor  antagonists  PPADS  (150  pM)  and  suramin 
(100 pM)  were  used.  Treatment  with  PPADS  (Fig 4.1.6A, B, E)  or  suramin 
(Fig 4.1.6C, D, E) did not result in decreased spread of activated ERK1/2  at 5  min 
post  laser  damage.  The  cellular  localisation  and  the  subcellular  distribution  of 
activated ERK1/2 in the cytoplasm and nuclei were also not affected by the presence 
of  PPADS  (Fig 4.16b)  or  suramin  (Fig4.1.6d)  compared  to  their  corresponding 
controls (Fig 4.16a, c, respectively).
4.1.7 ERK1/2 activation is dependent on the presence of extracellular Ca2+
As shown earlier the damage-induced activation of ERK1/2 and the generation of the 
Ca2+-wave similarly require the release of extracellular ATP. In addition, in many cell 
types  ERK1/2  activation  occurs  in  a  Ca2+-dependent  manner  (Neary  et  al.,  2003; 
Kupzig et al., 2005) leading to the question of whether changes in cytoplasmic Ca2+ 
levels are necessary for ERK1/2 activation. In chapter 3, describing the formation of 
the damage-induced Ca2+-wave it was observed that two distinct waves characterised 
by their velocity and origin of Ca2+ travel along the HC region. The faster wave was 
facilitated  by  the  entry  of extracellular  Ca2+  suggesting  the  requirement  for  ion 
channels;  potentially  a  P2X  receptor  dependent  mechanism.  Here,  it  was  tested
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whether removal of extracellular Ca2+ also affects activation of ERK1/2.  In 0 Ca2+ 
ERK1/2 were activated; however the spread along the Deiters’ cells was significantly 
reduced at 10 min post damage from 94.3 ± 19.9 pm in controls to 44.2 ± 10.5 pm in 
0 Ca2+ (Fig 4.1.7A-C) but not at 5 min post damage (P = 0.14, Fig 4.1.7C). Although 
the  levels  of activated  ERK1/2  were  not  quantified,  the  apparent  intensity  of the 
staining  in pairs  matched for laser excitation  strength  was  consistently reduced  in 
0 Ca2+ (Fig 4.1.7A, B). The cellular and subcellular distribution of activated ERK1/2 
as seen in orthogonal projections of z-stack images in 0 Ca2+ was similar to controls. 
Next,  it was  assessed whether global  Ca2+  changes  are  critical  to  induce  ERK1/2 
activation following pre-incubation of cochlear cultures for 90 min in the membrane- 
permeable  Ca2+-chelator  BAPTA-AM  (10 pM).  During  these  experiments  the 
formation of the Ca2+ wave in response to damage was monitored and the explants 
were then processed to study ERK1/2 activation. In order to measure the extent of the 
Ca2+ wave a lower magnification objective  lens  (20 x)  was  required.  The N2  laser 
could  not be  used with  this  lens  and  so  the  HC  epithelium  was  damaged  with  a 
microneedle (as described previously).  The pattern of activated ERK1/2 spread and 
its cellular and subcellular localisation were similar in response to damage induced 
with a microneedle to that observed when the HC epithelium was ablated with a N2 
laser (Fig 4.1.7D compare to A, d). In the presence of BAPTA the spread of activated 
ERK1/2 was not significantly reduced at 5  or  10 min post damage  (Fig 4.1.7D-F). 
Furthermore,  BAPTA  did  not  affect  the  cellular  or  subcellular  distribution  of 
activated  ERK1/2.  Ca2+  imaging  experiments  confirmed  that  BAPTA-AM  was 
sufficient to  chelate  a  significant  amount  of the  rise  in  Ca2+,  decreasing  the  peak 
changes  in intracellular Ca2+ to 26.5 ± 3.3 %  of control  levels  at 70-90  pm and to
21.5  ± 3.2 % at  110-130 pm (Fig 4.1.7G)  and was at least if not more potent than 
removal of extracellular Ca2+(Fig 4.1.7 G).
4.2  The activation and role of ERK1/2 during neomycin-induced hair 
cell death
4.2.1  Characterisation of neomycin-induced hair cell death
Aminoglycoside antibiotics are known to be ototoxic both in vivo and in vitro (Forge 
and Schacht, 2000; Wang et al., 2003a). Recent reports have indicated that they enter
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HCs  via  the  mechano-transduction  channel  and  therefore  specifically  target  these 
cochlear cells (Gale et al., 2001; Marcotti et al., 2005). In order to determine whether 
ERK1/2  activation  is  a  common  damage  signalling  event  in  the  rat  cochlea  the 
aminoglycoside antibiotic neomycin was used to induce HC death specifically. Basal 
and middle turn cochlear explants were exposed to  1  mM neomycin for 8 or 24 hrs. 
First, it was confirmed that HCs are damaged after 8 hrs of neomycin treatment using 
i) the DNA intercalating agent DAPI to assess nuclear morphology and ii) fluorescent 
phalloidin to monitor the integrity of actin-rich hair bundles.  A significant number of 
IHC  nuclei  were  observed  to  show  signs  of condensed  chromatin  after  8 hrs  of 
neomycin  exposure  (Fig 4.2.IB).  IHCs  with  pyknotic  nuclei  characteristically  had 
missing  or  damaged  hair  bundles  (Fig 4.2.1 A).  At  this  time  point  OHCs  mostly 
appeared healthy as assessed by the integrity of their nuclei and hair bundles. After 
24 hrs exposure to neomycin only pyknotic nuclei lined the length of the IHC row 
which was also marked by the absence of hair bundles.  OHC nuclei show different 
degrees of chromatin condensation and disordered organisation (Fig 4.2.1H).  Again 
the hair bundles of OHCs marked by pyknotic nuclei were either lost or damaged and 
dysmorphic (Fig 4.2.1G). It is known that HCs in the base of the cochlea are more 
sensitive to ototoxic  stress than those further apical.  The  same trend was  observed 
during these experiments between basal and middle turn cochlear explants for both 
IHCs and OHCs (Fig 4.2.2).
4.2.2  Characterisation of neomycin-induced ERK1/2 activation
ERK1/2 activation during exposure of cochlear explants to neomycin was assessed 
using  immunocytochemistry  as  described  earlier.  ERK1/2  activation  followed  the 
pattern of cell damage as indicated by the presence of pyknotic nuclei. The formation 
of pyknotic  IHC  nuclei  after  8 hrs  of neomycin  exposure  coincided with  ERK1/2 
activation in phalangeal and border cells  (Fig4.21C, D, f - f ’).  On rare  occasions, 
ERK1/2  activation could be observed in HCs.  Activated ERK1/2  was  observed in 
both  clusters  and  single  cells  and  in  almost  all  cases  the  cells  were  adjacent  to 
pyknotic  nuclei.  On  occasion,  single  Deiters’  cells  as  indicated  by  its  phalangeal 
process  in Fig4.2.1C&D  exhibited ERK1/2  activation although the OHC  nuclei  in 
those regions appeared healthy.  However, after 24 hrs exposure to neomycin when 
pyknotic  OHC nuclei were present clusters of cells labelling for activated ERK1/2
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were  frequently  observed  in  the  OHC  region  (Fig 4.2.11, J).  Again,  the  cells  that 
activated  ERK1/2  were  support  cells  -   the  Deiters’  cells  and  they  surrounded 
pyknotic HC nuclei.  At this time point although pyknotic IHC nuclei were present 
ERK1/2 activation was observed less frequently compared to that in the OHC region. 
Along the  OHC rows  the  labelling  intensity  for activated ERK1/2  varied between 
distinct clusters of cells.
4.2.3  The effect of U0126 on neomycin-induced hair cell death
Here, the role of ERK1/2 during neomycin-induced HC death was examined using 
the MEK1/2 inhibitor U0126.  Cochlear explants were exposed to neomycin alone or 
in  the  presence  of U0126  (10 pM)  or  its  inactive  analogue  U0124  (10 pM).  As 
expected, the activation of ERK1/2 was abolished by U0126 but not by U0124 treated 
neomycin-exposed cochlear explants. To quantify the effect of U0126 the number of 
pyknotic  HC  nuclei  of  DAPI  stained  explants  were  determined.  After  8 hrs  of 
neomycin  in  the  presence  of  U0126  the  number  of  pyknotic  IHC  nuclei  was 
significantly decreased compared to neomycin treatment alone  (Fig 4.2.3).  Along a 
100 pm  segment  of a  cochlear  coil  on  average  11  IHCs  were  present  in  control 
explants  (Fig 4.2.6).  After  8 hrs  of neomycin  there  were  4.9 ±  1.2  pyknotic  IHC 
nuclei/100 pm and when U0126 was included in the media the number was reduced 
to  1.0 ±0.4/100 pm (Fig4.2.6A).  The inactive analogue U0124 during exposure to 
neomycin resulted in similar numbers of pyknotic IHC nuclei (4.0 ± 1.6/100 pm) as 
in neomycin only treated explants (Fig 4.2.6A). The number of pyknotic OHC nuclei 
was relatively low at 8 hrs and so no differences were observed for the various test 
conditions  (Fig 4.2.3,  Fig4.2.8A).  Along  a  100 pm section  of the  cochlear coil  on 
average  40  OHCs  are  arranged  in  the  three  rows.  After  24 hrs  of neomycin  only 
pyknotic  nuclei  lined  the  IHC  row  (Fig 4.2.4).  When  U0126  was  applied  IHC 
pyknotic nuclei were observed at this time point, showing that the protective effect of 
U0126 was only temporary (Fig 4.2.4). Fewer pyknotic OHC nuclei were present at 
24 hrs when neomycin exposed explants were treated with U0126. Neomycin induced 
21.9 ±5.8  OHC  nuclei/100 pm  to  undergo  nuclear  condensation  whereas  in  the 
presence  of U0126  only  11.9 ±5.8  pyknotic  OHC  nuclei/100 pm  were  observed 
(Fig 4.2.8A).  However,  this  reduction  was  not  statistically  significant  (P = 0.26, 
n = 4).  As basal levels of activated ERK1/2 most likely play a pivotal role during
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normal  HC  physiology  it  was  tested  whether the  application  of U0126  to  control 
explants for 24 hrs affects cochlear HC integrity.  The number of IHCs per  100 pm 
was  not  significantly  changed.  However,  in  explants  treated  with  U0126  only
35.4 ± 1.2 OHCs/100 pm  were  observed  in  comparison  to  normally  occurring
40.2  ± 0.9 OHCs/100 pm across the three rows of OHCs. This effect was significant 
(P < 0.03). To summarise, MEK1/2  inhibition during neomycin induced ototoxicity 
delays HC death. However, long-term inhibition of MEK1/2 in the absence of a toxic 
stimulus results in HC death.
4.2.4 The effect of U0126 on hair cells transiently exposed to neomycin
Inhibition  of  ERK1/2  activation  delayed  IHC  death  following  8 hr  exposure  to 
neomycin. Subsequently it was tested whether U0126 is sufficient to rescue HCs that 
are  exposed  only  transiently  to  neomycin.  Therefore,  explants  were  treated  with 
neomycin for 8 hrs and allowed to recover for another  16 hrs. In experiments where 
U0126  or U0124 were tested the  inhibitor treatment was  continued throughout the 
recovery phase.  Following this  application paradigm there  were  6.4 ± 0.6 pyknotic 
IHC  nuclei/100 pm  in  neomycin-treated  explants  (Fig 4.25,  Fig 4.2.6A).  The 
presence of U0126 or U0124 during neomycin exposure did not affect the numbers of 
pyknotic IHC nuclei resulting in 6.0 ± 0.6 and 5.5 ± 0.5 pyknotic IHC nuclei/100 pm 
respectively  (Fig 4.2.5,  Fig  4.2.6A).  In  the  OHC  region  very  few  pyknotic  nuclei 
were observed when explants were treated with neomycin for 8 hrs and recovered for 
an additional 16 hrs (Fig 4.2.5, Fig 4.2.8A). Transient exposure to neomycin for 8 hrs 
followed by a 16 hr recovery phase resulted in similar numbers of pyknotic IHC and 
OHC nuclei compared to those explants that had received neomycin for  8 hrs only 
when assessed (Fig 4.2.6A,  Fig 4.2.8A).  However,  the number of remaining nuclei 
could potentially be changed as a result of removal or lysis of cells and this has to be 
considered too. In order to assess any such effect the total number of IHCs i.e.  the 
sum  of  pyknotic  and  remaining  healthy-appearing  nuclei,  was  determined  and 
compared between the various drug application paradigms assuming that the number 
of IHCs at the start of the experiment was similar. The total number of IHC nuclei 
was significantly reduced in explants transiently treated with neomycin and allowed 
to  recover  compared  to  those  exposed  to  only  8 hrs  or  24  hrs  of neomycin  (Fig 
4.2.6B). Explants additionally treated with U0126 or U0124 for 8 hrs and allowed to
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recover for  16 hrs showed a similar reduction in the total number of IHC nuclei to 
those treated with neomycin only (compare Fig 4.2.7 and Fig 4.2.6B). Moreover, in 
some  cochlear  explants  the  structure  of condensed  chromatin  appeared  differently 
shaped  and  less  rounded  following  the  transient  exposure  paradigm  compared  to 
those pyknotic nuclei in explants treated with neomycin for  8 or 24 hrs (Fig 4.2.3 -  
Fig 4.2.5). The total number of OHC nuclei did not differ significantly between the 
various  exposure  lengths  for  neomycin  including  those  additionally  treated  with 
U0126 or U0124 (Fig 4.2.8B, Fig 4.2.9). The difference between total OHC nuclei in 
control explants to the various neomycin treated conditions results  from estimating 
the number of remaining OHCs. Taken together these data suggest that inhibition of 
ERK1/2 activation during a transient period of neomycin exposure was not sufficient 
to rescue IHCs.
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4.3 Discussion
Spatio-temporal aspects of ERK1/2 activation
ERK1/2  are activated in a range of cell types and organs and are thought to  exert 
various effects during traumatic and toxic stimuli, including wound repair, induction 
of cell death or conversely cell survival (Xia et al., 1995; Nowak, 2002; Matsubayashi 
et al., 2004;  Sperandio  et al.,  2004).  However,  the  activation  of ERK1/2  resulting 
from damage has not been directly studied in the cochlea. Therefore, in this chapter 
the  following  were  examined  i)  whether  ERK1/2  are  activated,  ii)  the  activation 
mechanisms and iii) the possible role of ERK1/2 activation.
An N2-laser damage technique was  applied to  allow precise timing  of the  damage 
onset.  This  also  enables  determination  of  the  temporal-spatial  characteristics  of 
ERK1/2 activation.  The results of this study demonstrate that laser damage induced 
the transient and specific activation of ERK1/2 in a subset of support cells but not in 
HCs.  The  signal  spread non-uniformly  from the  lesion  site  with  maximum  spread 
occurring  10 min after damage.  A number of studies have  shown that ERK1/2  are 
activated in several cell types resulting from different damage stimuli  (Neary et al., 
2003; Matsubayashi et al., 2004; Yang et al., 2004b). As shown here the activation of 
ERK1/2 can spread quite a distance from the site of damage to cells in non-damaged 
areas  and is  in agreement with data by Matsubayashi  et al.  (2004).  Two waves  of 
ERK1/2 activation were described by Matsubayashi et al. (2004): the first wave was 
activated rapidly and transiently reducing to only cells in close proximity of the lesion 
site by 30 min after damage. The second wave commenced 60 min post damage and 
was sustained for at least 4 hrs. In this chapter, activation was measured only up to 
60 min.  During  this  time  period  a  transient  wave  similar  to  that  described  by 
Matsubayashi et al. (2004) was detected.
The duration of ERK1/2 activation can determine the subsequent cellular processes. 
In PC 12 pheochromocytoma cells transient activation of ERK1/2 by EGF results in 
proliferation  whereas  sustained  activation  by  NGF  or  overexpression  of the  EGF 
receptor  induces  neurite  outgrowth  indicative  for  differentiation  of  these  cells 
(Cowley  et  al.,  1994;  Traverse  et  al.,  1994).  On  the  contrary,  fibroblasts  that 
experience transient ERK1/2 signals maintain their differentiated nature. However, in
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fibroblasts  stimuli  that  cause  sustained  activation  lead to  their  transformation  and 
tumour  formation  (Cowley  et  al.,  1994;  Mansour  et  al.,  1994).  The  downstream 
effects  of transient  versus  sustained ERK1/2  activation  are  context  dependent  and 
consequently it is not appropriate to extrapolate the fate of support cells that exhibit 
damage-induced ERK1/2 activation.
The function and downstream targets of activated ERK1/2 are also dependent on the 
cellular  and  subcellular  localisation.  A  particularly  interesting  aspect  of the  data 
presented here is that in a complex organ like the cochlea damage activated ERK1/2 
in a cell specific manner. Only a subset of cochlear support cells including Deiters’, 
phalangeal, border and in some cases pillar cells are triggered to activate ERK1/2 but 
not the sensory HCs or Claudius-like  cells.  The majority of research on damage- 
induced ERK1/2 activation has been carried out using preparations of cellular mono­
layers  consisting  only  of a  homogenous  population  of cells  or  by  Western  blot 
analysis. Neither technique allows the detection of cell type specific activation. In the 
retina  -   another  multicellular  organ  -  light-induced  overstimulation  elicited  the 
activation  of ERK1/2  in  sensory  cells,  surrounding  Mueller  cells  but  only  in  a 
subpopulation of neuronal cells (Liu et al.,  1998).  The data presented here together 
with  those  by  Liu  et  al.  (1998)  clearly  indicate  that  damage-induced  signalling 
leading to ERK1/2 activation can occur in a cell type specific manner. Therefore, in 
order to understand not only the function of ERK1/2 but other signalling pathways 
activated during pathological conditions it is a necessity to determine the cell specific 
site of activity and action.
The subcellular distribution of activated ERK1/2 can potentially also point towards a 
function of damage-induced ERK1/2. Here, activated ERK1/2 were observed in the 
cytoplasm and the nucleus, suggesting that ERK1/2 could have separate functions in 
these cellular compartments. On the other hand the activation of downstream events 
in  both  the  nucleus  and  cytoplasm  at  the  same  time  might  be  necessary  for  a 
concerted response  following damage.  Activated ERK1/2  in the cytoplasm targets 
molecules such as myosin light chain kinase, m-calpain or vinexin that are involved 
in migration or cytoskeletal remodelling (Klemke et al.,  1997; Nguyen et al.,  1999; 
Glading  et  al.,  2004;  Mitsushima  et  al.,  2004).  Activated  ERK1/2  have  also  been 
shown to modulate gap junction function (Brandes et al., 2002) and to activate PLA2
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which produces arachidonic acid (Lin et al.,  1993; van Rossum et al., 2001). In the 
nucleus activated ERK1/2 can phosphorylate transcription factors such as Elk-1  that 
lead to the expression of immediate early genes such as c-fos, egr-1 and junB (Hodge 
et al., 1998).
Activation via the classical RAF-Mek pathway
In this study it was investigated whether damage-induced ERK1/2 activation occurs 
through the activation of cRaf and MEK1/2 using the c-Rafl  inhibitor I and U0126 
respectively.  Residual  damage-induced  ERK1/2  activation  was  observed  in  the 
presence  of the  inhibitor  for  c-RAFl  whereas  it  was  completely  abolished  when 
MEK1/2 were inhibited. Thus the classically activated signalling cascade to ERK1/2 
through c-RAFl and MEK1/2 activation is engaged following damage (Raman et al., 
2007). However, inhibition of c-RAFl  did increase basal levels of ERK1/2 in both 
HCs and support cells  in undamaged areas  of the explants  indicating that ERK1/2 
activation  can  be  triggered  in  HCs  depending  on  the  stimulating  conditions.  The 
mechanism by which ERK1/2 was activated when c-RAF was inhibited is unknown.
Damage-induced release of extracellular ATP triggers ERK1/2 activation 
The present data show that damage-induced ERK1/2  activation in the  cochlea was 
elicited  by  the  release  of  extracellular  ATP.  P2 receptor  mediated  activation  of 
ERK1/2  as a result of ATP released by damage has been  shown for other cellular 
systems (Neary et al., 2003; Yang et al., 2004b).  Both ionotropic and metabotropic 
P2 receptors are expressed in the cochlea (Jarlebark et al., 2000; Gale et al., 2004) see 
section 1.3). Following noise trauma endolymphatic ATP levels are increased (Munoz 
et al., 2001) and can subsequently act on P2 receptors that can potentially activate 
downstream signalling pathways  such as ERK1/2  as  shown here.  Damage-induced 
ERK1/2 activation could be mimicked by exogenous application of ATP. However, 
only a relatively high dose of ATP (100 pM) for a short period (10 s) was sufficient 
to induce a similar activation pattern. UTP an agonist specific for P2Y2,4,6 ,11 and P2X3 
receptors stimulated ERK1/2 activation in Deiters’ cells, but not in inner phalangeal 
or border cells. Neither UDP active on P2Y6 (Nicholas et al.,  1996) nor ADP which 
activates  P2Yi  receptors  was  found  to  induce  ERK1/2  activation  in  rat  cochlear 
explants. Taken together these data suggest that P2Yi and P2Y6 can be excluded as 
the  receptors  leading  to  ERK1/2  activation.  The  intensity  of  activated  ERK1/2
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labelling induced by UTP was lower compared to that by ATP.  This suggests that 
ERK1/2  activation  mediated  by  ATP  involved  two  pathways  -   one  that  required 
UTP-sensitive  P2Y receptors  and a  second,  based on the  insufficiency  of ADP  to 
trigger ERK1/2 activation, P2X receptor-mediated pathway. Potential candidates for 
triggering  ERK1/2  activation  are  P2X  and  P2Y2,4,n  receptors.  The  activation  and 
spread  of ERK1/2  was  not  affected  by  the  P2  receptor  antagonists  PPADS  and 
suramin. P2Y2 and the human P2Yn  receptors are sensitive to  suramin, but not to 
PPADS (Communi et al., 1999; van der Weyden et al., 2000; Wildman et al., 2003). 
Thus,  these  receptors  are  unlikely  the  mediators  of  damage-induced  ERK1/2 
activation. P2Y4 receptors are insensitive to both PPADS and suramin and cannot be 
excluded to stimulate ERK1/2 activation. The majority of P2X receptors are inhibited 
by at least one if not both of the antagonists at the concentrations used here, except 
for P2X4 receptor which is less sensitive (Buell et al.,  1996; Rassendren et al.,  1997; 
Chessell et al., 1998; Jones et al., 2000; King and Townsend-Nicholson, 2003). Taken 
together,  the  likely  candidates  are  P2X4  and  P2Y4  receptor.  However,  the 
pharmacological  data  for  the  various  P2  receptor  subtypes  were  obtained  from 
heterologous expression systems. The interaction between various native P2 receptors 
might  alter  their  pharmacological  profiles  as  it  has  been  demonstrated  by 
co-expression experiments (Liu et al., 2001; Gallagher and Salter, 2003; Greenwood 
et  al.,  2007).  Thus  the  proposed  interpretation  of  the  antagonist  data  must  be 
considered with caution.
Gap junctions -  potential candidate mediating ERK1/2 spread 
The potential role  of gap junctions  in mediating ERK1/2  spread was  investigated 
using CBX -  a known gap junction blocker and it was found that it was sufficient to 
reduce  the  spread  of activated  ERK1/2.  This  effect  can  potentially  arise  via  two 
mechanisms:  first,  a  signal  such  as  IP3,  cAMP  or  cGMP  could  pass  through  gap 
junctions (Bevans et al., 1998; Ayad et al., 2006; Bedner et al., 2006) and mediate the 
activation  of ERK1/2;  or  second,  ATP  could be  released  from  cells  via  connexin 
hemichannels  (Stout  et  al.,  2002;  Pearson  et  al.,  2005).  The  permeability  of gap 
junctions/hemichannel  heavily  depends  on  the  connexin  subtypes  that  form  the 
channels. The permeability for the aforementioned potential mediators has not been 
determined for the heteromeric gap junctional pores formed by connexin 26 and 30 
that  are  expressed  in  the  cochlea.  IP3  has  been  suggested  to  pass  through  the
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connexins that form gap junctions in the cochlea (Beltramello et al., 2005).  ERK1/2 
activation was abolished in the presence of both CBX and apyrase. Thus two separate 
pathways  may  contribute  to  the  activation  of  ERK1/2.  In  contrast,  CBX  was 
demonstrated to  reduce the damage-induced  Ca2+ wave but not exert a synergistic 
effect  when  applied  together  with  apyrase.  Taken  together,  this  comparative 
examination  of the  actions  of apyrase  and  CBX  suggests  that  the  CBX-sensitive 
mechanism mediating ERK1/2 spread occurs independently of Ca2+.
Recently,  CBX  was  reported  to  exert  inhibitory  effects  on  P2X7  receptors  and 
voltage-gated  Ca2+ channels  (Vessey  et  al.,  2004;  Suadicani  et  al.,  2006).  If these 
channels  or  connexin  hemichannels  were  activated  following  damage  they  would 
allow  influx  of Ca2+  and this  should  be  reflected  in  changes  of intracellular  Ca2+ 
levels.  However,  CBX  did  not  exert  an  additional  effect  to  that  by  apyrase  on 
reducing  damage-induced  Ca2+  levels.  Thus,  the  CBX-sensitive  mechanism  that 
results in ERK1/2 activation is unlikely occurring through the action of any of these 
channels and therefore gap junctions are the likely mediators of ERK1/2 spread.
Ca~-dependent and independent mechanisms leading to ERK1/2 activation 
The  removal  of extracellular  Ca2+  also  reduced  the  spread  of ERK1/2  activation 
suggesting a role of Ca2+ in activating the ERK1/2  cascade.  However,  buffering of 
intracellular Ca2+ levels with BAPTA did not affect ERK1/2 activation or its spread. 
These  data  are  further  evidence  that  two  components  result  in  the  activation  of 
ERK1/2  -   one  dependent  on  the  presence  of  extracellular  Ca2+  and  the  other 
independent of cytoplasmic Ca2+.  The reduction of the fast Ca2+ wave as shown in 
chapter  3  together with  the  decreased  spread  of activated  ERK1/2  as  well  as  the 
dependency on extracellular ATP are indicative of P2X receptor mediated activation 
of ERK1/2.  Moreover,  activation  of ERK1/2  by  UTP  which  only  facilitates  the 
activation of P2Y receptors resulted in decreased labelling intensity compared to that 
induced by ATP (matched for acquisition settings).  This effect was similar to that 
observed when cochlear explants were damaged in 0 Ca2+ compared to their controls 
in the presence of extracellular Ca2+, respectively, supporting the notion that P2X and 
P2Y receptors facilitate the damage-induced activation of ERK1/2.  However, other 
mechanisms such as the opening of voltage-gated Ca2+-channels (Hur et al., 2001) or
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store-operated Ca2+ entry could also operate and result in the activation of ERK1/2. 
Entry of extracellular Ca2+ caused the rise of the fast damage-induced Ca2+ wave that 
did not depend on the release of Ca2+ from intracellular stores (see chapter 3). Hence 
the role of store-operated Ca2+ entry in the activation of ERK1/2 can be excluded. 
The  entry  of Ca2+ through  could  account  for  the  inability  of BAPTA  to  reduce 
ERK1/2 spread. The opening of ion channels could result in the rapid formation of 
Ca2+ microdomains that enable ERK1/2 activation. Although BAPTA is a fast Ca2+ 
buffer  it  is  still  unable  to  buffer  and  counteract  the  rapid  formation  of  high 
Ca2+-microdomains  very  close  to  ion  channels  (Naraghi  and  Neher,  1997).  This 
suggests  that  the  Ca2+dependent  cascade  leading  to  ERK1/2  activation  requires  a 
rapid local elevation rather than global changes in cellular Ca2+.  However,  another 
explanation is that both the activation of ERK1/2 and the deactivation of the MAPK 
cascade have been shown to be dependent on Ca2+ (Farnsworth et al.,  1995; Cook et 
al.,  1997; Lockyer et al., 2001; Neary et al., 2003; Paul et al., 2003;  Schmitt et al., 
2004; Kupzig et al., 2005). Hence in the present experiments, BAPTA could affect 
both pathways  and therefore  a reduced deactivation  rate  could  counteract reduced 
activation of ERK1/2.
The  Ca2+-independent  component  of  ERK1/2  activation  likely  occurred  in  a 
P2Y-mediated  manner  that  could  potentially  recruit  a  Ca2+-independent  PKC, 
choline-specific PLC or other G-proteins (Jo et al., 1997; Neary et al., 1999; Neary et 
al., 2003; Nicole et al., 2005).
ERK1/2 inhibition delays inner hair cell death
ERK1/2  were  originally thought to  function  as  survival  kinases  (Xia  et  al.,  1995; 
Arthur et al., 2006). More recent evidence suggests that cell type dependent ERK1/2 
activation can induce apoptosis (Nowak, 2002; Sperandio et al., 2004; Subramaniam 
et  al.,  2004;  Chen  et  al.,  2005).  Data  presented  in  this  report  demonstrated  that 
ERK1/2 were activated in support cells during neomycin-induced otoxicity. Together 
with the results following mechanical damage these data indicate that this activation 
is a common mechanism to signal damage in the rat cochlea.  Moreover, inhibiting 
MEK1/2 and thus ERK1/2 activation delayed neomycin-induced HC death. A critical 
observation  was  that  ERK1/2  were  not  activated  in  dying  HCs  but  in  their
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surrounding support cells which survive.  This  indicates that the death of HCs  was 
caused by intercellular interaction with their surrounding support cells. These data are 
in contrast to previous reports that presented ERK1/2 dependent cell death of the cells 
in which activation occurred. In those reports, the effect of MEK1/2 inhibition was 
studied in a homogenous population of cells, whereas in this thesis it was probed in a 
multicellular organ.  This  indicates  that it is  critical to understand signalling in the 
context  of  multicellular  organs  to  assess  effects  exerted  by  intercellular 
communication.
Inhibition  of MEK1/2  activation  can  however  only  temporarily  protect  HCs  from 
neomycin-induced  ototoxicity.  Moreover,  inhibition  of ERK1/2  activation  over  a 
period of 24 hrs resulted in OHC death even without any ototoxic stimuli. This is in 
agreement  with  Battaglia  et  al.  (2003)  reporting  that  U0126  itself applied  over  a 
period  of 48  hrs  elicited  an  increase  in  OHC  death  compared  to  controls.  This 
indicates  that  basal  levels  of activated  ERK1/2  act  as  a  factor  crucial  for  OHC 
survival. Therefore, over longer periods observed in this thesis, the protective effect 
of MEK1/2 inhibition in support cells observed following 8 hrs of neomycin might be 
counteracted by the absence of activated ERK1/2 in HCs that acts as a survival factor. 
Another possible explanation is the activation of other signalling pathways that result 
in  the  execution  of  cell  death  when  MEK1/2  are  inhibited.  Those  signalling 
mechanisms would overcome the protective effect exerted by inhibition of MEK1/2. 
It is even likely that the two possible mechansisms described above act together to 
counteract the protective  effect and to  cause  HC  death  over prolonged periods  of 
neomycin exposure.
Transient exposure to neomycin followed bv a recovery phase 
Data  presented  in  this  chapter  demonstrate  that  continued  inhibition  of ERK1/2 
during  exposure  of cochlear explants  to  an  8 hr pulse  of neomycin  followed by  a 
16 hr recovery phase cannot protect HCs. Again ERK1/2 might function as a survival 
signal  in HCs, which might be  crucial  for the HCs  in order to regain a functional 
status.  This  raises  the  question  whether  inhibition  of  ERK1/2  activation  during 
transient  application  of neomycin  followed by  a recovery phase  during which  the 
MEK1/2 inhibitor is omitted could rescue HCs?
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During 8 hrs of neomycin followed by 16 hrs recovery a similar number of pyknotic 
IHC nuclei were observed compared to explants that were treated with neomycin for 
8 hrs only. However, the total number of nuclei (comprised of pyknotic and healthy 
appearing nuclei)  was  significantly  reduced  in  explants  treated  with  neomycin  for 
8 hrs and allowed to recover for 16 hrs when compared to those following 8 or 24 hrs 
of neomycin  exposure.  These  data might  suggest that the  removal  of the  ototoxic 
stimulus might induce signalling cascades that result in secondary traumatic injury. It 
has been shown that ROS are generated in astrocytes during hypoxic events and that 
another boost of ROS production occurs in the period of reoxygenation.  The latter 
was suggested to cause secondary injury observed during reoxygenation (Abramov et 
al.,  2007).  In  addition,  following  removal  of  neomycin  a  mechanism  could  be 
triggered  that  accelerates  the  elimination  of cellular  corpses.  This  hypothesis  is 
supported by the less rounded and misshapen structure of pyknotic nuclei compared 
to those seen after 24 hrs of neomycin. The accelerated removal of dead cell bodies 
could be established through an increase in support cell activity to remove cells or a 
signal could be released that attracts macrophages.
ERK1/2 activation in support cells influences hair cell death -  a potential mechanism 
In this chapter it was shown that during neomycin-induced ototoxicity ERK1/2 were 
specifically activated in support cells that surround pyknotic HC nuclei. Inhibition of 
the upstream kinases of ERK1/2 -  MEK1/2  delays  HC  death.  Unless  HC  survival 
results  from  inhibiting basal  levels  of ERK1/2,  which  were  not  detected with  the 
chosen method, a convincing explanation has to be found. The simplest interpretation 
is that support cells exert an effect on HCs which consequently promotes HC death. 
Support  cells  could  influence  HC  death  potentially  via  two  mechanisms  -   one 
involving migration and wound repair and the other the release of a soluble factor by 
support  cells  that triggers  the  subsequent HC  death.  Migration has  been  shown to 
occur in an ERK1/2 dependent manner (Klemke et al.,  1997; Nguyen et al.,  1999). 
More  importantly  a  recent  report  suggests  that  activated  ERK1/2  are  crucial  for 
wound  repair  resulting  in  the  closure  of the  scrape-wounded  area  in  MDCK  cell 
monolayers  (Matsubayashi  et  al.,  2004).  Apoptotic  cells  can  be  cleared  by  ‘non­
professional phagocytes’ that are the cells neighbouring the dying cells and cochlear 
support cells have been suggested to fulfil this function (Forge and Li, 2000; Pamaik
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et al., 2000; Abrashkin et al., 2006). Thus, if the support cells can sense the impaired 
integrity of HCs,  they could be triggered to instigate a wound repair program that 
then as a result of structural rearrangements in the cochlea imposed by support cells 
promotes HC death.
Another mechanism could rely on ERK1/2  inducing the  formation  of free radicals 
such superoxide (O2*) or nitric oxide (NO).  Both free radicals have been suggested 
to be employed by microglia to execute cell death (Chao et al.,  1992; Marin-Teva et 
al., 2004). Similarly, support cells could produce free radicals and promote HC death. 
Moreover,  the  formation  of free  radicals  is  thought  to  be  involved  in  the  death 
executing cascade during noise-damage and aminoglycoside ototoxicity (Hirose et al., 
1997; Hirose et al.,  1999; Ohinata et al., 2003).  Therefore O2' and NO are suitable 
candidates for a mechanism that involves support cells in triggering HC death.  The 
NADPH  oxidase  one  of the  enzymes  that  produces  O2’  has  been  reported  to  be 
activated following binding of arachidonic acid. PLA2 can liberate arachidonic acids 
from  lipids  in  cellular  membranes  following  the  activation  by  ERK1/2.  NO 
production is also documented to be downstream of ERK1/2  activation (Joy et al., 
2006).  However,  NO  production  is  not  associated  with  HC  death  during  noise- 
exposure as implicated by studies using inhibitors (Ohinata et al.,  2003).  However, 
these  studies  investigated  a  late time  point  following  acoustic  overstimulation.  As 
shown here ERK1/2 promotes HC death during the early phase of neomycin exposure 
but prolonged ERK1/2 inhibition can result in HC death. Similarly, NO could play a 
role during the early phase that was not detected as a consequence of the chosen late 
time point (Ohinata et al., 2003).  The MEK1/2 inhibitor U0126 has also been shown 
to act on MKK5 -  the kinase that phosphorylates ERK5 (Mody et al., 2003). At the 
present  it  can  not  be  excluded  that  ERK5  participates  in  the  signalling  cascade 
leading  to  neomycin-induced  HC  death  and  further  investigations  are  required  to 
eliminate this possibility.
Does damage-induced ERK1/2 plav a role in support cells?
It is an interesting aspect that ERK1/2 activation in support cells promotes the death 
of a different cell type.  However,  it raises the  question whether ERK1/2  exerts  an 
effect on the cell in which it is actually activated. The downstream targets of ERK1/2 
activation are diverse and include survival signalling (Xia et al.,  1995; Arthur et al.,
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2006)  as  well  as  proliferation  (Cowley  et  al.,  1994;  Mansour  et  al.,  1994). 
Proliferation in avian utricular sheet cultures is reduced when ERK1/2 activation is 
inhibited (Witte  et  al.,  2001).  Recombinant human  glial  growth  factor-2  triggered 
cells in mammalian utricular sheet cultures to proliferate and this process was also 
partially dependent on the activation of ERK1/2 (Montcouquiol and Corwin, 2001). 
In avian HC epithelia the  support cells  are the progenitors that generate new HCs 
(Warchol and Corwin, 1996) after ototoxic insults. The specific activation of ERK1/2 
in support cells poses the question whether ERK1/2 are a proliferative signal in the 
non-proliferating mammalian cochlea? Simultaneously occurring inhibitory signalling 
events  could  lead  to  abrogation  of the  proliferative  signalling  cascade  which  is 
initiated  by  ERK1/2.  Further  research  will  clarify  the  function  of  ERK1/2  and 
determine its potential role as a proliferative signal in the mammalian cochlea.
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Fig  4.1.1  Spatio-temporal  characteristics  of  damage-induced  ERK1/2  activation  in 
the organ of Corti.
A)  Average of confocal z-stack images of a phalloidin-stained explant depicts  hair bundles 
of the three OHC and  IHC rows. The integrity of the HC  rows is disturbed by the lesion site 
(star) which is a typical lesion induced with a N2-laser at 1  min post damage.
B-E) Averages of confocal z-stack images immuno-stained for activated ERK1/2 at B)
1  min (corresponding image to A), C) 10 min D) 30 min and E) 60 min post damage.
F)  The  lines  in  cartoon  indicate  the  OHC  and  IHC  regions  that  were  subjected  to  a  line 
scan  analysis.  ERK1/2  spread  was  determined  longitudinally  (arrows)  to  both  sides  from 
the  lesion  site  (filled  black  circle)  and  averaged  for  each  region.  Red  line  represents  the 
middle of the lesion site.
G)  The graph  depicts the  spread  of activated  ERK1/2  as  a function  of time  post damage. 
Mean ± S.E.M,  n £ 4 scale bar,  50 pm
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Fig 4.1.2 ERK1/2 activation is specific to supporting cells in the organ of Corti.
A-B) 3-D reconstruction of activated  ERK1/2 around the lesion site (LS) with view onto (A) 
the  OHC  region  and  (B)  at  a  different  focal  level  onto  the  IHC  region  at  10  min  post 
damage.
C-E)  Orthogonal  projections  of  higher  power  confocal  z-stack  images  at  10  min  post 
damage  labelled  for  (C)  nuclei  with  DAPI,  (D)  activated  ERK1/2  and  (E)  DAPI  and 
activated ERK1/2 channels are merged.
Filled  arrows  =  processes  of  Deiters’  cells;  arrowheads  phalangeal  cells,  star  =  OHC; 
Cross =  IHC; open white arrow = pillar cell; circle =  Deiters’ cell nuclei;  LS =  lesion site.
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Fig  4.1.3  Damage-induced  activation  of  ERK1/2  occurs  via  a  c-RAF  and  MEK1/2- 
dependent mechanism.
A-C) Averages  of confocal  z-stack  images  of activated  ERK1/2  at  5  min  post  damage  in 
(A) control, explants exposed to (B) RAF1  inhibititor I or (C) MEK1/2  inhibitior U0126
a,  b)  Orthogonal  x-z  projection  of  activated  ERK1/2  in  (a)  control  and  (b)  presence  of 
RAF1  inhibitor I.
D)  Average of confocal z-stack images  labelled with fluorescent phalloidin  (corresponding 
image to C)
n = 3; scale bar, 50 pm
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Fig 4.1.4 ERK1/2 activation is dependent on the release of extracellular ATP and 
sensitive to CBX.
A-D) Averages of z-stack images immuno-stained for activated  ERK1/2 at 5 min post laser 
damage in (A) control, in the presence of  (B) 40 U/ml apyrase (APY),  (C) 75 pM CBX or 
(D) APY and CBX applied together.
E) ERK1/2 spread measured  using a line scan analysis for the conditions in A-D.
Mean ± S.E.M, * indicates P < 0.05 between treated and control, # indicates P < 0.05 
between APY and APY + CBX; +  indicates P < 0.05 between CBX and APY + CBX ,  n = 9 
(control),  n = 5 (APY),  n = 4 (CBX),  n = 4 (APY + CBX),  Student’s f-test;  Scale bar, 50 pm
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Fig  4.1.5  Purinergic  activation  of 
ERK1/2.
A-F)  Averages  of  z-stack  images 
immuno-labelled  for  activated 
ERK1/2  at  5  min  post  exposure  to 
exogenous  puff  application  of  (A) 
1   pM  (10  s),  (B)  10  pM  (10  s),  (C) 
100  pM  ATP  (10  s),  (D)  100  pM 
UTP (10 s),  (E)  100  pM  UDP  (20 s) 
and (F) 100 pM ADP (20 s).
c,  d)  x-z  projection  of  confocal 
z-stack  images of activated  ERK1/2 
corresponding to (C) and (D).
n £ 3, scale bar, 50 pm.
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Fig  4.1.6  Damage-induced  ERK1/2  activation  is  insensitive  to  the  P2  receptor 
antagonists PPADS and suramin.
A-D)  Averages  of  confocal  z-stack  images  labelled  for  activated  ERK1/2  at  5  min  post 
laser damage in (A,  C)  matched  control for (B)  150  pM  PPADS  and  (D)  100  pM  suramin 
exposed explants respectively.
a-d) Orthogonal x-z projections of activated ERK1/2 corresponding to (A-D)
E)  Spread of activated ERK1/2 for conditions in (A-D).
Mean ± S.E.M.;  n > 3;  P > 0.05; Student’s f-test; scale bar, 50 pm.
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Fig 4.1.7 ERK1/2 activation partially depends on influx of extracellular Ca2+.
A,  B,  D,  E) Averages of z-stack images immuno-labelled for activated  ERK1/2 at 10 min 
post laser damage in (A, D) matched control to (B) in 0 Ca2+ and (E) BAPTA.
a, b, d, e) x-z projections of activated ERK1/2 corresponding to (A, B, D, E).
C,  F) Spread of activated ERK1/2 at 5 and  10 min post laser damage for (C) 0 Ca2+ and 
(F) BAPTA-AM.
G)  Damage-induced peak Ca2+ changes at various distances from the lesion site in 0 Ca2+ 
and  presence of BAPTA-AM expressed as percentage of control changes.  Damage was 
introduced with a microneedle.
n  <  7  (control/0  Ca2+),  n  <  12  (control/BAPTA-AM);  *  indicates  P  <  0.05; 
Student’s f-test; scale bar, 50 pm.
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neomycin -  8 hrs  neomycin -  24 hrs
Fig 4.2.1  Neomycin-induced activation of ERK1/2
A-D,  G-J)  Averages  of confocal  z-stack  images  of  cochlear  explants  treated  with  1  mM 
neomycin after (A-D) 8 hrs or (G-J) 24 hrs labelled for:
A, G) actin with fluorescent phalloidin.
B, H) DNA with  DAPI
C, I) activated ERK1/2.
D, J) Double-labelling of DNA and activated  ERK1/2.
E,  K)  Single  image  of a  confocal  z-stack  showing  an  extract  of  D  or  J  respectively  at  a 
higher zoom.
f-f \  m-m”) x-z projection corresponding to (D, J, respectively)  labelled for (f, m) DAPI,  (f , 
m’) activated  ERK1/2 and (F’, m ”) double-labelled.
Arrowheads  =  morphologically  healthy  appearing  nuclei;  arrow  =  nuclei  with  condensed 
chromatin structure. Scale bar in J for A-J, f-f’,  m-m”, 20 pm;  E and  K,  10 pm
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Fig 4.2.2 Tonotopical gradient of neomycin-induced hair cell death after 8 hrs.
Comparison  of the  number of pyknotic  IHC  and  OHC  nuclei/100  pm  present  in  basal  and 
middle turn cochlear explants after exposure to neomycin for 8 hrs.
The black and red dotted  lines indicate the number of IHC and OHC nuclei per 100 pm per 
cochlear turn, respectively.  Note that the number of OHCs is given for one row only.
Mean ± S.E.M, n = 7 (basal IHC & OHC), n = 5 (middle  IHC & OHC)
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Fig  4.2.3  Inhibition  of neomycin-induced  ERK1/2 activation  reduces  hair cell  death 
at 8 hours.
Averages of 5 z-stack  images  (z-slice:  0.86)  labelled  for  DNA with  DAPI  at three  different 
consecutive  planes  starting  at  the  apical  surface  of  IHCs  and  progressing  towards  the 
basal end of the 3rd row of OHCs.
The  average  in  plane  (i)  shows  nuclei  in  IHC  region;  plane  (ii)  includes  IHC  +  OHC, 
whereas plane (iii) focuses on the lower level of OHCs.
Panels from the  left to the  right show:  (column  1) control,  a cochlear explant treated with 
(column  2)  neomycin  for  8  hours,  (column  3)  10  pM  U0126  or  (column  4)  its  inactive 
analogue U0124 (10 pM) in addition to neomycin.
n £  11. Scale bar, 20 pm
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neomycin  + U0126
Fig 4.2.4 Inhibition  of neomycin-induced 
ERK1/2  activation  is  not  sufficient  to 
protect hair cells from death at 24 hours.
Averages of 5 z-stack images (z-slice:  0.86) 
labelled  for  DNA  with  DAPI  at  three 
different  consecutive  planes  starting  at  the 
apical  surface  of  the  IHC  and  lowering 
towards  the  basal  end  of  the  3rd  row  of 
OHC.
The average shows nuclei in the plane of (i) 
IHCs,  (ii)  IHCs  +  OHCs,  (iii)  lower  level  of 
OHCs.
(column 1) 1mM  neomycin and (column 2)
additionally  treated  with  10  pM  U0126  for 
24 hours.
Scale bar, 20 |jm
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neomycin  + U0126
8hr+16hr  8hr+16hr
recovery  recovery
Fig  4.2.5  ERK1/2  inhibition  during  and 
following  transient  exposure  to 
neomycin is not effective to protect IHCs 
from death.
Averages of 5 z-stack (z-slice:  0.86) images 
labelled  for  DNA  with  DAPI  at  three 
consecutive  planes  starting  at  the  apical 
surface  of  the  IHC  and  lowering  towards 
basal aspects of 3rd row OHCs.
The averages show nuclei in the plane of (i) 
IHCs,  (ii)  IHCs  +  OHCs  and  (iii)  lower 
aspects of 3rd row OHCs.
(column  1)  neomycin  for 8  hrs followed  by 
a  16  hour  recovery  phase  or  (column  2) 
additionally  treated  with  10  pM  U0126 
throughout the 24 hrs.
Arrows point on irregular structures of some 
nuclei in the IHC  region. Scale bar, 20 pm.
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Fig 4.2.6 The effect of ERK1/2 inhibition on the viability of cochlear IHCs  exposed to 
neomycin.
A) Comparison of the number of pyknotic IHC nuclei/100 pm  in cochlear explants exposed 
to  neomycin  or  in  the  additional  presence  of  U0126  or  U0124.  Explants  were  exposed  to 
the aforementioned conditions for 8, 24 or 8 hrs plus a  16 hr recovery phase (quantification 
paradigm  see  2.7.5).  The  dotted  line  indicates  the  number  of  IHC  nuclei  present  along 
100 pm of the cochlear turn.
B) Total number of IHC nuclei comprised of pyknotic and  healthy nuclei  present along  100 
pm  in  control  cochlear  turns  and  those  exposed  to  neomycin  for  8,  24  or  8  plus  16  hrs 
recovery.
Mean ± S.E.M., *P < 0.05,  n = 3 (control),  n =  12 (neomycin 8 hrs),  n  =  11  (+U0126,  8hrs), 
n  =  3  (+U0124,  8  hrs),  n  = 4  (neomycin,  +U0126,  24hrs),  n  =  9  (neomycin,  +U0126,  8  + 
16hrs recovery),  n = 5 (+U0124, 8 +  16hrs recovery).
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□  viable control 
■  viable neo + U0126 
□  viable neo + U0124
|  pyknotic control 
■  pyknotic neo + U0126 
□  pyknotic neo + U0124
control  8 hr  24 hr  8 hr + 16 hr 
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Fig 4.2.7 The effect of inhibition of neomycin-induced ERK1/2 activation on the total 
number of IHC nuclei.
Total  number  of  nuclei,  comprised  of  pyknotic  and  morphologically  healthy  appearing 
(“viable”)  IHC  nuclei  in  control  and  in  the  presence  of  neomycin  and  U0126  or  U0124, 
respectively. The conditions were applied for 8, 24 or 8 hrs neomycin +  16 hrs recovery.
Mean  ±  S.E.M.,  *P  <  0.05  between  control  and  test  conditions,  n  =  3  (control),  n  =  11 
(+U0126, 8hrs),  n = 3 (+U0124, 8 hrs),  n = 4 (+U0126, 24hrs),  n = 9 (+U0126, 8 +  16hrs 
recovery), n = 5 (+U0124, 8 +  16hrs recovery).
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Fig  4.2.8  The  effect  of  ERK1/2  inhibition  on  the  formation  of  pyknotic  nuclei  in 
cochlear explants exposed to neomycin.
A)  Comparison  of  the  number  of  pyknotic  OHC  nuclei  in  cochlear  explants  exposed  to 
neomycin or additionally to U0126 or U0124 for 8, 24 or 8 hrs followed  by a  16 hr recovery 
phase. The dotted  line indicates the number of OHC nuclei  present in the three rows along 
100 pm of the cochlear turn.
B)  Total  number  of  OHC  nuclei  comprised  of  pyknotic  and  morphologically  healthy 
appearing (“viable”) nuclei in control and exposed to neomycin for 8,  24 and 8 hrs followed 
by a recovery phase.
Mean ± S.E.M.,  P > 0.05,  n = 3 (control),  n  =  12 (neomycin 8 hrs),  n =  11  (+U0126,  8hrs), 
n  =  3  (+U0124,  8  hrs),  n  =  4  (neomycin,  +U0126,  24hrs),  n  =  9  (neomycin,  +U0126, 
8 +  16hrs recovery), n = 5 (+U0124, 8 +  16hrs recovery).
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Fig  4.2.9  The  effect  of  ERK1/2  inhibition  on  the  total  number  of  OHC  nuclei  in 
cochlear explants exposed to neomycin.
Total  number of OHC nuclei comprised of pyknotic and  morphologically healthy appearing 
(“viable”)  nuclei  per  100  pm  in  the  three  OHC  rows  in  control,  neomycin  and  U0126  or 
U0124 exposed for 8, 24 or 8 hrs followed by a  16 hr recovery phase.
Mean  ±  S.E.M.,  *P  <  0.05  between  control  and  test  conditions,  n  =  3  (control),  n  =  11 
(+U0126, 8hrs),  n = 3 (+U0124, 8 hrs),  n = 4 (+U0126, 24hrs),  n = 9 (+U0126, 8 +  16hrs 
recovery),  n = 5 (+U0124, 8 + 16hrs recovery).
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5. P2 receptor function in damage-induced signalling
In chapters 3 and 4 it was demonstrated that the release of extracellular ATP during 
damage  and  its  action  on  P2  receptors  is  a  key  initiator  of the  damage-induced 
signalling  cascade.  P2Y  and  P2X  receptors  were  suggested  to  participate  in  the 
formation of the damage-induced Ca2+ wave and to trigger ERK1/2 activation.  The 
question which P2 receptor subtypes signal damage in the mammalian cochlea and in 
particular which result in the activation of ERK1/2 in support cells was approached 
using  two  separate  techniques:  i)  whole-cell  currents  were  recorded  from  Deiters’ 
cells  coupled to  its  support cell  syncytium when  cochlear  coils  were  subjected to 
damage or to exogenous application of purinergic agonists; ii) the expression profile 
of UTP-sensitive P2Y and various P2X receptors was determined in cochlear explants 
using immunocytochemistry.
5.1 Electrophysiological study of damage-induced and purinergic 
events in Deiters’ cells
5.1.1 Characterisation of the damage-induced currents
Damaging the mammalian cochlea induced the propagation of an intercellular wave 
of increased cytoplasmic Ca2+ triggered by the release of extracellular ATP (chapter 
3.1).  To  investigate  whether  damage  elicits  whole  cell  currents  patch  clamp 
recordings  were  made  from  Deiters’  cells  maintained  in  their  cellular  network  or 
support cell syncytium (Fig 5.1.1 A right panel). Deiters’ cells were voltage-clamped 
at -90 mV and a microneedle, placed five cells  from the patched Deiters’  cell was 
used  to  induce  damage  to  the  HC  region  (Fig 5.1.1 A,  left  panel).  A  baseline 
(-20 min) was recorded before the “first lesion” was induced followed by a 30 min 
interval and a second lesion at the  same  site.  Recordings  from Deiters’  cells were 
characterised by spontaneously occurring inward currents as illustrated by the trace 
that represents 5 min of recording (Fig 5.1.IB). Damage activated an inward current 
in Deiters’ cells located approximately 50 pm from the lesion site. The magnitude of 
the inward current was greater than the majority of spontaneously occurring current 
oscillations (Fig 5.1. IB upper panel). Moreover, a prolonged ion flux was observed in 
contrast  to  the  shorter  spontaneous  inward  currents.  The  rise  time  of the  inward
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current was  not determined  as  the  damage protocol was  not  automated.  Therefore 
marking of the event was not very accurate, so that it was not possible to determine 
the exact starting point. Following the initial rise an increase in the noise in the trace 
was observed suggesting an increase in the number of openings and closings of ion 
channels (Fig 5.1. IB lower panel).  The current recovered to baseline within 16.2 ± 
4.6 s following the first lesion (n = 3, Table 5.1). During the recovery phase smaller 
single  events  that  most  likely  arise  from  spontaneous  oscillations  add  to  a 
prolongation of the damage-induced signal (Fig 5.1. IB lower panel).
The peak current and the  integral  of the whole  cell  current,  the  charge transferred 
across the plasma membrane, were measured in order to quantify the magnitude of 
damage-induced  currents  in  Deiters’  cells.  The  magnitude  of the  damage-induced 
current  is  a  function  of the  membrane  resistance  Rm   (Fig5.1.2A).  Assuming  that 
Deiters’  cells  have  approximately  the  same  resistance,  Rm   is  an  estimate  of the 
number of cells in the syncytium and thus actually represents the syncytial resistance 
Rsync- The lower Rsync the higher was the observed peak current measured in Deiters’ 
cells.  The  total  charge  transferred  following  damage  was  similarly  dependent  on 
Rsync-  These data suggest that the current is a property of the  syncytium.  A rise in 
intracellular Ca2+  has  been  suggested to  modulate  gap junctional  connectivity  and 
lead  to  their  closure  (Dakin  et  al.,  2005).  Damage  triggers  the  formation  of an 
intercellular Ca2+ wave of increased cytoplasmic Ca2+ (chapter 3.1). In order to test 
whether  damage  affects  Rsync  over  longer  periods  Rsync  was  determined  using  a 
10 mV  voltage-step  protocol.  There  was  no  significant  difference  between  Rsync 
measured before and 2 -3  min after damage (pre:  192 ± 36 MQ; post:  180 ± 29 MQ; 
n = 8 ; P = 0.27).
Two consecutive lesions separated by an interval of 30 min were made in the same 
region of the HC epithelium. The damage stimuli differed in their intensity with the 
second being stronger (chapter 2.3.2). Both damage stimuli were sufficient to elicit 
inward currents in Deiters’ cells (Fig 5.1.2B, Table 5.1.). The peak current induced by 
the  first  lesion  was  -324.8  ±  155.2pA  and  the  second  lesion  reached 
-622.4 ± 179.6 pA  (n = 3).  Similarly  the  charge  transferred  across  the  plasma 
membrane was increased to 8.5 ± 2.8 pC compared to -2.1 ± 0.7 pC following the
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Table 5.1 Comparison of currents resulting from two consecutive lesions (n = 3)
Mean Lesion 1 Lesion 2 P value
Rsync [MQ] 122.8 d =  45.5 119.3 ±42.9 0.32
Peak current [pA] -324.8 ± 155.2 -622.4 ± 179.6 0.15
Charge [nC] -2 .1 ±0.7 -8.5 ±2.8 0.13
Atcurrent [s] 19.0 ±4.4 30.7 ±6.9 0 .2 0
Atpeak-baseline [s] 16.2 ±4.6 25.6 ±6.2 0.29
first lesion (Fig 5.1.2C, Table 5.1.1).  The differences were however not statistically 
significant. These data indicate that Deiters’ cells maintain their capacity to respond 
to two consecutive damage stimuli.
5.1.2  The effect of P2 receptor antagonist PPADS
It is possible that P2 receptor activation during damage triggered the inward current. 
Therefore  damage was induced in the presence  of the broad  spectrum P2  receptor 
antagonist  PPADS  (150  pM).  PPADS  abolished  the  spontaneous  inward  currents 
suggesting that these events occur in a P2 receptor dependent manner. In contrast the 
damage-induced inward current persisted in the presence of PPADS (Fig 5.1.1C). The 
magnitude of the peak current and the total charge transferred as a result of damage 
were determined in order to assess the effect of PPADS. As shown it is critical for the 
comparison of these damage-induced currents that Rsync is taken into account. Note 
that Rsync in the PPADS group was greater than that of the control (Table 5.2). This 
was  not  a  result  of PPADS  application  because  the  Rsync  measured  prior  to  the 
exposure to PPADS was 281.2 ± 55.4 MQ. In order to compensate for the difference 
in Rsync it was assumed that the current-Rsync relationship is linear (see Fig 5.1.2A). 
Thus the peak current and the charge transferred were normalised to the conductance
Gsync  (G   = —-—).  The  data  are  summarised  in  Table 5.2  and  Fig 5.1.3.  The
sync
damage-induced In0rm  in the presence of PPADS was decreased to a minor degree but 
it was not statistically significant from control data. Similarly, the normalised total
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Table 5.2: Comparison of damage-induced currents
Mean Control PPADS P value
Rsync [MQ] 122.8 ±45.5 281.2 ±55.4 0.09
Peak currentnorm [arb. units] -54.2 ± 5.6 -34.9 ± 11.3 0 .2
Chargen0nn [arb. units] -796.4 ± 168.2 -439.1 ± 157.7 0.098
Atcurrent [s] 30.7 ±6.9 48.2 ± 4.6 0 .1 0
Atpeak-baseline [s] 25.6 ±6.2 45.4 ±5.2 0.07
charge transferred was also reduced when exposed to PPADS compared to controls. 
The given P-value of 0.097 indicates that this effect was not statistically significant 
with a sample number of three.
5.1.3  Characterisation of whole-cell Deiters’ currents elicited by purinergic 
agonists
In  order  to  explore  whether  P2  receptors  are  the  likely  mediators  of  the 
damage-induced  currents  the  response  was  compared  to  that  induced  by  various 
agonists.  Deiters’  cells  were  exposed to brief local  puff applications  of purinergic 
agonists to the apical surface of cochlear turns. P2X receptor mediated currents arise 
instantaneously  whereas  metabotropic  P2Y  receptors  require  intermediate  steps  to 
initiate the opening of ion channels and thus the response is delayed. Exogenous puff 
application of ATP  (100 pM)  for  10 ms  elicited  an  immediate  inward current Ifast, 
which  reached  its  peak  within  approximately  100-150 ms  (Fig  5.1.4B).  A  second 
inward current Isi0w developed during the decay phase of Ifast-  The charge transferred 
during the second response was larger compared to Ifast- Moreover, Isiow  appeared to 
be  comprised  of  smaller  events  that  resulted  in  a  fluctuating  noisy  response 
(Fig5.1.4B).  IS ]O W   was  abolished  when  gap  junctional  coupling  was  inhibited  by 
octanol (1 mM, Fig 5.1.4B) strongly suggesting that the current was a property of the 
syncytium.
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Exogenous application of 100 pM UTP for 10 ms was not sufficient to mediate Ifast in 
Deiters’  cells  (Fig5.1.4B).  However,  a  current  with  similar  kinetics  to  Isiow  was 
observed.  ADP and UDP did not trigger ion flux (Fig 5.1.4B).
The data in Fig 5.1.5A and B reiterate that only ATP elicits a rapid current. The mean 
charge  transferred  during  Ifast  was  -0.039 ± 0.023 nC  whereas  that  of  Istow   was 
-1.383 ± 0.186 nC.  The  peak  of  Isiow  measured  in  response  to  ATP  was 
-428.5 ± 105.3 pA and thus greater than that observed with UTP (-262.2 ±  138.3 pA). 
Similarly, the total charge transfer elicited by ATP was larger than that triggered by 
UTP (-1.383 ± 186.0 nC, -0.651 ± 0.375 nC; respectively).
5.1.4  Characterisation of ATP-induced whole-cell currents
In  order  to  record  from  single  Deiters’  cells  the  syncytium  was  uncoupled  using 
octanol (1 mM). Fig 5.16A and B show a comparison of the response to ATP before 
and after uncoupling of the syncytium. Isiow was no longer observed after exposure to 
octanol whereas Ifast remained.  The peak Isiow was reduced from -633.5 ± 170.7 pA to 
-104.6 ± 66.9 pA  in  the  presence  of  octanol.  The  charge  transferred  across  the 
membrane  during  Isiow  was  also  decreased  when  cochlear  coils  were  exposed  to 
octanol (-1.913 ± 0.563 nC to -0.071 ± 0.029 nC). In a few cases cells were found to 
be uncoupled under control conditions. These cells exhibited the same phenotype as 
those recorded from in the presence of 1  mM octanol. Spontaneously uncoupled cells 
were  subjected to repetitive application of ATP  (10 ms)  during voltage-commands 
ranging  from  -100 mV  to  +60 mV  stepping  in  40 mV  increments.  Representative 
current  traces  are  displayed  in  Fig5.1.6C.  The  current-voltage  (I-V)  relationship 
revealed an inwardly rectified current (Fig 5.1.6C, D).  The I-V curve represents an 
average of currents obtained from three voltage-clamped Deiters’ cells (2 animals). A 
number of other Deiters’  cells (n = 3) also showed inward rectification of the ATP- 
induced current; however the magnitude of the current was smaller and was thus not 
included in the average. As the second current was dependent on the gap junctional 
connectivity  it was  not possible  to  determine  the  current-voltage  relationship.  The 
UTP-induced current was similarly dependent on functional gap junction coupling.
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Table 5.3: Comparison of Idam age and IA Tp
Mean Damage LI ATP Islow P value
Rsync [MQ] 230.7 ±83.0 119.1 ±23.9 0.27
Peak current [pA] -111.5 ±37.4 -428.5 ± 105.3 0.047
Charge [nC] -0.88 ±0.31 -1.29 ±0.14 0.29
Atcurrent [s] 21.3 ±1.8 8 .6 ±0.55 0 .0 0 2
At]siow[s] - 8.3 ± 0.62 -
Fig 5.1.7 displays that the peak current reduced as a function of increased Rsync- Thus 
the  current-voltage  relationship  of  the  UTP-induced  current  could  also  not  be 
assessed.
5.1.5  Comparison of damage-induced and purinergic currents
Damage elicited one current (Idamage) in comparison to the biphasic current induced by 
exogenous application of ATP (100 pM). Isiow  and Idam age share the following features:
i)  dependency on Rsync and ii) current fluctuations. In contrast, Idam age occurs over a 
time course of 21.3 ± 1.8 s whereas the ATP-induced total ion flux was considerably 
shorter (8 .6 ± 0.55 s), although the total charge transferred by the ATP-mediated Isiow  
was larger than that of Idam age (Table 5.3).  However, this effect was not statistically 
significant. The peak of Isiow  was significantly greater than that of Idam age (Table 5.3).
5.2 P2 receptor expression
The activation profile of ERK1/2 and the induction of currents by ATP and UTP but 
not by UDP  or ADP,  suggest a specific  role  for the  P2Y2,  P2Y4,  P2Yn  and P2X 
receptor subtypes. The expression pattern of various P2X receptor subtypes has been 
determined  in  cryosections  using  immunocytochemistry  (Housley  et  al.,  1999; 
Jarlebark et al., 2000; Nikolic et al., 2001; Jarlebark et al., 2002; Nikolic et al., 2003; 
Szucs  et  al.,  2004).  Knowledge  about  the  cell  type  specific  expression  of P2Y 
receptors in the cochlea, is more limited. Moreover, protein expression profiles may 
change in culture models compared to in vivo. Thus, the expression pattern of various 
P2Y and P2X receptors were studied in cochlear cultures.
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5.2.1  P2Y receptor expression in neonatal rat cochlear explants
UTP-induced ERK1/2  activation together with the  insufficiency of ADP  and UDP 
implicate a role for the P2Y2, P2 Y4 and P2Yn receptor subtypes. Thus, in this section 
the expression pattern of these subtypes was determined in cochlear explants. Single 
confocal z-stack images  are displayed at two  levels  to  show the expression of the 
examined P2 receptors. The P2Y2 receptor was expressed in Deiters’ cell bodies and 
their  processes  as  well  as  in  Hensen  and  outgrowing  Claudius-like  cells 
(Fig 5.2.1 C-E).  P2Y2  did  not  appear  to  be  present  in  HCs.  Additionally  punctate 
staining was observed along the region of the IHCs (Fig 5.2.1C).  Double-labelling 
with synaptophysin suggests that this punctate pattern represents nerve boutons that 
are already synapsed with IHCs at this time in development (Fig 5.2.1C inset).  The 
specificity of the labelling was tested using the peptide against which the antibody 
was raised. The antibody was pre-incubated for 30 min with the peptide. Fig 5.2.1 A is 
a representative averaged image for P2Y2 receptor expression that shows  extensive 
punctate  labelling  in  the  region  of  the  IHCs.  Moreover,  the  OHC  region  was 
characterised  by  structurally  defined  labelling  of  Deiters’  cells.  In  contrast, 
pre-incubation  with  the  peptide  abolished  the  labelling  in  the  OHC  region  and 
reduced  the  punctate  pattern  (Fig 5.2.IB).  The  expression  pattern  of  P2Y4  was 
different to that of P2Y2. P2Y4 was strongly expressed in HCs (Fig 5.2.1I-L).  The 
labelling of Deiters’, pillar, Hensen and IS cells was observed but to a lesser extent 
than in HCs.  In Deiters’  cells the P2Y4 receptor localised to the plasma membrane 
whereas  in  the  other  cell  types  the  labelling  was  additionally  observed  in  the 
cytoplasm and in nuclei of HCs. The cellular differences of P2Y4 receptor expression 
are most likely not due to reduced accessibility of the antibody to Deiters’  cells. At 
least 3rd row Deiters’  cells would be  expected to  label similarly to  OHCs as  these 
should be exposed to the antibody to a similar extent as the OHCs.  Pre-incubation 
with  the  control  peptide  abolished the  P2Y4  receptor labelling  suggesting  that the 
expression pattern obtained was specific (Fig 5.2.1G, H).
Assessment  of the  P2Yn  receptor  subtype  revealed  a  different  expression  pattern 
(Fig 5.2.2).  Labelling  was  observed  at  the  plasma  membrane  of  HCs.  Diffuse 
labelling was  also  found in  the  cytoplasm of HCs,  pillar and Hensen  cells.  In  the 
Deiters’ cell region it was difficult to distinguish whether the labelling is attributable
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to dendrites/nerve fibres or Deiters’ cells. The pattern as seen at the level of Deiters’ 
cell nuclei in Fig 5.2.2B is quite irregular and the labelling does not outline the cell 
borders  of all  Deiters’  cells.  Averages  of five  confocal  z-stack  images  of P2Yn 
receptor labelling at the apical aspects of Deiters’ and HCs revealed a specific pattern 
(Fig 5.2.2E, F).  The  1st row of OHCs  is displayed and was characterised by strong 
staining of discrete triangular structures that aligned and represented a row of Deiters’ 
cell processes (Fig 5.2.2E). Neighbouring labelling of 1st row OHCs and intercalated 
outer pillar cell processes was also observed.  Fig 5.2.2F shows that inner pillar and 
IHCs were also characterised by P2Y11 receptor labelling at their apical aspects.  Pre­
incubation with the peptide against which the anti P2Yn antibody was raised against 
abolished the labelling (Fig 5.2.2G, H).
In summary, P2Y2, P2Y4 and P2Yn receptors were expressed in distinct patterns in 
rat cochlear explants. In Deiters’ cells, all three receptors were expressed with P2Yn 
being localised to the top of Deiters’ cell processes.
5.2.2  P2X receptor expression in neonatal rat cochlear explants
The ionotropic P2X2 receptor was strongly expressed in Deiters’ cells but not in HCs 
or neurons (Fig 5.2.3A-F). In Deiters’ cells its expression was polarised with stronger 
staining at the top of their phalangeal processes compared to the other regions of the 
cell (Fig 5.2.3A-F). Outer pillar, Hensen and Claudius-like cells also expressed P2 X2 
receptors.  Pre-absorption of the P2X2 antibody to the peptide it was raised against 
abolished the labelling (Fig 5.2.3A, B).
P2X3 receptor expression was characterised by punctate labelling that was localised 
to HCs. Moreover, Deiters’ cells showed labelling, as indicated by the regular pattern 
at the level of Deiters’ cell bodies (Fig 5.2.3 J). The Deiters’ cell phalangeal processes 
are  outlined  at  the  level  of  HCs  as  displayed  in  Fig 5.2.31.  This  supports  the 
interpretation that P2X3 receptors  are expressed in Deiters’  cells.  However, the x-z 
projection does  not give  a clear image  and rather suggests  neuronal  expression  of 
P2X3 receptors (Fig 5.2.3K, L). Neuronal expression is supported by the outline of a 
neuronal fibre in the IHC region and one that crosses the pillar cell region to the OHC 
region  (Fig 5.2.31, J).  Furthermore,  the  average  of 20  images  in  Fig 5.2.3G  also
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suggests  neuronal  expression  of  the  P2X3  receptor.  Punctate  staining  was  also 
observed in Hensen, Claudius-like and cells beneath the basement membrane. When 
the antibody was pre-adsorbed to its specific peptide the immuno-reactivity and the 
labelling were abolished (Fig 5.2.3H).
Punctate labelling was observed for P2X4 receptors in OHCs, Deiters’, Hensen and 
pillar  cells  as  illustrated  in  the  orthogonal  x-z projections  (Fig 5.2.4F, G).  Some 
immuno-reactivity was  also observed around the IHCs  and in cells underneath the 
basement  membrane.  Furthermore,  an  average  of five  images  at  the  level  of the 
Hensen and Claudius-like cells revealed strong expression in structures that resemble 
macrophages (Fig 5.2.4B).  P2X4-labelling of neural projections was variable.  In the 
example shown neural projections were immuno-negative, but in a different explant 
P2X4  receptors  were  present  in  neurons.  The  immuno-labelling  of  the  cochlear 
explants was eliminated when the P2X4 antibody was pre-incubated with its specific 
peptide  (Fig 5.2.4C).  In  summary,  the  P2X2  receptors  were  strongly  expressed  in 
support cells  including Deiters’, outer pillar,  Hensen and Claudius-like cells.  P2X3 
and P2 X4 were also observed in Deiters’ cells but these receptors were additionally 
expressed in HCs and other cell types.
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5.3 Discussion
This  chapter  investigated  P2  receptor  expression  in  Deiters’  cells  assessed  using 
immunocytochemical localisation studies and voltage-clamp recordings in the context 
of damage-induced signalling. Immunocytochemical localisation revealed that P2X2, 
P2X3,  P2X4,  P2Y2,  P2Y4  and  P2Yn  receptors  are  expressed  in  cochlear  explants. 
P2Y2 and P2X2 receptor subtypes were expressed in Deiters’ cells and other support 
cells  but not  in HCs.  Thus  these  receptors  represent  likely  candidates  that trigger 
ERK1/2 activation in Deiters’ cells. Mechanical damage elicited ion flux in Deiters’ 
cells. The magnitude of the resultant current was inversely proportional to Rsync and 
thus was dependent on gap junctional connectivity. This current was challenged with 
the P2 receptor antagonist PPADS and compared to currents elicited by P2 receptor 
agonists.  The  P2  receptor  antagonist  PPADS  was  not  effective  at  reducing  the 
damage-induced current. The agonists ATP and UTP activated currents whereas ADP 
and UDP did not. ATP evoked a biphasic response -  comprised of Ifast and Isiow  and 
the latter was found to require functional gap junctions. UTP application mimicked 
the slowly developing ion flux implying that P2Y receptors are the mediators.  The 
magnitude was also dependent on the Rsync similarly to that of the current evoked by 
damage leading to the hypothesis that the underlying mechanisms are identical.
Immunocytochemical analysis of P2Y receptor expression
The  expression  pattern  of  P2Y  receptor  subtypes  P2Y2,  P2Y4  and  P2Yn  was 
determined.  P2Y2  was  detected  in  Deiters’,  Hensen  and  outgrowing  Claudius-like 
cells,  but  not  in  sensory  HCs.  Gale  et  al.  (2004)  reported  the  presence  of P2Y2 
receptors  in  Hensen  and  Claudius-like  cells  which  is  in  agreement  with  the  data 
presented here.  However,  Gale  et al.  (2004)  also  observed  labelling  of stereocilial 
bundles  of IHCs  and  a different  study  detected  localisation  of P2Y2  in  the  apical 
aspects  of OHC  bodies(Szucs  et  al.,  2004).  These  studies  are  in  contrast  to  the 
observation of this report demonstrating that HCs did not label positively for P2Y2. 
Species and age differences might explain the opposing results.  The model used in 
this study and by Gale et al. (2004) only varies by the lengths of time the cochlear 
explant was maintained in culture. A potential extra day in culture as in the model of
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Gale et al. could change the expression pattern and cause the observed localisation of 
P2Y2 to stereocilial bundles of IHCs.
P2Y4 receptor expression was  observed in HCs  and to  a lesser degree  in Deiters’, 
pillar, Hensen, Claudius and IS cells. There is little knowledge about P2Y4 receptor 
expression in the cochlea. The expression of P2Y4 mRNA was detected in cochleae of 
P2  rats by RT-PCR (Gale  et  al.,  2004).  Moreover,  an immunohistochemical  study 
suggested that P2Y4 receptors are present in Deiters’ cells but not in HCs (Parker et 
al., 2003).  The localisation of P2Y4 in Deiters’  cells  is in agreement with the data 
presented here. In contrast to the study by Parker et al. (2003), HCs expressed P2Y4 
receptors. There are a number of reasons that could explain the differences: i) species
ii)  developmental stage, iii) dissection and maintenance in vitro for 24 hrs could alter 
gene expression.
P2Yn  receptor expression was observed at the apical aspects  of HC bodies  and in 
Deiters’  and pillar cells phalangeal processes.  A possible explanation is that P2Yn 
receptors co-localise to the region of the basal body.  However, this was not tested. 
Labelling was also observed in the basal region of Deiters’ cells, but it was difficult to 
determine  whether  the  pattern  was  resulting  from  expression  in  Deiters’  cells  or 
neurons. The expression of P2Yn receptors has not been investigated in auditory or 
vestibular  HC  epithelia.  The  peptide  used  to  raise  the  anti-P2Yn  antibody  was 
subjected to a Blast search and revealed only similarity to P2Y11 clones from various 
species and thus suggests specificity of the antibody. However, Western Blot analysis 
carried out by the supplier of the antibody (Alomone Labs, data sheet, Lot #: AN-01) 
gave rise to several protein bands. Hence, the expression profile presented here has to 
be taken with caution.
P2X receptor expression
The expression patterns of P2X2, P2 X3  and P2X4 were investigated in rat cochlear 
explants.  P2X2  receptors  were  localised  in  Deiters’,  outer  pillar,  Hensen  and 
Claudius-like  cells.  Previously,  the  expression  of P2X2  has  been  reported  for  the 
support cell  subtypes  mentioned above  with the  exception  of the  outer pillar  cell. 
However those reports in contrast to the data presented here detected P2X2 receptor
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immunoreactivity also in stereocilial hair bundles of outer and in some species inner 
HCs (Housley et al.,  1999; Jarlebark et al., 2000; Jarlebark et al., 2002). There are a 
number of reasons that could explain the differences:  i) developmental stage, ii)  in 
vitro alteration in gene expression, iii) different antibodies used.
HCs, Hensen and Claudius-like cells express P2X3 receptors. Moreover, the labelling 
pattern  also  suggests  expression  in  neuronal  fibres  and  Deiters’  cells.  At this  age 
immunohistochemical data using cryosections revealed P2 X3 receptor expression in 
HCs  and spiral ganglion neurons, but not in  support cells  of mouse cochleae.  The 
differences  in  the  expression  might  be  related  to  the  species  or  to  the  different 
antibodies used in the two studies (Huang et al., 2005).
P2X4 was widely expressed in cochlear explants. Cells include hair, Deiters’, Hensen, 
pillar, Claudius-like cells and also those beneath the basement membrane.  Previous 
studies  have  shown  that  P2X4  mRNA  was  present  in  postnatal  day  1   to  16  rat 
cochleae (Brandle et al.,  1999). Published immunohistochemical data are scarce and 
focused on spiral ganglion neurons and isolated outer HCs. Both cell types expressed 
the P2X4 receptors (Xiang et al.,  1999;  Szucs et al., 2004).  Here, the expression of 
P2X4 receptors in neuronal fibres was variable.  P2X4 expression was  characterised 
predominantly  by  punctate  labelling.  In  olfactory  bulb  neurons  P2X4  receptors 
localised  to  early  endosomes  and  continuous  receptor  trafficking  was  described 
(Bobanovic et al., 2002).
P2X4  receptor expression  was  also  observed  in  cells  with  dendritic  processes  that 
most  likely resemble macrophages.  There  is  some  evidence  that macrophages  and 
microglia express P2X» receptors  (Bowler et al., 2003)
P2 receptor expression in the light of ERK activation
Damage-induced ERK 1/2 activation was observed in a subset of non-sensory support 
cells, Deiters’ and phalangeal cells. In contrast, HCs did not respond to damage with 
ERK 1/2  activation.  The P2  receptor expression profiles that most closely resemble 
the ERK 1/2  activation pattern are those  of the P2 X2  and the P2Y2 receptors.  Data 
presented here show that both receptors are expressed in Deiters’ cells but not in HCs
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and are thus potential candidates for triggering the activation of ERK 1/2 in Deiters’ 
cells. However, it can not be excluded that other P2 receptors that are expressed in 
both  Deiters’  and HCs  stimulate  the  activation  of ERK1/2.  The  same  P2  receptor 
subtype  could recruit different downstream  signalling molecules  depending  on the 
cell  type  resulting  in  diverse  signalling  events.  P2X7  receptors  which  were  not 
examined here are known to be expressed in postnatal and adult Deiters’ and IHCs. 
This P2 receptor is only present during the first days after birth in OHCs (Nikolic et 
al., 2003). In P2X7 transfected cells it has been shown that activation of the receptor 
leads to the activation of ERK1/2 (Amstrup and Novak, 2003; Gendron et al., 2003). 
However, PPADS, which is an effective blocker of P2X7 receptors failed to reduce 
ERK1/2  spread; thus P2X7 receptors can likely be  excluded.  The  absence of P2Xi 
receptor  expression  in  Deiters’  cells  (Nikolic  et  al.,  2001)  excludes  that  these 
receptors  mediate  ERK1/2  activation.  To  summarise,  based  on  the  selective 
expression  of  P2X2  and  P2Y2  receptors  in  Deiters’  cells,  these  are  the  likely 
candidates to initiate signalling towards ERK 1/2 during inner ear damage.
P2 receptor expression and Ca-signalling
Propagation of the damage-induced Ca2+ wave into the distinct regions of the cochlea 
required different sources  of Ca2+.  In the  OS  region  the  Ca2+ rise  was  established 
solely through release of Ca2+ from intracellular IP3 sensitive stores suggesting P2Y 
receptors as the main regulators. P2Y2, P2Y4 and P2Yn receptors were expressed in 
Hensen and Claudius-like cells. Based on the agonist study UDP and ADP-sensitive 
receptors  could  contribute  to  the  Ca2+  wave.  The  expression  of those  receptors 
remains to be determined. The redundancy of extracellular Ca2+ in the propagation of 
the damage-induced Ca2+ wave suggests that P2X receptors are not involved in the 
OS region. In contrast, P2X2, P2X3 and P2X4 receptors were observed in Hensen and 
Claudius-like cells and could thus also facilitate the formation of the damage-induced 
Ca2+ wave.  It is possible that during the damage-induce Ca2+ wave the levels of ATP 
released might not be sufficient to activate P2X receptors and thus to mediate influx 
of extracellular Ca2+.
Two distinct Ca2+ waves propagated along the HC region.  Influx of Ca2+ from the 
extracellular space  facilitated the  formation of the  fast wave whereas  IP3  sensitive
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Ca2+ stores were required to mediate the slow Ca2+ wave. HCs and Deiters’ cells can 
contribute  to  the  signal  measured  along  the  HC  region.  The  receptor  subtypes 
investigated were present in one or the other cell type if not in both. Thus it is not 
possible to  extrapolate  their  specific  contribution  to  the  wave  propagation.  Again, 
ADP  and  UDP  were  able  to  elicit  a  Ca2+  response.  Therefore,  ADP-  and  UDP- 
sensitive P2Y receptors which were not investigated here might contribute to a minor 
extent. ADP has also been demonstrated to activate P2X3 receptors or its heteromer 
P2X2-3/3 (Greenwood et al., 2007). Both P2X2 and P2X3 receptors are expressed in the 
HC region and thus could be the mediators of the ADP-induced rise in intracellular 
Ca2+. However it is not known whether the specific P2X2-3 splice variant is present in 
hair or Deiters’ cells in cochlear explants.
Propagation  of the  damage-induced  Ca2+  wave  into  the  IS  region  required  both 
extracellular Ca2+ and release from intracellular stores. However, it is possible that a 
third mechanism acts in this region to facilitate the Ca2+ wave. The only P2Y receptor 
clearly expressed in the IS region was P2Y4. As UTP was the most potent agonist to 
elicit an intracellular rise in Ca2+ it is likely that P2Y4 is the predominant candidate to 
evoke  the  IP3  dependent  Ca2+  wave  formation.  As  ADP  was  able  to  elicit  Ca2+ 
changes ADP-sensitive P2Y receptors might play a minor role.  P2X2, P2X3 and P2X4 
receptor subtypes were not observed in this region. Thus other P2X receptors might 
mediate the influx of extracellular Ca2+.
Damage-induced currents
Mechanical  damage  of cochlear cells  elicited  an  inward  current  in  a Deiters’  cell 
located  five  cells  (~50 pm)  from the  site  of damage.  During  the  damage  protocol 
Deiters’ cells were maintained in their support cell syncytium. The magnitude of the 
peak current was inversely proportional to  R sync,  which is inversely proportional to 
the  number  of  cells  in  the  syncytium.  Therefore,  the  magnitude  of Idamage  is
proportional to the number of cells in the syncytium.  Cell death of keratinocytes or 
nociceptive  neurons  elicited  an  inward  current  in  surrounding  nociceptors.  The 
current induced by a dying nociceptor was inhibited by TNP-ATP -  a P2X receptor 
antagonist (Cook  and McCleskey,  2002).  In  this  report the  application  of the  P2
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receptor antagonist PPADS did not significantly reduce the peak current. There was a 
reduction in the total charge transferred across the Deiters’ cell membrane during the 
damage-induced  response,  but  again  this  was  not  statistically  significant.  Only  a 
subset of P2 receptors are sensitive to PPADS (King and Townsend-Nicholson, 2003) 
and  therefore  a  variety  of antagonists  are  required  to  clarify  whether  ATP  is  a 
mediator  of the  damage-induced  current.  Of course,  cell  damage  is  likely  to  also 
result in the release of other molecules such as glutamate which could result in inward 
currents at negative holding potentials (Glowatzki et al., 2006).
Gap junctional coupling has been suggested to be modulated by elevated intracellular 
Ca2+ (Dakin et al., 2005).  However mechanical  damage of the  HC  epithelium that 
results  in  increased  intracellular  Ca2+  (see  chapter 3)  did  not  affect  Rsync  when 
assessed 2-3 min after damage. Ca2+ levels return to baseline typically within 1.5 min 
following damage in the HC region. The Ca2+ concentrations achieved might not be 
sufficient to uncouple gap junctions. Moreover, Dakin et al. (2005) demonstrated that 
gap junction uncoupling was dependent on the mechanism that resulted in elevated 
intracellular Ca2+.  Agonist-induced Ca2+ rises triggered by histamine  or bradykinin 
were not sufficient to dissociate gap junctions. In contrast, store-operated Ca  entry 
was able to mediate gap junctional uncoupling. This might suggest that the pathway 
required to  uncouple  gap junctions  is  not activated  in response  to  the  mechanical 
stimulus used in this study.
Nucleotide-induced currents
Whole-cell  currents were recorded from Deiters’  cells  in  a  support cell  syncytium 
exposed  to  exogenous  application  of  various  P2  receptor  agonists  in  order  to 
investigate  whether  such  currents  mimic  the  damage-induced  current.  Here  the 
features  of  P2  receptor  activated  currents  are  discussed  and  in  the  following 
subsection the currents are compared to those elicited by damage.
Local pressure application of ATP elicited two temporally separate inward currents -  
Ifast  and  Isiow   and  the  latter  requiring  a  functional  syncytium.  The  current-voltage 
relationship  of  the  first  component  reveals  an  inward  rectification.  This  is  in 
agreement with previous reports for ATP-induced currents in Deiters’ cells (Chen et
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al., 2000; Lagostena and Mammano, 2001). P2X2 receptor and splice variants specific 
to the cochlea have been reported to inwardly rectify (Zhou and Hume, 1998; Chen et 
al., 2000). In addition P2Xi/s receptors exhibit inward rectification to a minor degree 
(Haines et al.,  1999) but not P2 X4 receptors (Khakh et al.,  1999b). Published data on 
the P2X receptor subtype dependent rectification assessed in heterologous expression 
systems  are  quite  scarce.  Moreover  in  a  native  tissue  several  P2X  receptors  are 
expressed simultaneously and are likely to form heteromers which might render their 
properties. Thus in agreement with the immunohistochemical data the likely receptor 
expressed  in  Deiters’  cells  that  infers  rectification  is  a  P2X2-like  receptor.  The 
current-voltage relationship of the second component was not determined as clamping 
the voltage of the syncytium was not possible.
Due to the  slow decay of Isiow  the total charge transferred was  considerably larger 
compared to  that  of Ifast-  A  similar biphasic  current  in  response  to  ATP  has  been 
described in Hensen cells of adult guinea pigs (Lagostena et al., 2001). In contrast in 
Deiters’ cells from adult guinea pigs only a monophasic current that was identical to 
Ifast was observed (Lagostena and Mammano, 2001). Results presented here show that 
UTP but not ADP or UDP was sufficient to elicit Isiow. The data indicate that Isiow  is 
mediated through the  activation of one of the UTP  sensitive  P2Y2, P2Y4  or P2Yn 
receptors.  Moreover,  as  Ifast  was  not  observed  with  UTP  this  suggests  that  P2X3 
receptors  are  absent  from  the  apical  aspect  of  Deiters’  cell.  These  data  are  in 
agreement  with  an  IP3  dependent mechanism  that was  described  for  Hensen  cells 
(Lagostena  et  al.,  2001).  The  nature  of  that  current  was  a  Ca2+-induced  Cl" 
conductance. Thus the ionic current observed in Deiters’ cells in this thesis might be 
mediated by the same mechanism.  However, unless octanol -  a gap junction inhibitor 
affects the  suggested channels,  the  absence  of the  slow  current in the presence  of 
octanol has to be explained.  Deiters’ cells that uncoupled without the addition of gap 
junction inhibitors were also characterised by the absence of Isiow; thus suggesting that 
octanol  does  not  exert a  direct  effect on the  channel  that mediates  Isiow -  The  data 
suggest  that Isiow   does  not originate  from  Deiters’  cells.  Lagostena and Mammano 
(2001) reported a biphasic response to ATP in Hensen cells that was composed of a 
fast P2X-mediated and a slower Ca2+-activated Cl' conductance. Thus Isiow  observed 
in Deiters’ cells likely originates from nearby Hensen cells. In addition it cannot be
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excluded that other support cell types or cells in the IS region also contribute to the 
generation of IS ]0w However, data are not available for other support cell types.
Comparison of Ia tp  and
Exogenous application of ATP resulted in a biphasic current that consisted of Ifast, a 
P2X-mediated  current,  and  Isiow   which  was  mediated  by  P2Y  receptor  activation. 
Damage elicited a current that was similar to the second component Isiow  in that it was 
dependent on the activity of the support cell syncytium.  Thus it is likely that these 
currents  result  from  the  activation  of the  same  receptor  -   a  UTP-sensitive  P2Y 
receptor. Ifast -  the P2X-like current was not obvious as a component of the damage- 
induced current.
One possibility is that the damage stimulus used would result in more gradual release 
of  ATP  than  the  stepped  pulse  of  ATP  application.  Therefore,  the  onset  of 
P2X receptor  activation  might  be  delayed  and  thus  coincide  with  that  of  P2Y 
receptors. Therefore, this might result in the masking of Ifast  by Isi0w-  A smaller  Ifast 
component could also have been missed due to the  spontaneous current activity in 
recordings from Deiters’ cells in a syncytium. Both Isi0w and the spontaneous activity 
were reduced when Rsync was high. Therefore, it might be expected that Ifast would be 
observed at high Rsync’s due to its  continued presence as  shown when treated with 
octanol  (see  section  5.1.4).  This  was  however  not  observed,  which  indicates  that 
P2X receptor activation does not occur in Deiters’ cells during damage of the cochlea.
Damage-induced currents typically lasted longer than those triggered by exogenous 
ATP  application.  This  likely  represents  a  prolonged  presence  of ATP  during  the 
damage stimulus compared to the 10 ms bolus of ATP.
Damage-induced Ca~-waves and ERK 1/2 activation in the light of damage-induced 
currents
The  aim  of  this  study  was  to  elucidate  whether  damage  induces  P2X  and 
P2Y-mediated  currents  for  comparison  with  data  on  damage-induced  Ca2+  wave 
formation and ERK 1/2 activation. The data presented here favour a model that can
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Table 5.4 Comparison of features of Idam age and ERK1/2 activation
Idamage ERK1/2 activation
PPADS sensitivity No No
P2Y-mediated (UTP) Yes Yes
Gap junctions Yes Yes
exclude P2X receptors  (see previous  section)  in the  facilitation  of damage-induced 
signalling. However, exclusion of P2X receptors results in a conundrum with respect 
to the mechanism of the fast Ca2+ wave that requires influx of extracellular Ca2+ and 
the  partial  activation  of ERK 1/2.  Idam age  shares  properties  with  the  P2Y-mediated 
ATP-induced Isiow   arguing  that it does  not  involve  the  entry  of extracellular Ca2+, 
unless  the  current results  in voltage  changes  in  neighbouring  cells  that  enable  the 
opening of voltage-gated Ca2+ channels over quite some distance. However, there is 
only one report suggesting that voltage-gated Ca2+ channels are expressed in Deiters’ 
cells (Hafidi and Dulon, 2004). It is possible that the entry of extracellular Ca2+ is not 
associated with Deiters’ cells but actually occurs in HCs. Furthermore, ATP released 
during  damage  could  provoke  HCs  to  release  a  molecule  that  triggers  ERK 1/2 
activation in surrounding cells.
Table 5.4  summarises  the  features  of  Idam age  and  ERK1/2  activation.  Idam age  and 
damage-induced ERK 1/2 are both characterised by their i) P2Y-mediated activation 
based on their activation by UTP, ii)  insensitivity to the P2 receptor 
antagonist PPADS  and iii) requirement for functional  gap junctions  (Table  5.4).  It 
could  be  speculated  that  the  mechanism  underlying  those  events  are  the  same. 
However,  gap  junction  mediated  ERK 1/2  spread  occurred  independently  of 
intracellular Ca2+, whereas the damage-induced current is likely a Ca2+-activated Cl' 
current; thus indicating that both events require gap junctions but are likely occurring 
independently of each other.
In  contrast  to  the  activation  of  ERK 1/2  and  the  generation  of  damage-induced 
currents, the formation of the damage-induced Ca2+ wave was significantly reduced in 
the  presence  of  PPADS.  This  indicates  different  underlying  mechanisms.  The
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remainder of the Ca2+ wave was predominantly the fast Ca2+ wave (see section 3.5 
and 3.6) that was proposed earlier to partially mediate ERK 1/2 activation.
Spontaneous oscillations
Spontaneous  oscillations  of  inward  currents  were  observed  when  Deiters’  cells 
maintained in their support cell syncytium were held at -90 mV. These currents were 
sensitive to PPADS suggesting that they result from the action of extracellular ATP 
or  a  nucleotide  analogue  on  P2  receptors.  This  is  the  first  observation  of  such 
ATP-induced  spontaneous  oscillations  in  Deiters’  cells.  Megakaryocytes  exhibit 
spontaneous current oscillations. The frequency of these spontaneous oscillations is 
reduced in megakaryocytes harvested from both P2Xf7 ' and P2Yi'7 ' mice (Tolhurst et 
al., 2005). Similarly, these receptors could be employed by cochlear Deiters’ cells to 
facilitate the spontaneous events.
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Fig 5.1.1  Damage-induced ionic currents in Deiters’ cells.
A)  Experimental layout,
Left  panel:  Damage  to  the  HC  region  was  induced  using  a  microneedle.  The  patched 
Deiters’ cell was situated 5 cells from the lesion site along the cochlear length.
Right panel:  currents were  recorded  from  a voltage-clamped  Deiters’  cell  in  a  syncytium 
of support cells held at -90 mV.
B, C) Current traces of two Deiters’ cells in a syncytium subjected to damage in (B) control 
(Rsync = 209 MQ) and (C) 150 pM PPADS (Rsync = 254 MQ).
Upper panel  a  5  min  trace that  includes  spontaneous  inward  currents  and  one  damage. 
The arrow marks the time of damage.
Lower panel: higher temporal resolution of the damage-induced current.
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Fig 5.1.2 Comparison of whole-cell Deiters’ currents resulting from two consecutive 
lesions.
A,B,C) Whole-cell  currents from  Deiters’  cells  in  a  syncytium  recorded  during  damage  of 
the  HC  region.  Two lesions were  introduced  to the  same  cochlear  region  at an  interval  of 
30 min.
A) Peak current of lesion  1  (closed triangle) and 2 (open triangle) as a function of Rsync.
B) Damage-induced peak current following lesion  1  (L1) and 2 (L2).
C) Total charge transferred following lesion 1  (L1) and 2 (L2).
Mean ± S.E.M., n = 12 for A, n = 3 for B, C
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Fig 5.1.3 Quantification of damage-induced currents recorded from Deiters’ cells in 
the  presence of PPADS.
A) Damage-induced peak current normalised to the conductance (see 2.8.6) in control and 
PPADS.
B) Total charge that was transferred across the Deiters’ cell membrane following damage 
(normalised to the conductance of the Deiters’ cell) in control and PPADS.
Mean ± S.E.M., n  = 3, P > 0.05, Student’s f-test.
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Fig  5.1.4  Whole-cell  currents 
recorded  from  Deiters’  cells  in  a 
syncytium stimulated by exogenous 
application of purinergic agonists.
A)  Experimental  layout:  The  puff 
electrode  was  placed  above  the 
stereocilia  of the  cell  neighbouring  the 
patched  Deiters’  cell.  Whole-cell 
currrents  were  recorded  from  Deiters 
cells maintained in the syncytium.
B)  The  top  trace  represents  the  puff 
application  stimulus  followed  by traces 
displaying  the  currents  elicited  by 
exogenous application  of 100  pM  ATP 
(10  ms),  ATP  in  the  presence  of 
octanol,  UTP,  ADP,  UDP  (from  top  to 
bottom).
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Fig 5.1.5 Quantification of agonist-induced currents recorded from Deiters’ cells in a 
syncytium.
A) Comparison of peak lfast and  lsk)W  induced by 100 pM ATP,  UTP, ADP or UDP.
B)  Comparison  of charge transferred  during  lfast and  lsk)W  following  exogenous  application 
of 100 pM ATP,  UTP, ADP or UDP.
Cells  that  closely  matched  Rsync  across  the  range  of  agonists  were  included  into  the 
comparison. Mean ± S.E.M., n  = 3
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Fig 5.1.6 Characterisation of ATP-induced currents recorded from Deiters’ cells.
A) Effect of octanol on the ATP-induced peak lfast and lS |0W .
B) Effect of octanol on the charge transferred during lfast and  ls,ow 
For (A & B) Mean ± S.E.M., n = 3
C)  Application  of  100  pM  ATP  (10  ms)  during  five  voltage-steps  of  40  mV  increments 
starting at a holding potential of -100 mV.  Note the Deiters’ cell  uncoupled without addition 
of a gap junction inhibitor displayed only lfast.
D)  Averaged  ATP-induced  peak  lfast-voltage  relationship,  (n  =  3  cells,  2  animals).  The 
three  cells  included  in  the  average  uncoupled  without  the  addition  of  a  gap  junction 
inhibitor.
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Fig 5.1.7 Dependency of UTP induced peak current on Rsync.
Peak current induced by exogenous application of UTP (100 pM) as a function of Rsync.
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Fig 5.2.1 Expression of P2YZ  and P2Y4 receptors in rat cochlear explants.
A-F, G-L) Immunocytochemical labelling of cochlear explants with an antibody against (A- 
F) P2Y2 or (G-L) P2Y4 receptors.
A, B, G, H) Average of 20 confocal z-stack images (optical slice:  1.43 pm) displaying (A) 
P2Y2 and (G) P2Y4 receptor labelling or (B, H respectively) following pre-incubation with 
their specific peptide antigens.
C,  D,  I,  J)  Higher  magnification  single  confocal  images  at  the  plane  of  (C,  I)  OHCs  or 
(D, J)1st and 2nd row Deiters’ cell nuclei.  Inset in (C) x-z projection focused on  IHC triple­
labelled for P2Y2 (green), synaptophysin (red) and nuclei (blue).
E, F, K, L) Average of 5 consecutive x-z projections labelled for (E, K) the respective P2Y 
receptors and (F, L) double-labelled with DAPI (blue).
Arrowheads in (A, C) point on labelling in synaptic region -  likely afferent boutons; arrow in
(E)  indicates a Deiters’ cell  process.  Scale bars,  50 pm in (B,  H) for (A,B,G,H);  10 pm in 
(D,L) for (C-F, l-L).
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Fig 5.2.2 Expression of P2Y1 1  receptors in rat cochlear explants.
A, B) Single confocal z-stack images of cochlear explants labeled with an antibody against 
P2Y11  receptors at the plane of (A) OHC and (B)  1st and 2nd row Deiters’ cell nuclei.
C,  D) Average  of 5  consecutive x-z  projections  of (C)  P2Y^ receptor expression  and  (D) 
double-labelled with  DAPI (blue).
E, F) Higher resolution images of P2Y^  at the plane of apical aspects of (E)  1st row OHCs 
and (F) IHCs.
G, H) Averages of 20  lower magnification  confocal z-stack images  (optical slice:  1.43  pm) 
of (G) P2Y^  receptor labelling and (H) following pre-incubation with its specific peptide.
White  arrowheads  in  (D,  E)  indicate  apical  aspects  of OHCs,  yellow  arrowheads  of  IHCs
(F).  White arrows  indicate apical  aspect of Deiters’  cells  (E),  pink arrow of outer pillar (E) 
and  yellow arrow of inner piller cells (F) Scale bars,  10 pm  in (D) for (A-D) & (F) for (E,F); 
50 pm in (H) for (G+H).
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Fig 5.2.3 Expression of P2X2 and P2X3 receptors in rat cochlear explants.
A-F, G-L) Immunocytochemical labelling of cochlear explants with an antibody against (A- 
F) P2X2 or (G-L) P2X3 receptors.
A,  B, G,  H) Average of 20 confocal z-stack images  (optical slice  1.43  pm) displaying (A) 
P2X2 and (G) P2X3 receptor immuno-reactivity or (B, H respectively) when pre-incubated 
with their specific peptides
C-F, l-L) Single confocal images at higher magnification at the level of (C,  I) OHCs or (D, 
J) 1st and 2nd row Deiters’ cell nuclei.
E, F, K, L) x-z projections (average of 5) labelling (E, K) the respective P2X receptor and 
(F, L) double-labelled with DAPI (blue).
Arrow  in  (E)  indicates  Deiters’  cell  top.  Arrowheads  in  (G,  I,  J,  L)  indicate  potential 
neuronal fibres. Scale bars, 50 pm in (B, H) for (A,B,G,H); 10 pm in (F,L) for (C-F, l-L).
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Fig 5.2.4 Expression of P2X4 receptor and synaptophysin in rat cochlear explants.
A-G,  H-K)  Immunocytochemical  labelling  of cochlear  explants  with  an  antibody  against 
(A-G) P2X4 or (H-K) synaptophysin.
A, C) Average of 20 confocal z-stack images (optical slice:  1.43 pm) for (A) P2X4 receptor 
immunoreactivity or  (C)  when  pre-incubated  with  its  specific  peptide.  (B) Average  of  10 
confocal  z-stack  images  at  the  level  of  Hensen  and  Claudius-like  cells  labelling 
macrophages (arrow head).
D-G) Higher magnification single confocal images at the plane of (D) OHCs and (E) 1st and 
2n d  row Deiters’ cell nuclei.
F,  G)  Average  of  5  consecutive  x-z  projections  of  (F)  P2X4 receptors  and  (G)  double­
labelled with DAPI (blue).
H-K) Labelling of synaptophysin at similar planes as in (D-G).
Scale bars, 50 pm in (C), for (A-B); 10 pm in (G, K) for (D-K).
180Chapter 5 -  Figures
181Chapter 6 -  General discussion
6. General Discussion
The experiments presented in this thesis address damage-induced signalling events in 
the  neonatal  rat  cochlea.  These  events  include:  i)  activation  of ionic  currents  in 
Deiters’  cells;  ii)  formation  and  propagation  of intercellular  Ca2+  waves  into  the 
distinct cochlear regions;  iii) activation of ERK1/2 in Deiters’  and phalangeal cells 
and iv) MEK1/2 dependent HC death that could involve the action of support cells. 
This general discussion will review the damage paradigms used and then attempt to 
establish a model of damage-induced signalling events in the mammalian cochlea.
Damage model
Acoustic overstimulation can either result in temporary or permanent threshold shifts 
depending  on  the  magnitude  of the  sound  stimulus.  The  most  common  cause  of 
permanent threshold shifts is the death of sensory HCs (Nicotera et al., 2003; Wang et 
al., 2003a). Intense noise stimuli can result in the rupture of the HC epithelium (Wang 
et al.,  2002b).  In the  present  study the HC  epithelium was  mechanically  damaged 
using  a  microneedle  or  an  N2-laser  in  order  to  investigate  subsequent  signalling 
pathways. The magnitude of damage induced using these in vitro techniques can be 
considered  to  represent  the  in  vivo  situation  during  the  sorts  of  acoustic 
overstimulation  leading to permanent threshold shifts  and epithelial  rupture.  Thus, 
these damage models offer the opportunity to have precise timing enabling the study 
of signalling events that are short-lasting and are therefore unlikely to be detected in 
vivo. Moreover the interplay between different signalling cascades can be relatively 
easily assessed.
However,  of  course  this  model  has  limitations  that  might  affect  the  signalling 
cascades. The apical and basal aspects of cochlear hair and support cells are exposed 
to  distinct extracellular fluids -  endolymph and perilymph,  respectively.  The  ionic 
balance of these fluids is tightly regulated. The endolymph is characterised by high 
K+  and  low  Ca2+  whereas  the  composition  of the  perilymph  is  similar  to  other 
extracellular  fluids  (high  Na+  and  Ca2+  and  low  K+).  Using  organotypic  cochlear 
explants means that the apical aspects of cells are exposed to an extracellular fluid 
that  is  most  similar  to  perilymph.  P2  receptor  responses,  key  elements  of  the
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signalling cascades presented here,  have been described to be modulated by high K+ 
and  Ca2+ (Ding  and  Sachs,  1999;  Mammano  et  al.,  1999;  Ding  and  Sachs,  2000; 
Kanjhan et al., 2003; King and Townsend-Nicholson, 2003; Pitt et al., 2005). Thus 
depending  on whether ATP  acts  at the  apical  or baso-lateral  sites  of cells  the  P2 
receptor responses might be altered accordingly. It is worth noting that during excess 
damage  in vivo,  especially when the  HC  epithelium is  ruptured the  ionic  gradient 
across  the  epithelium will  not be  maintained  and P2  receptors  in both  apical  and 
baso-lateral membranes of the cells are likely to experience similar conditions at the 
immediate site of damage.
Age of animal
The onset of hearing occurs in rats between P12  and P14  (Geal-Dor et al.,  1993; 
Freeman et al.,  1999). The early postnatal period up to the onset of hearing and even 
beyond is characterised by developmental restructuring of the cochlea and changes in 
various protein expression profiles.  The key players -  that enable damage-induced 
signalling, the propagation of a Ca2+ wave and activation of ERK1/2 are P2 receptors 
and  gap  junctions.  The  expression  of  both  constituents  of  the  damage-induced 
signalling cascade has been observed to be changed during the early postnatal period 
(Nikolic  et al., 2003;  Huang et al.,  2005;  Jagger and Forge,  2006).  Although,  the 
exact P2 receptors that mediate damage-signalling events in the rat cochlea are not 
known, it has to be considered that developmental changes of P2 receptor expression 
might alter the ability of the cells to induce the described signalling cascades.
The expression profile of connexins is also altered during postnatal development. At 
P0  coupling  occurs  between  Deiters’  cells.  This  is  however  not  mediated  by 
connexin 26 and 30,  as these are not expressed at this  stage.  Protein expression of 
these connexins and thus heteromer formation is observed by P8 (Jagger and Forge, 
2006). Gap junctions formed by different connexin subunits determine the nature of 
molecules that are enabled to pass.
Purinergic and damage-induced currents recorded from Deiters’ cells
Application of ATP induced a biphasic current in Deiters’ cells that were connected
to their support cell syncytium: The current consisted of Ifast, a P2X receptor mediated
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current, and Isiow, most likely a P2Y-mediated current. UTP activated Isiow  but not Ifast 
suggesting; i) that functional P2X3 receptors are not present at the apical aspects of 
Deiters’  cells and ii) that Isiow is mediated by P2Y2, P2Y4 or P2Yn  receptors.  The 
magnitude of Isiow is dependent on the syncytial resistance and is therefore a property 
of the  network of neighbouring  cells.  Taken together,  data presented here  and by 
Lagostena et al. (2001) indicate that Isiow is a P2Y receptor mediated Ca2+-activated 
C1‘ current. Idam age was characterized by the absence of Ifast and by its dependency on 
Rsync,  identical  to  UTP-induced  Isiow.  Thus  Idam age  is  likely  to  be  a  P2Y  receptor 
induced Ca2+ activated Cl" current. The absence of Ifast indicates and absence of P2X 
receptor activation during damage. Unless Idam age resembles a current that is a merged 
response  of Ifast and  Isiow,  a  damage model  has  to  be proposed that  excludes  P2X 
receptors.
Proposed model of damage-induced Ca—  waves in the organ of Corti 
Mechanical damage of the HC epithelium triggers the release of extracellular ATP 
which activates an intercellular Ca2+ wave that propagates into the distinct cochlear 
regions.  The  model  in Fig 6.1  summarises  specifically the  mechanism  resulting  in 
Ca  wave  propagation  in  the  HC  region  where  damage  elicits  two  distinct 
intercellular Ca2+ waves.  Different velocities,  extent of spread and sources  of Ca2+ 
distinguish the  two  intercellular Ca2+ waves.  The  slower Ca2+  wave  depends upon 
IP3-sensitive stores, whereas the faster wave requires extracellular Ca2+.  Combining 
analysis of Ca2+ signals activated by purinergic agonists with the observed restriction 
of the Ca2+ wave propagation in the presence of the P2 receptor antagonists suramin 
and PPADS implicates a role for P2Y2 ,4 or n receptors. P2Y] and/or P2Y6 receptors 
may also be involved, but to a lesser extent (see chapters 3.4 -  3.6). A requirement for 
extracellular Ca2+ to generate the faster Ca2+ wave suggests the involvement of ion 
channels and thus most likely of P2X receptors. However, in the presence of PPADS 
and suramin, which inhibit the majority of P2X receptors except for P2X4, the faster
94-
Ca  wave was still observed. Idam age recorded from Deiters’ cells resembles Isiow  -  the 
component of the ATP-activated current that is observed when UTP is  applied.  In 
contrast, an Ifast-like ATP-activated P2X current was not observed for Idam age- Taken 
together,  the  results  of the  patch-clamp  and  antagonist  study  indicate  that  P2X 
receptors are unlikely to be involved in damage-induced signalling and are thus not
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Fig 6.1 Model of damage-induced Ca2+ wave propagation in the HC region
Damage of the HC epithelium triggers the release of ATP that mediates the propagation of 
two Ca2+ waves. The question mark indicates a yet unknown mechanism that results in the 
formation of the faster Ca2+ wave.
the source for influx of extracellular Ca2+. This raises the question to the nature of the
0 -4 -
mechanism that mediates the influx of extracellular Ca  .
Ca2+  wave  propagation  was  also  reduced  in  the  presence  of CBX.  Assuming  that 
CBX  affects  connexins  this  suggests  an  involvement  of  either  functional 
hemichannels and/or gap junctions. The damage-induced Ca2+ wave was not further 
reduced  when  CBX  treatment  was  combined  with  apyrase  indicating  that  both 
substances act on the same underlying mechanism- that is the action of ATP.  This 
hypothesis assumes that that apyrase is not  100 % efficient based on its i) enzymatic 
activity and ii) residual Ca2+  signals  are recorded in the presence  of apyrase.  CBX 
might affect the release of ATP by connexin hemichannels, whereas apyrase degrades 
ATP. P2X7 receptors and voltage-gated Ca2+ channels have also been described to be 
inhibited  by  CBX  (Vessey  et  al.,  2004;  Suadicani  et  al.,  2006).  However, 
damage-induced  P2X7  receptor  activation  was  excluded  on  the  basis  of  the 
insensitivity of the fast Ca2+ wave, which requires Ca2+ entry, to PPADS. Thus, it is
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unlikely  that  CBX  acts  on  P2X7  receptors  to  inhibit  the  Ca2+  wave.  However, 
inhibition of voltage-gated Ca2+ channels could give another explanation of the effect 
of CBX.
Model of damage-induced ERK1/2 activation in the organ of Corti 
Damage-induced activation of ERK1/2 occurred in Deiters’ and phalangeal cells and 
was observed to  spread preferentially along their rows.  The model in Fig 6.2  is an 
attempt  to  bring  together  the  results  presented  in  this  thesis  on  damage-induced 
ERK1/2  activation.  Two  apparently  independent pathways  -  one  that requires  the 
influx of extracellular Ca2+ and the other occurring independently of Ca2+ -  mediate 
the activation and spread of ERK1/2. Based on the data presented in this thesis the 
simplest  explanation  is  that  the  Ca2+  dependent  pathway  is  linked  to  the  faster 
damage-induced Ca2+ wave mediated by influx of extracellular Ca2+. The conclusion 
of a Ca2+-independent pathway is based on interpretation of the effects of CBX and 
apyrase on both the damage-induced Ca2+ wave and the activation of ERK1/2.  For 
ERK1/2  activation,  CBX  and  apyrase  were  demonstrated  to  act  synergistically  to 
completely  abolish  its  activation.  In  contrast,  with  respect  to  the  damage-induced 
Ca2+ wave no synergistic action was observed. Taken together, these aspects suggest 
that  CBX-sensitive  ERK1/2  spread  occurs  independently  of  Ca2+.  CBX  is  a 
promiscuous  drug  that  in  addition  to  gap  junctions  also  inhibits  connexin 
hemichannels, P2X7 receptors and voltage-gated Ca2+ channels (Vessey et al., 2004; 
Suadicani  et  al.,  2006).  All  of these  are  effectively  ion  channels  that  allow  Ca2+ 
influx. If CBX was active at these sites during damage a significant decrease in Ca2+ 
signals would be predicted.  The latter was not observed and therefore an action of 
CBX at these channels can be ruled out. This leaves CBX activity at gap junctions as 
the most likely site for the Ca2+-independent ERK activation signal.
In  addition  to  the  CBX-sensitive  pathway  the  reduction  of ERK 1/2  spread  in  the 
presence of apyrase suggests that damage triggers the release of ATP that mediates 
the activation and spread of ERK 1/2. Exogenous application of ATP and UTP
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Fig 6.2 Model of the mechanism that results in damage-induced ERK1/2 activation
Two  pathways  mediate  damage-induced  ERK1/2  activation  -   one  that  requires 
extracellular  Ca2+  (red)  and  the  other  occurring  independently  of  Ca2+.  Question  marks 
indicate yet unknown intermediate steps.
mimicked  the  damage-induced  ERK 1/2  activation  pattern.  First  the  focus  will  be 
turned to UTP -  an agonist at P2Y2,  P2Y4,  P2Yn,  P2X3   and  its  heteromer P2X2/3  
receptors (Nicholas et al.,  1996; van der Weyden et al., 2000; Liu et al., 2001; White 
et al., 2003; Wildman et al., 2003). The absence of Ifast in response to UTP indicates 
that functional P2X3  receptors are not present at apical aspects of Deiters’  cells and 
therefore UTP-induced ERK1/2 activation is likely to be mediated by P2Y2, P2 Y4 or 
P2Yn.  The  lack  of effect  of  suramin  implicates  a  model  in  which  ERK 1/2  are 
activated in a P2Y4 dependent manner.
The  comparison  of intensity  levels  of activated  ERK 1/2  induced  by  ATP  to  that 
induced by UTP suggest that ATP might activate an additional P2 receptor resulting 
in  increased ERK 1/2  activation  compared to  UTP.  As  ADP  did not  elicit ERK 1/2 
activation other ATP-sensitive, but UTP-insensitive P2Y receptors can be excluded.
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This indicates that a second mechanism resulting in ERK1/2 activation is mediated by 
P2X receptors  except for UTP-sensitive P2X3  receptors. However,  as discussed for 
the formation of the faster Ca2+ wave the lack of sensitivity to PPADS and suramin 
together with the absence of Ifast during Idam age suggests that it is unlikely that P2X 
receptors are involved in damage-induced ERK 1/2 activation.  This again raises the 
question to the nature of the Ca2+ influx pathway.
P2 receptor agonist and antagonist studies implicate a model in which ERK 1/2  are 
activated in  a P2Y4  dependent manner.  In  contrast the  expression profile  of P2Y2 
receptors in Deiters’ cells but not in HCs rather favours a role of P2Y2 over P2Y4 or 
P2Yn  receptors  that  labelled both  Deiters’  and  HCs.  As  discussed  in  chapter  4.3 
functional  and  pharmacological  profiles  are  rendered  by  co-expression  of  P2 
receptors. Thus P2 Y2 and P2Yn  receptors cannot be confidently excluded from the 
model.
ERK 1/2 spread is proposed to be mediated via two mechanisms - one that requires the 
release of extracellular ATP and the subsequent influx of extracellular Ca2+ and the 
other occurring independently of Ca2+ but in a gap junction dependent manner. P2Y 
receptor activation is also suggested to activate ERK 1/2. However, it is not possible 
to  conclude  from  the  data  presented  here,  through  which  of  the  two  described 
pathways  P2Y  receptors  mediate  ERK 1/2  activation.  It  is  also  possible  that  P2Y 
receptor activation is a third mechanism in addition to the two discussed pathways. 
Similarly, if it is assumed that apyrase cannot eliminate an excess of released ATP the 
activation  of P2  receptors  could potentially  also  be  upstream  of the  gap junction 
mediated ERK 1/2 spread. Thus, P2Y receptors could be the initiators of a signal that 
passes  through  gap  junctions  to  mediate  ERK 1/2  activation  and  spread.  The 
suggestion is that this would be a Ca2+ independent process, which finds support in 
the lack effect of BAPTA-AM in reducing the spread of ERK1/2.
Inhibition  of cRAF  almost  completely  abolished  and  that  of MEK1/2  prevented 
ERK1/2 activation (shown in section 4.3). These data indicate that all of the ERK1/2 
activation pathways described resulted from the hierarchical activation of cRAF and 
MEK1/2.
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When the  aminoglycoside neomycin was used to  specifically target HCs,  ERK 1/2 
activation was also observed in Deiters’ and phalangeal cells. In the majority of cases 
those Deiters’  and phalangeal cells that activated ERK 1/2  surrounded pyknotic HC 
nuclei. Combining ERK 1/2 activation data from different models suggests that in the 
immature rat cochlea, the activation of ERK 1/2 in support cells surrounding damaged 
HCs is a common damage signalling mechanism. Further to this: recent work in the 
laboratory has shown that in chick utricles a similar support cell specific activation 
pattern  was  observed  (Bird,  2007).  Given  a  similar  cell  type  specific  activation 
pattern  of ERK 1/2  activation  during  aminoglycoside-induced  HC  toxicity  to  that 
following mechanical  damage  it is very likely that the underlying mechanisms  are 
also similar if not the same (see model in Fig 6.2).
ATP and P2 receptors -  key signalling elements during HC damage 
The  data presented  here  advance  the  understanding  of damage-induced  signalling 
mechanisms in the mammalian cochlea. In particular, two further events activated by 
damage have been attributed to the release  and action  of extracellular ATP  which 
consolidates evidence by various groups that ATP is a key signalling molecule during 
HC damage (Munoz et al.,  1995; Munoz et al., 2001; Gale et al., 2004; Zhao et al., 
2005).  Moreover,  different processes  activated by  ATP  during  damage  have  been 
demonstrated  herein  to  be  interlinked  -   the  damage-induced  fast  Ca2+  wave  and 
ERK 1/2 activation and also most likely the damage-induced current and the slower 
Ca2+ wave. Linkage of the latter processes is based on combining data presented here 
with those of Lagostena et al. (2001) suggesting that the damage-induced current is a 
Cl'current activated by IP3 mediated release of Ca2+ from intracellular stores.  This 
links the damage-induced slow Ca2+ wave and the damage-induced current.
This  study not only extended data on P2 receptor expression profiles especially for 
P2Y2, 4, 11  and P2X4 receptors but also narrowed the number of potential candidates 
that mediate damage-induced ERK 1/2 activation and Ca2+ wave formation.  However, 
questions unable to be answered by this research were the nature of the mechanism 
that  facilitates  the  fast  Ca2+  wave  by  extracellular  Ca2+  and  how  the  subsequent
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activation of ERK 1/2 occurs. The conundrum to the mechanisms underlying will have 
to be tackled in the future.
The role of connexins/gap junctions in damage-induced signalling 
In this thesis gap junctions were demonstrated to contribute to the damage-induced 
ERK 1/2  activation  (see  damage  model  for  ERK 1/2  activation).  The  nature  of the 
signal  that passes  through  gap junctions  to  mediate  ERK 1/2  activation  is  not  yet 
known,  although  likely  candidates  are  IP3,  cAMP  or  cGMP  (Bevans  et  al.,  1998; 
Ayad et al., 2006; Bedner et al., 2006). Gap junctions also allowed the coupling of ion 
fluxes  between  cells  in  the  support  cell  syncytium.  Taken  together  these  data 
strengthen  a  role  for  gap  junctions  to  signal  an  impaired  cochlear  integrity  to 
neighbouring cells.
Connexin  hemichannels  have  been  suggested  to  release  ATP  (Stout  et  al.,  2002; 
Pearson  et  al.,  2005;  Zhao  et  al.,  2005).  In  contrast  to  their  effects  on  ERK1/2 
activation,  CBX  and  apyrase  did  not  act  synergistically  to  reduce  the  Ca2+  wave 
propagation in the HC  region.  However,  CBX  alone was  effective  to  decrease  the 
Ca2+  wave  formation  suggesting  that  both  apyrase  and  CBX  act  on  the  same 
underlying mechanism which is the action of ATP. Thus CBX might exert its effect 
on  connexin  hemichannels.  However,  voltage-gated  Ca2+  channels  cannot  be 
excluded.
Cell specific damage responses
A critical observation is the cell type specificity of the Ca2+ wave. Two distinct Ca2+ 
waves were observed along the HC region. An explanation for the observation is that 
they originate from different cell types in the HC region i.e. HCs and Deiters’ cells. 
Another cell type  specific pattern was  seen with the damage-induced activation of 
ERK1/2  in Deiters’  and phalangeal  cells.  The majority of recent studies  aiming at 
understanding  signalling  pathways  involved  in  HC  death  revealed  activation  or 
specific  expression  in  HCs  (Pirvola  et  al.,  2000;  Matsui  et  al.,  2004)  or  used 
techniques,  such  as  Western  blotting,  that  do  not  distinguish  cell  type  specific 
responses. Here, it was shown that clusters of support cells surrounding pyknotic HC
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nuclei but not HCs themselves  activate ERK 1/2,  implicating a specific  function  in 
these cells during damage.
MEK1/2 dependent HC death mediated bv support cells
In an attempt to understand the role that ERK 1/2 activation might play MEK1/2 were 
inhibited during aminoglycoside-induced HC toxicity. MEK1/2 inhibition resulted in 
the reduction of HC death. The implication of these data is that activation of ERK 1/2 
in support cells can promote HC death, implying that support cells play an active role 
in HC death (see model 6.3).
In  chapter 4.3  two potential mechanisms were put forward.  Firstly,  ERK1/2 might 
cause the release of a molecule that stimulates HC death and secondly, ERK 1/2 might 
activate a wound repair program that triggers support cells to engulf HCs. There is 
some evidence in the literature that suggests that this can occur (Forge and Li, 2000; 
Gale et al., 2002; Abrashkin et al., 2006) and recent data from this lab has confirmed 
this  in  chick  utricular  epithelium  (Bird,  2007).  At  least  two  modes  of ERK1/2 
activation were described in chapter 4. It is possible that more than one mechanism is 
engaged in order to assure the execution of damaged HCs in case of failure of one of 
these pathways.
However, MEK1/2 inhibition only protected HCs temporarily. In agreement with data 
by Battaglia et al. (2003) inhibition of MEK1/2 over extended periods was observed 
to mediate HC death without any toxic insult. It is likely that ERK1/2 act as survival 
signals in HCs  in this  case.  Thus the protective  effect resulting  from inhibition of 
support cell actions could have been counteracted by a missing pro-survival signal in 
HCs. A cell specific knock down approach would be required to determine whether 
this signalling pathway is a major pathway for promoting HC death.  This knowledge 
would  indicate  whether  this  cascade  is  of potential  therapeutic  value.  A  greater 
understanding of the signals  activated both upstream and downstream could reveal 
potential therapeutic strategies for the future.
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Fig 6.3 Model of HC-support cell interaction in response to damage
(A)  Damage  to  HCs  triggers  them  to  (B)  signal  their  impaired  integrity  (cross  on  top  of  nuclei)  to  their  neighbouring  support  cells,  likely 
through release of ATP.
(C)  Support cells  respond  with  activation  of ERK1/2 that then  (D) triggers the  support  cells to  exert an  effect on  HCs  (release  of a  death 
inducing molecule or migration).
(E) Subsequently HCs die.
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